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Abstract
Exploring the methylome and transcriptome of young
adult and aged OPCs
Roey Baror
Remyelination is the restoration of myelin sheaths to denuded axons following de-
myelinating events, which occurs spontaneously in adult mammals, including humans.
The principal cells which participate in remyelination are the Oligodendrocyte Progen-
itor Cells (OPCs). Similar to other regenerative processes, remyelination efficiency
declines with ageing. It is still unknown how much of this decline can be attributed to
intrinsic changes in the OPCs themselves rather than environmental changes arising
from changes in the cellular niche. Thus, we currently have a fundamental gap in our
knowledge regarding the basic biology of adult OPCs, and therefore the changes that
occur to them with ageing.
In order to address these questions, I have developed a method to reliably isolate
all cell types of the oligodendrocyte (OL) lineage from adult rats. This allowed me
to identify the specific transcriptome state unique to adult OPCs, which is different
to the transcriptome of neonatal OPCs, upon which previous studies have focused.
This included genes which support the notion that following the initial phases of
developmental myelination, adult OPCs enter a quiescent mode, in a manner similar
to other tissue resident stem cells.
Moreover, using a recently established isolation method, I was able to isolate aged
OPCs, and develop a transcriptional database that can allow researchers to explore the
changes in aged OPCs and identify new targets for enhancing their function.
Lastly, I present in this thesis novel ideas regarding the influence of microglia cell
surface molecules on OPC differentiation. I show that changes in the cell surface of
aged microglia are inhibitory for OPC differentiation into OLs, and that these changes
in microglia are a result of the increase in TGFb levels with ageing.
In summary, this dissertation introduces new tools and methods that will allow
xfurther in-depth study of adult OPCs, and specifically will help to shed light on the
role of adult OPCs in the CNS in homeostasis. Furthermore, I explore the changes that
occur within OPCs as they age, and show how such changes reduce aged OPCs ability
to efficiently facilitate the process of remyelination.
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Ageing is the time dependent functional decline shared by all organisms (López-
Otín, Blasco, Partridge, Serrano, & Kroemer, 2013). Among the various phenomena
associated with the process of ageing, perhaps the most distinctive one is the decline of
the body’s endogenous regeneration capabilities. Understanding the factors that govern
the ageing process and the search for the secrets of longevity have been sought after
by people since ancient times. Today, due to rapid increase in human life expectancy
the world’s population becomes older (especially in developed countries)(Abajobir
et al., 2017), understanding the factors that affect ageing and its associated diseases
have become an evermore relevant goal. From an evolutionary point of view, ageing
can benefit the population of a specie as a whole, as aged members of the population
are replaced by a younger and healthier generation (Kirkwood & Austad, 2000). This
theory suggests that ageing is a planned evolutionary mechanism which has evolved
through time. Interestingly though, most animals in the wild do not live long enough
to grow old. Therefore, it seems that natural selection can only have limited effect on
the process of ageing, as natural mortality is usually caused by external factors and
occurs mainly in young individuals (Kirkwood & Austad, 2000). In addition to the
role of evolution and natural selection in shaping the ageing process, in recent years
it has been proposed that the cellular mechanisms that underlie ageing result mainly
due to stochastic events, and that cellular damage begins to accumulate from the
moment somatic cells and tissues first begin to form (Kirkwood, 2005). As expected,
the molecular and cellular processes that underlie ageing are highly complex. The
‘hallmarks of ageing’ as defined by Lopez-Otin and colleagues (López-Otín et al.,
2013) include increasing genomic instability, telomere attrition, altered intercellular
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communication, loss of proteostasis, deregulated nutrient sensing, mitochondrial
dysfunction, stem cell exhaustion, cellular senescence and epigenetic alterations. It is
important to note that most likely there is no one clear factor that controls ageing, but
rather a combination of the factors mentioned above.
In this thesis I will focus on the epigenetic mechanisms and their contribution to the
ageing phenotype, especially in the ageing central nervous system (CNS).
1.2 Epigenetics
The term ‘epigenotype’ was coined by Waddington in 1942 in order to describe the
complex process that lies between the genotype and the phenotype and connects
the two (as cited in(Waddington, 2012)). Today the term epigenetics relates to the
non-genetic (not encoded in the DNA sequence) mechanisms which control gene
expression. Epigenetic mechanisms are studied intensively in various fields of bi-
ology, including cancer, various diseases and ageing. Several mechanisms control
the epigenome, and the main ones being are the DNA methylation (A. Bird, 2002),
histone modifications (for example, acetylation, methylation, phosphorylation and
other modifications (Bannister & Kouzarides, 2011)), chromatin remodelling, and
non-codingRNA (ncRNA),including microRNA molecules (Sato, Tsuchiya, Meltzer,
& Shimizu, 2011). For many years, epigenetic mechanisms have been studied mainly
in connection to cancer, as many types cancers exhibit aberrant epigenetic mechanisms
that seem to be related to the onset and maintenance of the cancer (Esteller, 2008). This
extensive research led to a number of clinical trials which involve epigenetic altering
drugs (Nebbioso, Carafa, Benedetti, & Altucci, 2012). Today, more and more studies
connect epigenetic alterations to other pathological conditions, including ageing. Ac-
cording to the ‘epigenetic drift theory’ (Issa, 2014; Martin, 2009), ageing involves the
gradual accumulation of epigenetic errors (Huidobro, Fernandez, & Fraga, 2013), as a
result of environmental influences (Fraga et al., 2005) and stochastic events (Fraga,
Agrelo, & Esteller, 2007; Martin, 2009). This process is schematically illustrated in
figure 1.1, which is adapted from Issa et al., (Issa, 2014). As the different epigenetic
mechanisms control and affect each other (Fuks, Burgers, Brehm, Hughes-Davies,
& Kouzarides, 2000; Fuks, 2005), epigenetic alterations (and DNA methylation in
particular) are accumulated in self enhancing cycle with ageing, which ultimately
results in chronic changes in the cell transcriptome. In this cycle, DNA methylation
stochastic drift (mainly during stem cells proliferation) results in gene expression
mosaicism. This leaves the tissue resident stem cell pool depleted. Thus, in the case
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of injury which requires the activation of resident stem cells (including proliferation
and differentiation), the stem cell response will be inefficient and this can lead to poor
regeneration as is usually the result in older age. Other cell populations can harbour
epigenetic mutations that can lead to uncontrolled proliferation which will result in
cancer. The ageing phenotype promotes further epigenetic alteration by chronic in-
flammation and uncontrolled proliferation. This way, a vicious self enhancing cycle is
created.
Fig. 1.1 Epigenetic drift in adult stem cells Illustration of the epigenetic drift cycle.
In young age, the tissue resident stem cell population is relatively homogeneous
(green coloured cells). Cells can be activated due to normal tissue turnover or as a
response to injury. As the organism ages, multiple external forces act on the stem cell
population and produce heterogeneity in the population. Thus, the aged stem cell pool
is comprised of limited number of ’adequate’ stem cells (green cells) which are able to
proliferate and differentiate when needed. Other stem cells can become cancerous or
enter senescence, thus proving unavailable to to activation.
(adapted from (Issa, 2014))
1.2.1 DNA methylation
DNA methylation is one of the most extensively studied epigenetic markers, and
is common to many organisms. In mammalian cells, DNA methylation is mainly
performed on a cytosine nucleotide which is located next to a Guanine nucleotide,
a sequence usually known as CpG dinucleotide. The addition of methyl group is
performed by the DNA Methyltransferase (DNMT) enzymes (Grippo, Iaccarino,
Parisi, & Scarano, 1968).
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In the vertebrae genome most CpG sites are methylated. In contrast, CpG islands
(CGIs), which are regions in the DNA that are enriched in GC content (and usually
located around gene promotors - in the human genome, approximately half of the
promoters have CpG islands at their 5’ end (Deaton & Bird, 2011) ), are usually not
methylated (Cross & Bird, 1995).
There are two main types of DNMT enzymes: de novo DNMTs, which include
DNMT3a and DNMT3b which are responsible of creating new 5mC markings on
un-methylated DNA strand (Fig1.2A). The second type is the maintenance DNMT,
DNMT1. DNMT1 is usually localised around the replication fork during DNA repli-
cation. This enzyme is responsible for the heredity properties of DNA methylation,
as it methylates the newly formed semi-methylated DNA strand according to the
pre-existing pattern (A. Bird, 2002). Thus, after each cell proliferation, the daughter
cells will maintain a similar methylome to the parent cell (Fig1.2B).
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Fig. 1.2 De novo and maintenance DNA methylation in mammals Schematic il-
lustration of the DNA methylation mechanisms in mammalian cells. (A) Unmethy-
lated CpGs (marked by white circles) are de novo methylated (magenta circles) by
DNMT3A/B. Both strands of the DNA are methylated in a similar pattern. (B) Follow-
ing DNA replication (during cell division) the newly made DNA strand is unmethylated,
and is then methylated by DNMT1 according to the pattern of the original DNA strand.
(adapted from (T. Chen et al., 2003))
DNA methylation is usually associated with gene suppression and this can be
done by directly affecting the affinity of transcriptional proteins to the DNA strand
(Fig1.3A) or by recruiting repressive complexes (such as, MeCP2 or MBD1). These
proteins can then either directly prevent the binding of the transcriptional machinery
(Fig1.3C), or recruit histone modifications enzymes that will make the chromatin less
accessible to transcription (Fig1.3D) (Nan et al., 1998; Wolffe et al., 2000).
Alternatively, there are some examples of DNA methylation which enhance gene
expression. For example, in neural stem cells differentiation, DNAmethylation inhibits
the inhibitory PcG histone methylation (H3K27Me3) and is vital for the expression
of genes which promote neurogenesis (Wu et al., 2010). Another example is the
changing binding affinity of CTCF to enhancer regions related to the Igf2 gene. CTCF
is a transcriptional repressor, which has CpG rich binding sites. Methylation of these
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binding sites reduces the binding ability of CTCF, and therefore enhances the activation
of nearby genes (A. Bird, 2002).
Moreover, some reports claim that genes can be activated while being methylated,
as using histone modification inhibitor can activate genes despite their methylation
status (Raynal et al., 2012). This suggests a role of epigenetic memory for DNA
methylation, and not necessarily active gene silencing.
DNA methylation is considered to play a crucial role in embryonic development,
specifically in the control of cell differentiation (Cortese et al., 2011; Oda et al., 2013).
Fig. 1.3 Transcription inhibition by DNA methylation Schematic illustration of the
mechanisms in which DNA methylation in promoters can inhibit gene transcription.
(A) Active gene, with low rate of CpG methylation in the promoter region. Following
methylation, the gene can be silenced through three main mechanisms:
(B) DNA methylation of CpGs can directly inhibit the binding of specific transcription
factors to promoter and enhancer regions. (C) DNA methylated regions can be occu-
pied by proteins with Methylation Binding Domains (MBD), thus blocking the binding
of transcription factors and/or the transcription machinery itself. (D)Methylation of
CpGs can recruit HDACs and other histone modifiers which will compact the DNA
and make it unaccessible to the transcription machinery.
Adapted according to the following - (Cedar & Bergman, 2009; Fuks, 2005; Nan et al.,
1998; Wolffe et al., 2000).
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DNA methylation control
The dynamic turnover of DNA methylation and de-methylation is controlled by methy-
lation and recently discovered de-methylation enzymes. In 2009 it has been discovered
that enzymes from the TET (Ten-eleven translocation methylcytosine dioxygenase)
family (specifically, TET1) can promote active DNA de-methylation by transforming
5mC into 5-hmC (5-Hydroxymethylcytosine). 5-hmC can then be further transformed
and ultimately removed by the DNA base excision repair machinery (BER) (Branco,
Ficz, & Reik, 2012; Tahiliani et al., 2009). The discoveries of the further modifications
of cytosine to 5-hmC might present another layer of genome modifications which is
yet to be studied thoroughly.
DNA methylation can be affected by metabolic and mitochondrial processes. For
example, Krebs cycle intermediates (such as, succinate and fumarate) are inhibitors
of large family of 2-oxoglutarate-dependent dioxygenases (2-OGDO). This family
of enzymes includes the TET1 demethylation enzymes (see above). Moreover, TET
enzymes demethylation activity is dependent on a-ketoglutarate (another Krebs cycle
intermediate) (Salminen, Kaarniranta, Hiltunen, & Kauppinen, 2014).
Other control mechanisms that affect DNA methylation include the involvement of
miRNA and other ncRNA in control and guidance of DNA methylation. For example,
Di Ruscio and colleagues have discovered that a (l)ncRNA (long non coding RNA)
arising from a specific gene can directly regulate the methylation of the same gene by
connecting to DNMT1 and inhibiting its activity (Di Ruscio et al., 2013).
DNA methylation and ageing
Epigenetic mechanisms in general and DNA methylation in particular have long
been suspected to play a role in ageing, as a complex that can connect between
the environmental effects and the genotype in order to express a specific phenotype
(Calvanese, Lara, Kahn, & Fraga, 2009). Early studies described a global DNA
hypomethylation as organisms age, but more recent studies have shown local DNA
hypermethylation in specific genes (and especially CpG island methylation), some
associated with tumour suppression (Maegawa et al., 2010).
According to some researchers this accumulations of errors in the DNA methylation
patterns globally, will eventually lead to cellular malfunction, whether it is by ‘over-
silencing’ crucial genes, or by not silencing specific genes when needed. Although
the specific mechanisms relating DNA methylation and ageing are not clear yet, the
accumulations of errors in the methylome of the cell will inevitably result in aberrant
transcriptional control. This is especially important for quiescent stem cells, ‘waiting’
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in tissue niches for activation cues. Changes in these cells methylome, can render
them less responsive to external cues and will delay their timely activation, leading to
delayed regenerative capacity as the tissue remains damaged (see Fig1.1).
1.2.2 Histone modifications
A key epigenetic process involves histone tail modifications. Some modifications result
in transcriptional inhibition, whereas others enhance gene transcription. The following
section will survey the biology and key enzymes behind the main modifications which
have been shown relevant to oligodendrocyte biology.
• Histone acetylation - Histone tails acetylation is carried out by histone acetyl-
transferases (HATs), whereas the removal of the acetyl groups is carried out by
histone deacetylases (HDAC). By adding acetyl groups to lysine residues of his-
tones (both tails and body), HATs neutralise positive charges, thus destabilising
the structure of the histone, making it more accessible for transcription.
HDACs act to remove acetyl groups, thus restoring lysine positive charges and
thereby restoring the chromatin compact structure. This usually results in inhib-
ited gene transcription. HDACs are divided to multiple classes, including class
III HDACs named Sirtuins (NAD dependent HDACs). This group of enzymes
are involved in ageing and longevity in multiple organisms (Pollina & Brunet,
2011).
• Histone methylation - Histone methylation is usually performed on side chains
of lysines and arginines. Histone methylation alters the charge of the histone
protein. Moreover, histone methylation can occur in multiple forms: mono-, di-
or tri-methylated. The result of the methylation (suppression or enhancement of
gene transcription) depends on the site of methylation, as well as on the number
of methyl groups added. Histone methylation can also affect alternative splicing,
and recently has been shown to play a role in memory formation in neurons
(Ding et al., 2017).
• DNA methylation and histone modification cross talk - The cross talk be-
tween DNA methylation and various histone marks has been shown multiple
times. It is unclear which occurs first. Does DNA methylation induces further
repressive histone marks in order to ‘lock’ silenced gene transcription or whether
it is the opposite? (Fuks, 2005).
In regards to HDAC activity, in some cases histone deacetylation directs DNA
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methylation (Cervoni & Szyf, 2001), in which DNA methylation changes state.
The state of methylation or de-methylation is controlled by the histone marks
around that genomic area. The direct link between DNA methylation and histone
modifications can be mediated through methylcytosine-binding protein, such as
MECP2 or MBD1/2, all of which have been shown to be able to recruit histone
modification enzymes (Cedar & Bergman, 2009).
The epigenetic mechanisms described so far are relevant in multiple regenerative
processes in various tissues in the body. In the following sections I will describe the
process of remyelination, the regeneration of myelin sheaths in the central nervous
system, and the potential effects of epigenetic alterations on this process, with an
emphasis on ageing.
1.3 Remyelination
Regeneration processes are an essential during the lifetime of any organism. In
mammals, regenerative processes take place in most tissues to some extent, and
are usually dependent on the function of specialised tissue resident stem cells. The
regenerative capacity changes within the animal kingdom ranges from the remarkable
fully regenerative planarian flatworms (Montgomery & Coward, 1974), through full
limb recovery achieved by the salamanders (Sanchez Alvarado & Tsonis, 2006) up
to the comparatively limited mammalian regeneration abilities (Sanchez Alvarado &
Tsonis, 2006; Tanaka, 2003). Even though regenerative processes are limited within the
mammalian realm, there are some tissues that can undergo extensive repair following
lesion, such as skin and muscle (Muneoka, Allan, Yang, Lee, & Han, 2008). Moreover,
even in the Central Nervous System (CNS), which for years has been considered as
a non regenerative system, there are examples for regeneration processes that can
proceed throughout life. One of these processes, is the process of remyelination, in
which demyelinated axons are wrapped again by newly formed myelin sheaths. Neural
axons in the vertebrae central nervous system (CNS) and Peripheral Nervous System
(PNS) include myelinated and non myelinated axons. Myelin is made by specific cells,
Oligodendrocytes (OL) in the CNS and Schwann cells in the PNS. It consists mainly
of lipids (75%) together with various proteins, which play a critical role in myelin
compaction, as well as in transport of metabolic support to the axons (Morrison, Lee, &
Rothstein, 2013; Nave, 2010). Myelination allows the increase of signal transduction
velocity in the CNS, while maintaining relatively small axon diameter (Zalc, Goujet,
& Colman, 2008). This is achieved by partial myelination of stretches of axons named
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‘internodes’, as they stretch between ‘nodes of Ranvier’. The nodes of Ranvier are
areas on the surface of the axons which are characterised by high expression of various
ion channels. These areas allow the propagation of the neuronal action potential along
the axon, in what is known as saltatory conduction. In this way the axon potential
can be propagated 5-50 times faster than in a comparable unmyelinated axon, while
maintaining relatively small diameter. The increase in signal transduction has enabled
the dramatic advancement in the capabilities of the members of the vertebrae kingdom,
allowing more complex and efficient neuronal networks.
The role of myelinating glial cells is not restricted only to insulating roles and
signal transduction, but they also extend trophic support to the axons. Evidence for this
role is shown by studying mice which are deficient in various myelin proteins, such as
Plp-/- (Griffiths et al., 1998) or Cnp1-/- (Lappe-Siefke et al., 2003). These mice show
what seems to be complete and intact structure of myelin sheaths, but at the same time
show axonal degeneration. Thus, even though the myelin sheaths in these mice serve
their structural role as insulators for axons, they cannot give the support needed for
axonal maintenance. This phenomena is also expressed in humans who have mutations
in the Plp1 gene, and therefore suffer from the leukodystrophy Peliazeus Merzbacher
disease (PMD), which exhibits a similar pathology (Garbern et al., 2002).
Hence, due to the major role myelin serves in both supporting axons, as well as
enabling fast signal transduction, demyelination, the pathological process of myelin
loss due to OL damage and/or death, in which axons remain nude, can lead to axonal
and neuronal degeneration (Y. Lee et al., 2012). In humans, demyelination can result
from either genetic mutations in glial cells (for example, leukodystrophies) or from
inflammatory damage to myelin and OL cells as in Multiple Sclerosis (MS) (Franklin
& Ffrench-Constant, 2008). The leukodystrophies are a group of diseases that arise
due to impairment in myelin development and maintenance arising from genetic
mutations in various myelin proteins. This includes several diseases, such as X-
linked adrenoleukodystrophy (Abcd1 mutation), Pelizaeus-Merzbacher disease (Plp1
mutation) and Alexander’s disease (mutations in Gfap), among others. A common
outcome to all of these is axonal damage, caused due to myelin deformation (Mar &
Noetzel, 2010).
Inflammation based myelin damage does not usually result from genetic mutations
in myelin genes but is usually caused by autoimmunity, of which the most common one
is Multiple Sclerosis (MS) (Compston & Coles, 2008) . In this autoimmune disease,
OL specific proteins are targeted by the immune system, which leads to immune attacks
on the myelin sheaths. This results in myelin loss, and if the myelin is not restored this
leads to axonal damage. Remyelination, on the other hand, is the regenerative process
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in which myelin sheaths are restored to the axons following a lesion (W. Blakemore,
1974). The main cell type which plays a role in remyelination are the Oligodendrocyte
Progenitor Cells (OPC)(Ffrench-Constant & Raff, 1986; Raff, Miller, & Noble, 1983;
Zawadzka et al., 2010). These progenitor cells reside in the developing and adult CNS
are estimated to constitute 5% - 8% of the cells in the adult brain (Levine, Reynolds, &
Fawcett, 2001). While OPCs are the key mediators of remyelination, the major events
of this process are orchestrated by a variety of molecules and cells, including CNS
resident cells such as microglia (Miron et al., 2013), astrocytes (Talbott et al., 2005), as
well as non CNS cells such as circulating monocytes (Kotter, Setzu, Sim, Van Rooijen,
& Franklin, 2001) and T cells (Bieber, Kerr, & Rodriguez, 2003; Dombrowski et al.,
2017). The different activated cells are all aimed at recruiting OPCs to the lesion, while
creating a pro regenerative environment which will enable the OPCs to proliferate
and ultimately differentiate into mature myelinating OL in order to remyelinate the
axons. The process of remyelination can be divided into multiple phases (see Fig1.4),
according the function of the OPCs and the supporting cells. These steps include
the activation, recruitment and finally differentiation of OPCs. For the successful
completion of each step, an exact combination of cells and molecules are needed.
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Fig. 1.4 Remyelination An illustration of the remyelination process. During home-
ostasis, axons in the CNS (labeled in green) are myelinated by OLs (labelled in yellow).
OPCs (labelled in red) are present throughout the CNS in a non active bi-polar form.
Following demyelination, myelin and/or OLs are damaged. This activates a response
by microglia (and later on invading macrophages, labelled in blue) which arrive at
the lesion area and phagocyte myelin debris. In young mammals this is followed by
the activation and recruitment of OPCs to the lesion site where they differentiate into
newly formed OLs which then remyelinate the nude axons (marked in orange). In
aged mammals, this process fails mainly due the limited differentiation capacity of
aged OPCs, thus leading to axonal damage and ultimately neuronal death.
1.3.1 Studying remyelination
Since myelination plays a pivotal role in the normal neuronal activity it is important to
study how to enhance the regeneration of myelin (remyelination) after demyelinating
lesion, such as in Multiple Sclerosis. For that purpose, multiple animal models have
been developed, with the main ones being either toxin based models, or immune
mediated models.
• Toxin induced demyelination models - These models are based on the injec-
tion (or feeding) of specific toxins that mainly target OLs, and thus result in
rapid demyelination that does rely on immune system response. In models in
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which toxin is injected, it is common to use either Ethidium bromide (EB) or
Lysolecithin (Woodruff & Franklin, 1999) injected either to the spinal cord or the
cerebral peduncle. The injections are aimed at white matter areas and therefore
the toxins kill mainly OL, and this results in a local area of demyelination. Fol-
lowing the injection, a healing process begins following a well defined timetable
(according to the species used and its age). This model main advantage are the
local and specific lesion and known time scale for regeneration. However, these
are not intended to mimic MS as they do not include an immune component .
Another toxin based model of demyelination, is the cuprizone model. In this
model, animals are fed cuprizone (a copper chelating substance) in their regular
diet. This leads to OLs death, which is observed usually in the corpus callo-
sum. Once cuprizone is withdrawn from the diet of the animals, remyelination
processes begin (Gudi, Gingele, Skripuletz, & Stangel, 2014).
• Autoimmune based demyelination models - As the main demyelinating dis-
ease in humans is MS, which is caused to autoimmune attack aimed at OLs
(Compston & Coles, 2008), models have been developed to mimic the immune
component of the diseases, in addition to demyelinating one which is isolated
in the toxin based models. The main model in this category is the EAE model
(Experimental autoimmune encephalomyelitis). This model is based on injection
of myelin antigens (together with adjuvant) and eliciting immune response in
mice, thus activating the immune system against OLs. Unfortunately, the disease
course in animal models does not follow the exact same course as in humans,
thus making it difficult to use thus model for drug development. (Ransohoff,
2012). Moreover, due to the complexity of the initial immune response, it is
difficult to isolate the actual process of remyelination and the causes for its
failures.
As toxin based models give the advantage of isolating the demyelination process
itself without relying on immune response, it is a more common model used when
trying to elucidate the changes in remyelination efficiency and the responses of OPCs
to demyelinating lesions.
1.4 Oligodendrocyte Progenitor Cells (OPCs)
Ever though the process of remyelination was described several decades ago, (W. Blake-
more, 1974), it has been debated what is the origin of the remyelinating cells. Some
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researchers have suggested that surviving OL contribute to remyelination, but it is
has been shown that the majority (if not all) of remyelination that occurs follow-
ing demyelination lesions is due to the activity of Oligodendrocyte Progenitor Cells
(OPCs) (W. F. Blakemore & Keirstead, 1999; Gensert & Goldman, 1997; Levine &
Reynolds, 1999). More recently, usingMbp and Opalin reporter lines (marking only
mature oligodendrocytes) Crawford and colleagues have shown that mature OLs do
not contribute to remyelination in toxin induced models (A. H. Crawford, Tripathi,
Foerster, et al., 2016).
Earliest descriptions of OPCs were done already in the 1980’s (Ffrench-Constant
& Raff, 1986; Raff et al., 1983), where they were termed bi-potential oligodendrocyte-
type-2 astrocyte (0-2A) progenitor cells, in order to emphasis their dual differentiation
potential, as they can differentiate to astrocytes as well as oligodendrocytes. In later
years, it has been shown that adult OPCs can differentiate into multiple cell types,
including Schwann cells (Zawadzka et al., 2010) and neurons (Belachew et al., 2003),
as well as being able to proliferate (Dawson, Polito, Levine, & Reynolds, 2003) (see
Fig1.5 for illustrative summary).
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Fig. 1.5Multipotency of adult OPCs Illustration summarising the various cell fates
exhibited by OPCs. Adult OPCs have been shown to be able to give rise to mutliple cell
types in the CNS (marked in different colours), including oligodendrocytes (orange),
astrocytes (blue), Schwann Cells (magenta) and neurons (green), as well as being able
to self regenerate (red). Illustration was adapted from Crawford et al., (A. Crawford et
al., 2014).
OPCs arise in embryonic stages in multiple generation waves, both in the spinal
cord and the forebrain (A. H. Crawford, Tripathi, Richardson, & Franklin, 2016).
The first wave of OPCs in the spinal cord arises at embryonic day 12.5 (E12.5) from
the ventral ventricular zone and this process is controlled by the expression of Sonic
Hedgehog (Shh). Shh has been shown to be both necessary and sufficient for the ex-
pression of the bHLH (Basic Helix Loop Helix) transcription factor OLIG2, a central
transcription factor in OPC maintenance and differentiation (Lu et al., 2000). The
second wave of OPCs arise on E15.5 from the dorsal VZ, and is Shh independent (Cai
et al., 2005), and these will eventually make up approximately 20% of the total OPC
population.
In the developing forebrain, the first wave of OPCs arises at day E12.5 in the medial
ganglionic eminence (MGE) and anterior entopeduncular area in the ventral telen-
cephalon (forerunner of the forebrain). These cells will be largely eliminated by
16 Introduction
the time of birth. The second wave of OPCs (at day E15.5) arises from lateral and
caudal ganglionic eminences (LGE and CGE), and the final wave arises at the time of
birth at the cortical VZ (A. H. Crawford, Tripathi, Richardson, & Franklin, 2016). In
recent study it has been shown that OPCs which arise from different developmental
origins differ in their roles and remyelinating capabilities in adulthood and old age
(A. H. Crawford, Tripathi, Richardson, & Franklin, 2016). Further studies into the
differences between OPCs of differing origins are currently underway, with emphasis
on the role of OPCs in normal brain state (Forster 2017, personal communications).
It is unknown exactly what is the role of OPCs in adulthood, once developmental
myelination is completed (around the age of two months in rodents), but as described
above they play a pivotal role in recovery following demyelinating lesions. OPC
response to demyelination is a complex process which can be divided into several
phases.
The first stage includes the activation of OPCs. This includes a switch from a quiescent
state to more proliferative and responsive state. OPC activation is triggered by the
actions elicit by microglia and blood-borne macrophages which infiltrate the CNS and
populate the lesion area, as well as by activation of astrocytes. The release of multiple
inflammatory molecules following demyelination, activates the OPCs and induces
their re-entry into cell cycle (Franklin & Ffrench-Constant, 2008; Rhodes, Raivich,
& Fawcett, 2006) (a more comprehensive description of the roles of the immune
system in remyelination is found in section 1.4.1). The activation of OPCs includes the
up-regulation of multiple genes, including Cspg4 (NG2) (Levine & Reynolds, 1999),
Olig1/2, Nkx2.2 (Fancy, Zhao, & Franklin, 2004) and Sox2 (Zhao et al., 2015) among
other factors (full description of transcription factors involved in OPC differentiation
can be found in section 1.4.2).
Following their activation, OPCs migrate to the lesion area by following various
chemokines and growth factors released by the immune cells which colonise the lesion.
Upon arrival to the lesion site, OPCs will undergo extensive proliferation (Redwine &
Armstrong, 1998), thus more OPCs than required will be generated. Multiple factors
drive OPC proliferation, including PDGF, FGF and IGF-1 (Hinks & Franklin, 1999) -
• PDGF (platelet-derived growth factor) is secreted mainly by astrocytes, and acts
in OPCs through its type A receptor, PDGFRA (expressed mainly by OPCs in the
CNS). In vitro administration of PDGF promotes OPC proliferation (Wolswijk
& Noble, 1992). Similarly, over expression of Pdgf in vivo in transgenic mice
results in increased numbers of OPCs in demyelination lesions (Woodruff,
Fruttiger, Richardson, & Franklin, 2004)) (but does not improves remyelination
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in aged animals).
• FGF-2 (fibroblast growth factor) is another growth factors of which its levels
are increased during the early stages of remyelination (Hinks & Franklin, 1999).
FGF indirectly effects OPC proliferation by modulating PDGF dependent path-
way (McKinnon, Matsui, Dubois-Dalcq, & Aaronsont, 1990). FGF-2 production
is upregulated in astrocytes by the CNTF (Albrecht et al., 2003), and CNTF
itself promotes the survival of OPCs in vitro (Talbott et al., 2007).
• IGF-1 (Insulin-like growth factor 1) is suggested to have an important role in
both proliferation and the survival of OPC, as Igf1r-/- mice show poor remyeli-
nation following cuprizone induced demyelination (Mason, Xuan, Dragatsis,
Efstratiadis, & Goldman, 2003).
Besides these growth factors which are secreted mainly by astrocytes, various cy-
tokines released by immune cells present in the lesion (mainly activated microglia and
macrophages) play a crucial role in the activation and proliferation of OPCs.
Following their rapid proliferation, in order to complete the remyelination process,
OPCs must switch from proliferative cell type to a differentiating one, thus exiting
the cell cycle (Caillava et al., 2011) and activating a set of genes that will eventually
induce the production of myelin sheaths. A timely withdrawal of pro-proliferation
growth factors is essential for the successful exit of cell cycle and the beginning of
OPC differentiation (Hinks & Franklin, 1999, 2000; Tokumoto, Durand, & Raff, 1999).
Thus, any delay in arrest of growth secretion can cause a delayed differentiation, which
can result in axon degeneration.
The process of OPC differentiation includes both morphological changes, which are
accompanied by intrinsic changes in gene expression. Figure 1.6 illustrates both the
morphological changes that occur along OPC the differentiation of OPCs, as well
as shows some of the markers frequently used to identify the different phases in
differentiation.
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Fig. 1.6 OPC differentiation Illustration of the differentiation process of OPCs.
During the differentiation into oligodendrocytes, OPCs exhibit morphological and
transcriptomic changes. Changes in morphology include the transition from a bi-polar
cell (left hand side) to a multi process cell, and ultimately the generation of myelin
membranes and axon ensheathment. The lower panel of the figure shows important
markers and their expression patterns during OPC differentiation. OPC early markers
are labelled in red, while OL markers are labelled in blue. Green labelled markers are
expressed throughout the lineage.
Adapted from (Fancy et al., 2009).
Thus, the differentiation process in OPCs is governed by both extrinsic factors
(secreted by other cell types as well as other OPCs), and intrinsic mechanisms. In the
following sections (1.4.1 and 1.4.2) I will review the key external components and and
internal processes that govern OPC differentiation as known from current literature.
1.4.1 Extrinsic factors in remyelination and OPC differentiation
separate
Innate immune system in remyelination
The process of remyelination relies of a complicated orchestra on cells types with
multiple divergent roles. One of the most important cell types in the process of
remyelination, are the cells of the innate system, and more specifically the microglia
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cells, the resident mononuclear phagocytes of the CNS (Chan, Kohsaka, & Rezaie,
2007).
First described as separate cell type by Pio del Rio-Hortega in 1919 (Kettenmann
& Verkhratsky, 2008) the origins of the microglia in the CNS have remained a contro-
versial for many years. Unlike other glia cells types (astrocytes, OL and OPCs) and
neurons which all arise from the neuroepithelial layer, it has been disputed whether or
not microglia also rise from the neuroectoderm or do they derive from ancient meso-
dermal origin (similar to other tissue resident macrophages) (Cuadros & Navascués,
1998). In 2010, an extensive study by Ginhoux and colleagues seems to have ended
much of the dispute (Ginhoux et al., 2010). According to multiple lineage tracing
essays presented in the study, microglia cells originate from primitive myeloid precur-
sors. These precursors differentiate in the yolk sac of mammals before the onset of
blood circulation, and thereby arise before embryonic day 8 in the mouse. Throughout
adulthood, the microglial cell pool is mainly self renewed and does not rely on blood
circulating monocytes, which is the case in other tissue resident macrophages (Ajami,
Bennett, Krieger, Tetzlaff, & Rossi, 2007; Ginhoux et al., 2010; Mildner et al., 2007).
Microglia play important roles during development, as well as during normal
homeostasis in the brain (Paolicelli et al., 2011). In normal adult conditions, microglia
posses a ramified morphology and are distributed evenly throughout the CNS. Mi-
croglia constantly survey their environment and detect new threats, as well as playing a
role in maintaining brain homeostasis (Nimmerjahn, 2005). The constant surveillance
allows microglia to quickly respond to any event in the CNS and restore homeostasis
by phagocyting cellular debris. There are many differences between microglia and
infiltrating macrophages, both transcription wise (Lavin et al., 2014), as well as evi-
dence for the distinct role in states of inflammation, such as in MS (Yamasaki et al.,
2014). Due the similarities of microglia and infiltrating macrophages, only recently
tools have been developed that allow simple and reliable distinction between the two
populations (Bennetta et al., 2016).
Microglia play a crucial role during remyelination, and are thought to play an
important role in the beginning of pathological process in MS which can be exhibited
in two main forms studied extensively in past studies:
Firstly, microglia are responsible for clearing myelin debris from the lesion site
(Lampron et al., 2015). Microglia are the first cells which migrate to the lesion and
the removal of debris after injury/lesion is crucial step for a successful regeneration of
the lesion. Efficiency of myelin debris clearance can determine the efficiency of the
whole remyelination process as myelin debris is inhibitory to OPC differentiation both
in vitro (Robinson & Miller, 1999), and in vivo (Kotter, Li, Zhao, & Franklin, 2006).
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This is also evident in older animals in which myelin clearance is slower and therefore
inhibits OPC differentiation, although this can be reversed (Natrajan et al., 2015;
Ruckh et al., 2012). It has been proposed that higher efficiency of myelin clearance in
the PNS (in comparison to the CNS) is one of the crucial factors for which PNS axonal
regeneration is more successful in comparison to the CNS (Vargas & Barres, 2007).
The second role of microglia is the secretion of pro regenerative factors that at
the first step will induce OPC migration to the lesion site, and later will promote
their differentiation (Miron et al., 2013). Microglia express and secrete a variety
of molecules which can have either pro or anti regenerative effects. The microglia
expression profile depends largely on the their type of activation. Classical studies have
largely divided microglia activation states into two distinct modes: pro-inflammatory
(classical activation, also known as M1) and anti-inflammatory (termed as alternative
activation, M2). These activation modes, have been linked to in vitro settings. M1
macrophages are generated by activating microglia with Lipopolysaccharides (LPS)
and this imitate primed inflammatory microglia/macrophages in vivo. Similarly,
activation of microglia/macrophages using IL-4 directs them to a M2 phenotype,
which mimics an alternative activation mode. Classical notion holds that as a general
rule, pro-inflammatory microglia (M1), and inflammation in general are inhibitory
to regeneration in general and remyelination specifically, whereas M2 microglia are
supportive of regeneration and remyelination specifically (for example, (Miron et al.,
2013)). More recent studies have challenged both of these claims.
Firstly, the artificial divide between M1 and M2 microglia/macrophages, and the
notion that LPS/IL-4 in vitro activation mimics the in vivo phenotype is heavily
disputed by many researchers in the field (Martinez & Gordon, 2014; Ransohoff,
2016). This is supported by studies which use advanced genomic techniques that
show that there are profound differences between in vitro M1 microglia and their
in vivo counterparts they are suppose to mimic - primed microglia from inflamed
tissue. (Holtman et al., 2015) Another perhaps oversimplified assumption which is has
been challenged in recent years, is the assumption that inflammation (and therefore
M1, or pro inflammatory microglia/macrophages) are inhibitory to regeneration and
remyelination in general, whereas a M2 phenotype (alternative activation) is a more pro
regenerative one. For example, Butovsky and colleagues have shown that conditioned
media from LPS activated microglia inhibits Neural Stem Cells (NSCs) differentiation,
both into neurons as well as into OL. In comparison, conditioned media from IL-4
activated microglia, have enhanced NSCs differentiation in vitro (Butovsky et al.,
2006). Thus, it seems that this clear cut distinction regarding the protective role of
anti-inflammatory microglia versus the pro-inflammatory counterparts is not accurate.
1.4 Oligodendrocyte Progenitor Cells (OPCs) 21
Several reports have shown that pro-inflammatory cytokines play a crucial role on
remyelination, including TNFa (Tumour Necrosis Factor alpha) and IL1-b. TNFa (a
potent pro inflammatory cytokine) is beneficial and required for successful proliferation
of OPCs and remyelination (Arnett et al., 2001). In contrast, TNFa has also been
shown to play a role in the actual process of demyelination by inducing cell death
through TNF receptor 1 (Tnfr1) and thus causing OL death directly, and this is without
the contribution of BBB breakdown (Akassoglou et al., 1998). Despite this, TNFa
null mice show lower rates of remyelination, which suggests that TNFa beneficial
effects outweigh its deleterious effects (Arnett et al., 2001). Similarly, IL-1b has also
been shown to regulate OPC proliferation and promote their activation (Arnett, Wang,
Matsushima, Suzuki, & Ting, 2003; Mason, Suzuki, Chaplin, & Matsushima, 2001;
Vela, Molina-Holgado, Arévalo-Martín, Almazán, & Guaza, 2002).
Past studies have shown that microglia do not undergo major changes in their
transcriptome in the transition between demyelination and remyelination in cuprizone
model (Olah et al., 2012). According to Olah et al., microglia do not exhibit significant
global changes in their transcriptome upon transition from demyelination stage to
remyelination. This is in contrast to later studies, such as by Miron el al (Miron et al.,
2013) which show a significant switch in microglia phenotype during remyelination.
The discrepancies between the studies can arise from multiple technical reasons as
the two studies used different types of toxin induced demyelination (cuprizone vs
focal injections of lysolecithin/ethidium bromide). The models differ in processes
and development of the disease. Moreover, Olah et al have used a microarray which
does not encompass the full transcriptome (but only 9000 genes) whereas Miron et al
used specific M1/M2 markers to signify the transition that microglia undergo during
remyelination.
The role of neuronal activity in remyelination
The role of neuronal activity in myelination (as well as remyelination) is the subject of
intense research. Early studies have claimed that OPC proliferation in vivo is depended
on electrical activity in axons in developing rat optic nerve (B. a. Barres & Raff, 1993).
In these studies, lack of activity in in the optic nerve (either due to transection of
the nerve or by using TTX toxin) resulted in decreased proliferation of OPCs, which
could be overcome by the addition of PDGF. More recent studies have strengthened
the notion that axonal activity play a role in OPC activation by showing that OPCs
express NMDA receptors (Káradóttir, Cavelier, Bergersen, & Attwell, 2005) which
are activated in the event of ischaemia. Moreover, in the adult CNS a recent report has
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shown neuronal activity enhances myelination and that this myelination in the adult
CNS is required for some types of learning (Gibson et al., 2014). Other molecules
which have been shown to be released from neurons and affect OPCs are Semaphorins,
which usually act in directing axonal growths cones. In particular, class 3 Semaphorins
have been shown to exert various effect on OPCs migration and activation, in which
Semaphorin 3A acts to repel OPCs (Syed et al., 2011), whereas Semaphorin 3F acts as
a chemotactant and attracts OPCs (Piaton et al., 2011).
While these studies support the notion that myelination (both in the developing CNS,
as well as in the adult CNS) is dependent on axonal and synaptic activity, in vitro ex-
periments using artificial nano fibres show that OPC innate myelination capabilities are
robust and do not require signals from axons. In these experiments even though OPCs
are cultured in presence of inert nano fibres and receive no electrical/biochemical
signals from the fibres, quickly after differentiation they start wrapping the fibres
(S. Lee, Chong, Tuck, Corey, & Chan, 2013). Following these insights, a study by
Redmond and colleagues have shown that OPCs in culture can wrap around other
structures which are not necessarily fibres, such as cones. Using a comparison between
transcriptome data from axons and dendrites Lee and colleagues identified JAM2 as
a surface antigen expressed mainly on dendrites and which inhibits myelination by
OPCs (Redmond et al., 2016). It is important to note though that these experiments
were performed using neonatal OPCs, which by definition will be highly active and
responsive cell type, as they are isolated from a brain undergoing intensive myelination
and are not necessarily identical to adult OPCs, which are the cells which will be
functional in remyelination processes (Moyon et al., 2015). This experiment also gives
a good example to the importance of surface antigens and their potential effects on
OPCs and remyelination.
Extracellular matrix and surface molecules effects in OPC differentiation
When OPCs arrive at the location of the lesion, they encounter multiple cell types
which constantly shape the microenvironment, not only by the factors they secrete (as
described in above sections) but can also affect OPCs through direct cell to cell contact.
The following section will discuss some of the more relevant molecules expressed on
the surface of various cell types and contribute to the ECM in the lesion area. I have
chosen to focus on the molecules which have been shown to affect OPC differentiation
in demyelination lesions, and/or in in vitro settings and are relevant to ageing as will
be describe in further chapters.
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• Chondroitin sulfate proteoglycans (CSPGs)
CSPGs are a large family of proteoglycans, which are composed of a protein
core and a chondroitin sulfate side chain. In mammals, CSPGs are encoded
by eight genes, marked Cspg1-8. Many CSPGs have been shown to inhibit
remyelination (Lau et al., 2012). One of the CSPGs which has been shown to
inhibit OPC differentiation, is NG2, encoded by Cspg4 (Pendleton et al., 2013).
Cspg4 is mainly expressed by OPCs, and is upregulated upon their activation
(as described above). Larsen et al. have shown that up regulating MMP-9 can
oppose the inhibitory effects of NG2 by removing NG2 deposits (Larsen, Wells,
Stallcup, Opdenakker, & Yong, 2003).
Another, more recent study from the Yong lab, (Keough et al., 2016), further
explored the detrimental role of CSPGs in inhibiting OPC differentiation and
remyelination. The authors show that in the presence of CSPGs, none of the
therapeutic drugs previously reported to enhance OPC differentiation were able
to do so. This paper clearly shows the critical role of the lesion microenviron-
ment, with emphasis on the various components of the ECM in modulating OPC
differentiation. The authors further show that inhibition of CSPGs production in
astrocytes can reverse the negative effects of astrocyte cell surface antigens on
OPC differentiation in vitro.
• Fibronectin
Fibronectin is glycoprotein, encoded in humans by the gene Fn1. Fibronectin
is up regulated in active MS lesions, both by macrophages and endothelial
cells (Sobel & Mitchell, 1989). A recent study has claimed that fibronectin
aggregation in MS lesions inhibits remyelination (Stoffels et al., 2013). In situ
hybridisation showed Fn1 expression in macrophages/microglia, as well as in
astrocytes in demyelinating lesions, but very little co-localisation with cells
of the OL lineage. Further experiments show that fibronectin aggregates from
astrocytes directly inhibits OPC differentiation in vitro and remyelination in
vivo (shown by injecting fibronectin directly into toxin induced demyelinating
lesions).
• CD44
CD44 is glycoprotein expressed by multiple cell types throughout the body.
CD44 plays a role in multiple cell processes related to cell - cell and cell - matrix
interactions, including proliferation, adhesion and migration. The main ligand
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of CD44 is Hyaluronan (HA), a polymer which can be found in various sizes
in the body. The molecular weight of HA seems to play a crucial role in its
function (Jordan, Racine, Hennig, & Lokeshwar, 2015). In the CNS, CD44
is expressed mainly by astrocytes and in low levels in microglia (Zhang et al.,
2014). In MS lesions, demyelinated lesions show high levels of HA. HMW HA
can also directly inhibit OPC differentiation and remyelination in vivo and are
associated with high levels of CD44 expression (S. a. Back et al., 2005).
1.4.2 Intrinsic factors that govern OPC differentiation
Selected transcription factors and signalling pathways in OPC differentiation
The process of OPC differentiation is not only controlled by the extrinsic cues de-
scribed, but is also governed by a complex intrinsic network.
Research in past years has led to the discovery of the bHLH transcription factors,
OLIG1 and OLIG2. OLIG2 is essential and required for for the normal development
of OL (Takebayashi et al., 2002). Olig2 is expressed in high levels throughout the OL
lineage (Zhang et al., 2014) and it role in differentiation seems to come through the
regulation of several other important transcription factors, such as NKX2.2, NKX6.2,
TCF7L2 (also known as TCF4), MyTI, SOX10 and SOX17 (reviewed in (Boulanger
& Messier, 2014)). The following section will elaborate on some of the more notable
pathways and transcription factors (TFs) that play a role in OPC biology.
• SRY-box containing gene (SOX) family
Several TF from the SRY-box containing gene family play important roles in
OPC differentiation, in particular Sox2, Sox10 and Sox17.
SOX2 has been studied extensively in multiple stem cells, and is considered a
master gene in ESCs and is required for maintenance of pluropotency and self
renewal (Avilion et al., 2003). It is also one of the ‘Yamanaka factors’ required
for the reprogramming of Induced Pluripotent Stem Cells (IPSC) (Takahashi
& Yamanaka, 2006). In OPCs, Sox2 is expressed during development (Zhao et
al., 2015), but not in adult OPCs. Sox2 expression reappears in OPCs following
demyelination and OPC activation. SOX2 is required for the regulation OPC
proliferation and it ensures that sufficient numbers of OPCs are generated in the
lesion site before differentiation begins (Zhao et al., 2015).
SOX10 is a crucial transcription factor in glial development in general, and in
OPC differentiation specifically., as well as in Schwann cell development in
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the PNS (Kuhlbrodt, Herbarth, Sock, Hermans-Borgmeyer, & Wegner, 1998).
Sox10 is expressed throughout the OL lineage and changes the levels of its
expression throughout the stages of OL lineage (Kuhlbrodt et al., 1998). Sox10
deficient mice show a significant decrease in the expression of PLP and MBP
in the spinal cord (Stolt, 2002). In vitro experiments have also shown the
importance of SOX10, as in vitro inhibition of Sox10 using siRNA results in
decrease OPC differentiation, whereas over expression of Sox10 results in the
expression of NKX2.2, OLIG2, MBP and PLP (Z. Liu et al., 2007). Sox10 can
exert its effects synergistically with other transcription factors (such as Olig2
in OL development, or POUdomain protein Tst-1/Oct6/SCIP in Schwann cell
development (Kuhlbrodt et al., 1998)). It can also regulate MBP expression
directly as it can bind to three binding sites in the MBP promoter (Nicolay,
Doucette, & Nazarali, 2007).
One of the direct targets of SOX10 in OL is Myrf, whereas SOX10 binds to
Egr2/Krox2 in Schwann cells(Hornig et al., 2013; Lopez-Anido et al., 2015).
Myrf null mice have pre myelinating OL, but they exhibit extreme deficits in
the expression of myelin proteins. Similarly, over expression ofMyrf in vitro
results in enhanced expression of myelin genes (see further description in later
sections).
SOX17, a SOX F type transcription factor, plays a role in OPC maturation, as its
down regulation with siRNAs in cultured OPCs results in reduction of O4+ cells
in comparison to increase in A2B5+ cells. Further more, over-expression of
Sox17 in cultured OPCs results in increased expression of MBP, MAG and CNP.
Direct infection of Sox17 reduces the percentage of proliferating cells in vitro,
thus promoting OPC differentiation by inducing cell cycle exit (Sohn, 2006).
• NKX-homeodomain factor -
Multiple NKX factors are involved in OPC differentiation, including NKX2.2
and NKX6.2 (Cai et al., 2010).
NKX2.2 is rapidly up regulate in upon OPC activation, and is highly expressed
in proliferating OPCs (Zhang et al., 2014; Boulanger & Messier, 2014; Fancy
et al., 2004), but is down regulated upon the transition to mature OL, thus it
seems to play an important role in early differentiation, but not in the mature
myelinating OL.
NKX6.2 is thought to play a role in OPC differentiation as it expressed in
parallel to MBP and PLP (Awatramani et al., 1997). NKX6.2 is a DNA binding
protein and can bind multiple sites within the promoter regions of both Plp and
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Mbp (Awatramani et al., 1997).
• basic Helix Loop Helix (bHLH) factors -
The main bHLH factors described in relation to OPC biology are OLIG1 and
OLIG2. OLIG2 is expressed throughout the OL lineage, including OPCs and
OLs. OLIG2 is required for for normal development of OPC (Takebayashi et al.,
2002). Olig2-/- mice do not survive, making it difficult to fully understand the
role of OLIG2 in OPC differentiation. But what it is known is that OLIG2 is
required for maintaining OPCs in the OL lineage, as treating OPCs with Olig2
targeted siRNA inhibits their differentiation into OL in vitro (Cheng et al., 2007).
Unlike OLIG2 which is essential for both developmental myelination, as well
as remyelination, OLIG1 is not required for developmental myelination, but is
necessary for remyelination, sinceOlig1 null mice fail to remyelinate in response
to induced demyelination, but display small differences in developmental myeli-
nation (Arnett et al., 2004; Cheng et al., 2007). During OL maturation, OLIG1
is shuttled out of nucleus in immature OL to the cytoplasm in myelin forming
OL. Similar to the experiments described above regarding Olig2, treating OPCs
in vitro with siRNA against Olig1 results in reduction of OPC differentiation
(Cheng et al., 2007).
• Other selected transcription factors
More transcription factors which directly induce differentiation and myelin
formation, include the zinc-finger protein Myelin transcription factor 1 (MYT1)
which is thought to regulate and fine tune the transition between proliferation
and differentiation phases (Nielsen, Berndt, Hudson, & Armstrong, 2004; Vana,
Lucchinetti, Le, & Armstrong, 2007).
MyTI promotes OPC maturation, as over expression ofMyti in vitro promotes
OPC differentiation, measured by the expression of CNP (using luciferase
reporter essay). Moreover, infection of OPCs with truncated MyTI (in order to
interfere with the normal activity of MyTI) results with dramatic reduction in
differentiation capabilities of OPCs (Nielsen et al., 2004).
MYRF (Myelin Gene Regulatory Factor) is another transcription which is nec-
essary for OPC differentiation and OL maturation. MYRF is a DNA binding
proteins, and its targets include many myelin genes (Emery et al., 2009). In-
hibition of Myrf using siRNA results in reduction of OPC differentiation and
removing exon coding for DNA binding domain fromMyrf transcript prevent
myelination (Emery et al., 2009).
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Cell intrinsic pathways involved in OPC differentiation
• The Mammalian Target of Rapamycin (mTOR) pathway
mTOR is a serine threonine kinase which regulates cell growth in response
to PI3K/Akt stimulation, and is also involved in nutrient sensing. mTOR is
active through two distinct signalling pathways, which are characterised by
the complex which are formed: mTORC1 and mTORC2 (characterised by the
presence of the adaptor proteins RAPTOR or RIPTOR, respectively). Tyler
et al. (Tyler et al., 2009), have shown that mTOR is an essential pathway in
OPC differentiation, and that inhibiting mTOR prevents OPC to transition from
preOL to fully myelinating OL. The addition of Rapamycin in vitro in this
study resulted in decrease of OPC differentiation and increased expression of
multiple transcription factors which are associated with OPC early activation (e.g.
Nkx2.2), as well as genes associated with OPC proliferation (e.g. Id2/4), which
inhibit OPC premature differentiation (Kondo & Raff, 2000; Wang, Sdrulla,
Johnson, Yokota, & Barres, 2001).
• Wnt signalling pathway
Using an ISH expression array of transcription factors, Fancy et al., have un-
covered an important role for Wnt signalling in OPC differentiation (Fancy et
al., 2009), focusing on the role of TCF4 in this process, as TCF4/b-catenin
complex inhibits OPC differentiation. Furthermore, APC (b-catenin inhibitor) is
upregulated in differentiating OPCs, and mice that lack APC exhibit reduced
remyelination. Moreover, AXIN2 which is a target of the Wnt pathway (acting
as negative feedback by degrading b-catenin) is required for OPC differentia-
tion and its stabilisation can accelerate OPC differentiation (Fancy, Harrington,
et al., 2011). Wnt pathway is also inhibited by HDAC1/2 activity (Ye et al.,
2009). The authors further identify TCF7L2 (Transcription Factor 7 Like 2,
also known as TCF4) as a link between HDAC1/2 activity to Wnt pathway and
OPC differentiation. HDAC1/2 compete with b-catenin to interact with TCF7L2.
When HDAC1/2 interact with TCF7L2 it becomes an activator of OPC differ-
entiation. More recently it has been shown that Wnt signalling inhibits OPC
differentiation by working in cooperation with the BMP signalling (Feigenson,
Reid, See, Crenshaw III, & Grinspan, 2011). BMP signalling is known to inhibit
OL development and instead promote astrogenesis, both in OPCs (Neumann




Notch pathway have been described as a differentiation inhibitor, as it has been
shown Jagged1 (NOTCH receptor primary ligand) inhibits OPC differentiation
in vitro through the activation of two bHLH factors, HES1/5 which are down
stream targets of the Notch pathway. HES1/5 promote OPC proliferation and
inhibit cell cycle exit, thus preventing OPC differentiation. Adult unmyelinated
axons expresses JAGGED1, thus preventing their remyelination (Wang et al.,
1998). This view was contested by a more recent paper by Stidworthy et al.,
which have shown that in rodents, remyelination is not affected by NOTCH
signalling, as Notch-/- mice show no difference in remyelination, suggesting
that the NOTCH pathway role in inhibiting OPCs is limited to developmental
myelination.
Epigenetic mechanisms in OPC differentiation
• Histone deacetylases (HDACs)
As discussed previously (see section 1.2.2), HDAC are a group of enzymes
which play a important role in histone modifications. HDACs reverse the activity
of HATs (histone acetyltransferases), by removing acetyl groups from histones
lysine tails. This generally leads to chromatin compaction , thus reducing tran-
scription of specific genes. HDAC role in OPC differentiation in development
have been shown to be critical in both zebrafish (Cunliffe & Casaccia-Bonnefil,
2006) as well as in rodents (Shen, Li, & Casaccia-Bonnefil, 2005). In the devel-
oping rat brain, there is progressive decrease in acetylation of specific histones
(namely H3) in OL lineage cells (marked by SOX10 expression). Moreover,
administration of various HDAC inhibitors (such as, Valporic acid)specific re-
sulted in hypomyelination. This effect was limited to a specific time window,
after which the cells were immune to the effects of HDAC inhibitors, Thus,
HDAC are required specifically for the differentiation of OPCs, but not for the
maintenance of myelin once OL have been formed (Shen et al., 2005).
• Histone methyltransferases (HMTs)
Using ChIP-sequencing targeted at H3K9me3 and H3K27me3, Liu and col-
leagues revealed an increase in H3K9me3 markings in OLs in comparison to
OPCs. Genes regulated by this mark included Pax6, Lhx1, Grip1 and Dcx - all
genes related to neuronal fate modulation (J. Liu et al., 2015). As H3K9me3 is
known as a repressive histone marker, one can assume it is used to specify OL
fate in progenitor cells.
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• Micro RNA (miRNA)
Knocking out DICER under the Plp1 promoter results in demyelination, suggest-
ing that miRNAs play a role in the maintenance of OLs through maintenance of
lipids and redox reduction (Shin, Shin, McManus, Ptácˇek, & Fu, 2009). Further
studies examined the various miRNAs differentially expressed in OPCs and
OLs. Most up regulated miRNAs were expressed in OL, and the authors have
pointed specific roles for miR-338, miR-318 and specifically miR-219 in OPC
differentiation. Further study revealed that miR-219 inhibits key OPCs specific
genes, including Pdgfra, Sox6, Foxj3 and Zfp238 (Dugas, Cuellar, Scholze, &
Ason, 2010).
• DNA methylation
Unlike the role of other epigenetic mechanisms in OPC differentiation, very
few studies have studied the role of DNA methylation in the OL lineage. Early
studies from the 80’s have shown that injection of 5-azacytidine, a nucleoside
inhibitor of DNMTs, during developmental myelination resulted in decrease of
myelination (Ransom, Yamate, Black, & Waxman, 1985). The injection affected
mainly OL and not astrocytes, which suggests that DNA methylation plays a role
in differentiating cells and fully mature ones. Moreover, examination of the optic
fibres several days after the injection has shown small increase in myelination,
meaning the effects of AZA were limited to the currently differentiating cells.
Using more advanced methods Moyon et al. (Moyon, Huynh, et al., 2016)
studied the role of DNA methylation in OL development. The authors show an
increase in 5-mC in OLs in comparison to OPCs, as well as an increase in the
expression of DNMT3A in OLs. As expected, DNMT1 levels decreased with
OPC differentiation, as this enzyme is mainly active in cell division and DNA
replication (as explained above). ERRBS analysis revealed an increase levels
of methylation in promoters of multiple genes which related to progenitor state
in OLs, such as Nkx2.2 and Pax6. As expected, myelin related genes (such as,
Mog) were hypomethylated in OLs in comparison to OPCs. Dnmt1 KO under
the promoter of Olig1 resulted in hypomyelination and decreased survival of
the mice. Interestingly, knocking out Dnmt3a under the same promoter did not
lead to hypomyelination. The phenotype exhibited by the Dnmt1-/- mice was
not due to reduce progenitor numbers, but was concluded to be due to reduced
differentiation capabilities of the OPCs. This was due to alternative splicing
events, caused from the hypomethylation phenotype.
In adult OPCs, unlike neonatal ones, DNMT3A and not DNMT1 seems to play
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a more important role in OPC differentiation during remyelination (Moyon
et al., 2017). This is expected, since differentiating adult OPCs will need to
methylate specific gene sets in order to initiate a transcription network necessary
for differentiation.
1.5 Remyelination failure in ageing
While the process of remyelination is quite remarkable in its efficiency, exemplified
by the ability of rats to quickly recover from toxin induced demyelination lesions
(W. Blakemore, 1974), this is not always the case. Even though first studies have
concluded that remyelination does not decline with ageing (W. Blakemore, 1974),
more recent studies have clearly shown that remyelination efficiency does decline
with age (Ruckh et al., 2012; Shields, Gilson, Blakemore, & Franklin, 1999; Shen,
Liu, & Li, 2008; Shen, Sandoval, et al., 2008), similar to other regeneration processes.
The decreased efficiency of remyelination can be a result of decline in each of the
processes leading to remyelination, i.e. OPC activation and migration to the lesion,
OPC proliferation, OPC differentiation and final remyelination.
In aged animals OPC recruitment and differentiation was implicated to be delayed
(Sim, Zhao, Penderis, & Franklin, 2002), but in many cases it is the last step of OPC
differentiation which is rate limiting. For example, over expression of PDGF-A in
astrocytes (under the Gfap promoter) resulted in an increase of OPC numbers (i.e.
increased OPC proliferation), albeit, this enhanced proliferation does not translate into
increase OPC differentiation in aged mice (Woodruff et al., 2004). This suggests that
indeed the failure in remyelination does not stem from low numbers of OPCs, but from
lack of OPCs which can successfully differentiate in myelinating OLs.
Further evidence for the major role of OPC differentiation failure as a main reason
for remyelination failure is postmortem autopsies on MS patients. Multiple studies
have revealed that MS lesions contain sufficient number of OPCs but limited OPC dif-
ferentiation and remyelination (Chang, Tourtellotte, Rudick, & Trapp, 2002; Kuhlmann
et al., 2008; Wolswijk, 1998). More specifically, some reports have described multi
process pre-myelinating cells that express PLP protein, but do not engage and enwrap
axons (Lucchinetti, 1999). This strengthens the notion that:
1. OPCs are present in MS in sufficient numbers
2. OPC differentiation failure is a major rate limiting step for remyelination in MS
patients
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Some reports, such as by Boyd et al (Boyd, Zhang, & Williams, 2013), point out that
at least in a minority of lesions (approximately 37%), failure in efficient recruitment
of OPCs seems to be a critical factor in remyelination failure.
Since remyelination failure in MS is mainly present in chronic lesions, coupled
with the fact that chronic MS lesions numbers rise with age together with higher
incidences of neurodegenerative phases (Ransohoff, 2012), it becomes evident that
ageing is a contributing factor for remyelination failure in MS, not by limiting the
number of progenitor cells, but by affecting intrinsic and extrinsic factors that render
OPCs less likely to differentiate successfully. Therefore it is clear that there is a need
to describe and understand how do the effects of ageing affect OPCs and the other
cells active in demyelinated lesion environment.
The effects of ageing on the process of remyelination can be divided into two main
groups: the first, effect on the lesion microenvironment. For example, changes in
the activities of microglia/macrophages and astrocytes, as these cells are essential
in shaping a pro-remyelinating lesion environment in which OPCs can differentiate
and remyelinate the nude axons in in efficient and timely manner. The second effect
resulting from ageing, is the intrinsic changes in OPCs and how they contribute to
the decline in their differentiation capacity. In the next few sections I will review the
changes in ageing microglia (section 1.5.1) as well as the changes known in ageing
OPCs (section 1.5.2).
1.5.1 Ageing microglia
The changes in the microglia transcriptome with ageing have been described in multiple
studies (Hickman et al., 2013; Holtman et al., 2015). The classic view of the changes
in the microglia was to classify them as changing toward a more pro-inflammatory
profile (Norden & Godbout, 2013). It has been suggested that the priming of microglia
is induced through long term exposure to low levels of inflammation through life and
especially in ageing. It seems that this is an oversimplification. Using advance genomic
techniques and WGCNA, Holtman and colleagues demonstrate that ’primed’ microglia
(isolated from aged mice, as well as from mice models of various neurodegenerative
conditions) show a completely different expression profile in comparison to acutely
activated pro-inflammatory microglia (by using i.p. LPS injection). Therefore, as
mentioned before, it is critical to view the microglia specific roles in remyelination
and how the efficiency of microglia activity changes with ageing.
The most striking effect of ageing on microglia, is the dramatic decline in microglia
phagocytosis capabilities (Njie et al., 2012). Young microglia and blood derived
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macrophages exhibit high capacity of myelin phagocytosis, and this is critical for
successful remyelination to occur (H. Neumann, Kotter, & Franklin, 2009). The
efficiency of the phagocytosis process and myelin debris clearance is significantly
reduced in ageing microglia/macrophages (Natrajan et al., 2015), and this (at least
partly) have been shown to contributes to the failure of remyelination in aged animals
(Ruckh et al., 2012). This was shown in a study using heterochronic parabiosis (Ruckh
et al., 2012). In this study old and young mice blood circulation are connected. This
way, young mice serum could flow into the old mice, including circulating cells, such
as monocytes. Using GFP mutant, the authors were able to detect which cells crossed
from the young to old animals and aided in remyelination following toxin induced
lesions. Exposure to young milieu enhanced the proliferation of OPCs in the lesions
of the old animals, as well as their differentiation capabilities. This ultimately led to
enhanced remyelination in old animals which were paired with young animals. Most of
the invading cells (GFP+) in the lesions were macrophages. This led to the conclusion
that the improvement in remyelination could be due to young macrophages invading
the lesions in the old animals. The contribution of the young macrophages was deemed
limited to their enhance myelin clearance capabilities, as no differences were noted in
the production of key factors known to enhance OPC differentiation. It is important
to note that only a few factors have been tested, thus it is likely that the beneficial
effect is not only limited to the enhanced myelin clearance capability. Nonetheless,
this study shows that aged OPCs have the potential to regenerate to certain extent
by modulating the environment and exposure to specific serum factors. But this
rejuvenation was not complete, so it is clear that aged OPCs also harbour intrinsic
changes which need to be discovered in order to completely overcome the effects of
ageing on remyelination. Another method shown to reverse the decreased phagocytosis
efficiency was by activating RXR (Retinoid X Receptor) using RXR agonists, such as
bexarotene. Bexarotene has also been shown to enhance the phagocytosis capabilities
of MS patients derived monocytes (Natrajan et al., 2015), and is currently being tested
in clinical trials.
The changes relating the secretome profile of microglia and their effect on re-
myelination are less clear. Studies have shown that aged microglia exhibit delayed
recruitment to the lesion site. They have also shown that levels of multiple pro-
inflammatory secreted molecules (such as iNOS, TNFa, IL-6 and IL-1b) are present in
demyelinated lesions for longer periods of time in aged animals (Hinks & Franklin,
2000; Zhao, Li, & Franklin, 2006). It is logical to conclude that sustained high levels of
several inflammatory cytokines will inhibit remyelination, as some of these molecules
(such as, IL-1b and TNFa) have been shown to play a role in OPC proliferation
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(see section 1.4.1). This way, OPCs are recruited to the lesion site, where they can
proliferate, but do not receive the correct set of differentiation signals in a timely
manner, thereby missing a critical time window for remyelination, therefore the axon
is left demyelinated and vulnerable to further degeneration, due to the lack of trophic
support by OL (as described before). Therefore, according to this model, the delayed
differentiation of OPCs in lesions is at least somewhat due to lack of timely differen-
tiation signals from the resident microglia/macrophages. There has not been a full
transcriptome analysis which compares the responses of aged and young microglia in
remyelination, thus it is impossible to to test whether only pro-inflammatory cytokines
remain in higher levels, or this is also true for other types of molecules that might
be released by the microglia/macrophages in the lesion and will potentially delay the
OPC differentiation process.
Chapter 5 in this thesis describes the experiments I conducted using both young
and aged acutely isolated microglia. These experiments begin to explore the changes
in both the secretome of aged microglia (using conditioned media experiments), as
well as investigating the changes in microglia surface antigens and their effects on
OPC differentiation capabilities.
1.5.2 Intrinsic changes in aged OPCs
Due to the technical difficulties in isolating and culturing aged OPCs, we have little
knowledge regarding the intrinsic changes in OPCs that occur throughout ageing. Even
so, some studies have shown intrinsic changes within OPC function which render
them less effective. A direct evidence for the intrinsic changes in ageing OPCs was
provided by Shen et al., in two studies from 2008 (Shen, Sandoval, et al., 2008; Shen,
Liu, & Li, 2008). These studies show loss of epigenetic markers (specifically histone
acetylation and methylation) in aged animals. The loss of these modifications results
in higher activity of specific differentiation inhibitory genes, such as Hes5 and Id4.
These studies also show that the recruitment of HDAC1/2 in OPCs is essential for
successful OPC differentiation, as inhibiting HDAC activity using pharmacological
inhibitors results in reduced OPC differentiation. Moreover, the authors show a re-
duced recruitment of HDACs in aged animals which leads to reduced differentiation
capabilities. Examination of RNA-seq database (Zhang et al., 2014) shows very little
differences in HDAC expression through OPC differentiation. Combining the two
results leads to the conclusion that it is not simply a matter of up regulating HDAC
which required for differentiation, but it is their correct recruitment to specific genomic
locations, mainly to inhibit differentiation inhibitory genes. This must be depends on a
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correct expression of various transcription factors which are needed to direct HDAC to
correct genomic locations.
Furthermore, since heterochronic parabiosis aged animals did not completely reju-
venate, coupled with the fact that OPCs were not transferred between the animals,
suggests that there intrinsic changes in aged OPCs that needs to be reversed in order
to restore full remyelination capabilities in aged animals (and humans) (Ruckh et al.,
2012).
In conclusion, even though OPCs and remyelination have been studied for many years,
there is little knowledge about the unique effects of ageing on OPCs and how this is
related to their decline in regenerative capacities. Most of our knowledge regarding
OPC biology comes from studying neonatal OPCs, which display very different char-
acteristics than aged ones, both in vitro and in vivo (B. Neumann, Baror, Dietmann,
Wijngaarden, & Franklin, n.d.)
Therefore, there is an apparent need to describe and create a complete database of
the aged and young adult OPCs, in order to obtain the relevant targets for potential
therapeutic interventions. In chapters 3 and 4 I describe the generation of two main
databases: the first, a database which describes the epigenetic and transcriptomic
changes between the different cell types that compose the OL lineage in adulthood.
The second compares and describes the changes in the transcriptome and methylome
of ageing OPCs.
A further neglected area of study is the interaction between the different cell types
that play a role in remyelination and how this interaction is affected by ageing. In the
final chapter of this study I will bring examples for this kind of interaction between
microglia and OPCs, while addressing potential ageing effects.
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1.6 Aims and objectives of this study
Although it is accepted that adult stem and progenitor cells differ from their neonatal
counterparts, the intrinsic properties of adult OPCs and other cells in the OL lineage
have not been characterised, and most studies rely on findings based on studying
neonatal cells. Moreover, the importance of ageing in the decline of the regenerative
capacity of OPCs is of great clinical relevance, but it is not yet known what are the
intrinsic changes in OPCs that render them less capable of responding in the case of
demyelination. Similar gaps of knowledge hinder our understanding of changes that
occur in ageing microglia, with emphasis on non immune activities. Therefore, in this
thesis I set out to fulfil the following objectives:
1. Explore the intrinsic changes and mechanisms are in play during adult OPC dif-
ferentiation. This was achieved by establishing a novel dataset of the methylome
and transcriptome of the different cells in the OL lineage in the adult rat.
2. Discover intrinsic changes in aged OPCs in order to explain the decline in
efficiency of differentiation presented by aged OPCs by establishing a full
transcriptome and methylome of aged and young OPCs.
3. Explore the changes in aged microglia with emphasis on both the expression
of surface antigens and secreted molecules and their potential contribution to
decline in remyelination with ageing. This was done by using a novel in vitro
method to co-culture microglia and OPCs, which allows to isolate the effects of





Only Sprague Dawley rats were used for this study. Rats were bred and raised at the
Innes Building Animal Facility at the University of Cambridge. All animals were fed
standard diet and were kept under 12 hours cycles of light and darkness. All animals
used for experiments were sacrificed by schedule 1 approved methods, according to
the requirements and regulations set by the United Kingdom Home Office.
2.2 Cells immunohistochemistry
At the end of each in vitro experiment, cells were fixed by adding 4% PFA to each
well and incubating in RT for 10 minutes. Cells were then washed twice using PBS (5
minutes each wash, RT, shaking). Cell nuclei were labeled with 2µg/ml Hoechst 33342
(Sigma). Before applying primary antibodies, cells were blocked using 5% normal
donkey serum (NDS) for 20 minutes, RT. For intracellular stainings, 0.1% Triton was
added to the blocking solution. Primary antibodies (see table 2.1) were diluted in PBS +
5% NDS and samples were incubated overnight in 4°C. Following incubation, samples
were washed twice with PBS (10 minutes, RT, shaking) and secondary antibodies
(see table 2.1) were added accordingly. Secondary antibodies were diluted in PBS
+ 5% PBS, and samples were incubated in RT for 2 hours. Following incubation,
samples were washed 3 times with PBS, 10 minutes each time. Second wash included
Hoechst 33342 for nuclear staining (2ng/ml). Image acquisition was performed using
a Leica-SP5 microscope (Leica) and LAS software (Leica) or a Zeiss Observer A1
inverted microscope (Zeiss) and Zeiss Axiovision software. For each well (in 48 well
plate) 3-4 images were taken in randomly selected areas. Further image processing
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and analysis was performed using the ImageJ software package. Images quantification
was done using CellProfiler software (Broad institute, Harvard University). In total,
for each condition a minimum of 200 cells were counted.
Table 2.1: List of antibodies. All primary antibodies were IgG subclass antibodies
unless specified otherwise.
Antibody Dilution Vendor Catalog#
Primary antibodies
Mouse anti-A2B5 (IgM) 1:300 Millipore MAB312
Mouse anti-CD11b 1:300 Serotec MCA275R
Mouse anti-CNPase 1:300 Abcam ab6319
Mouse anti-O4 (IgM) 1:1000 R&D Systems MAB1326
Mouse anti-NG2 1:300 Milipore AB5320
Rabbit anti-Ki67 1:500 Abcam Ab166667
Rabbit anti-NG2 1:300 Millipore MAB5320
Rabbit anti-Olig2 1:1000 Millipore AB9610
Goat anti-Iba1 1:500 Abcam ab5076
Goat anti-Olig2 1:500 R&D Systems AF2418
Chicken anti-GFAP 1:1000 Abcam ab4674
Rat anti-MBP 1:300 Serotec MCA4095
Goat-anti-Mouse-MOG-Biotinilated 1:300 R&D systems BAF2439
Secondary antibodies
Alexa 488 donkey anti-mouse 1:500 Invitrogen A21202
Alexa 488 donkey anti-rabbit 1:500 Invitrogen A21206
Alexa 488 donkey anti-goat 1:500 Invitrogen A11055
Alexa 488 donkey anti-mouse IgM 1:500 Invitrogen A21042
Alexa594 donkey anti-mouse IgG 1:500 Invitrogen A21203
Alexa594 donkey anti-rat IgG 1:500 Invitrogen A21209
Alexa594 donkey anti-rabbit IgG 1:500 Invitrogen A21207
Alexa647 donkey anti-rabbit IgG 1:500 Invitrogen A31573
Alexa647 donkey anti-mouse IgG 1:500 Invitrogen A31571
Alexa647 donkey anti-Goat IgG 1:500 Invitrogen A21147
Table 2.1 Antibodies used for IHC
2.3 Isolation of adult OPCs
Note: all centrifugations were conducted in room temperature, unless specified other-
wise.
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2.3.1 Single cell suspension
Neonatal (P0-P20), young adult (P30-P90) and aged (12 -27 months) rats were decapi-
tated after lethal injection of phenobarbital or sacrificed by inhalation of increasing
CO2 concentrations. Brains were removed shortly after death (including cerebrum
and cerebellum) and placed into ice cold HALF isolation medium (Hibernate A Low
Fluorscence; see table 2.2 for full list of ingredients), supplemented with 2% of B27.
Meninges, olfactory bulbs and remains of spinal cord (if present) were removed and
brain tissue was chopped mechanically into 1mm pieces using sterile scalps. The
minced tissue was spun down in 100g for 2 minutes in RT. Brain tissue was then
suspended in dissociation solution (34U/ml papain (Worthington), 20µg/ml DNAse
Type IV (Gibco) in HALF) for 30 (neonatal) to 40 (adult) minutes in 37°C, on a shaker
set to 55 RPM. Digestion was stopped by adding cold HBSS- ( Hank’s Balanced Salt
Solution, no magnesium / calcium; Gibco). HBSS(-) was used in order to minimise
the possibility of cell attachment to tubes, as magnesium and calcium are necessary for
cell attachment. The tissue was centrifuged for 5 minutes, in 250g. Supernatant was
completely aspirated and tissue was re-suspended in neutralising solution (HALF +
2% B27 + 2mM sodium-pyruvate) for 5 minutes in RT. In order to create a single cell
suspension, cells were first titurated using a 5ml serological pipette and subsequently
three fire polished glass pipettes in decreasing opening sizes. After each trituration
step the tissue suspension was allowed to sediment and the supernatant, containing
the cells, was transferred into a fresh tube, while being passed through a 70µm cell
strainers to ensure single cell suspension. After removing the supernatant each time,
2ml of fresh neutralising solution were added to the remaining tissue. After the whole
tissue was passed though the cell strainer, a 90% pre-filtered (20µn filters) isotonic
Percoll solution (GE Healthcare, diluted in 10xPBS pH7.2 (Gibco)) was added. Final
Percoll concentration of 22.5% was achieved by adding phenol-red free DMEM/F12
(Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12; Gibco). The single cell
suspension was then centrifuged for 20 minutes in 800g. This resulted in separation
of debris and cells. Myelin debris was removed and the cells were washed using
HBSS-. Cells were then incubated for 1 minute in Red Blood Cell lysis buffer (RBC
lysis buffer; R7757; Sigma-Aldrich) in order to remove contaminating red blood cells.
Solution was then topped up by HBSS- and centrifuged again. Cells were suspended in
HALF based washing buffer (HALF WB) which included 2mM EDTA, 2mM sodium-
pyruvate, 0.5% BSA and 10ng/ml human recombinant insulin (Gibco) for antibody
staining according to the protocols described in the following sections of this chapter.
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Fig. 2.1 MACS isolation of glial cells from aged and young rats Schematic illus-
tration of isolation protocols used for isolation the various glial cells used in this
study. Young or aged rats were culled using lethal injection of Pentobarbital, followed
by dissection of whole brain. Brains were mechanically dissociated using scalpels
and then enzymatically dissociated using Papain digestion. Cells suspension was
then subjected to Percoll gradient in order to remove all myelin debris. Clean single
cell suspension was then labelled with relevant antibodies and MACS isolation was
performed as described in the following relevant sections.
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Chemical µM MW mg/5l
Amino acid
Glycine 400 75.07 150.1
L-Alanine 22 89.09 9.8
L-Arginine hydrochloride 483 174.2 420.7
L-Asparagine-H2O 5.5 150.13 4.1286
L-Cysteine hydrochloride-H2O 7.7 313.2 12.06
L-Histidine hydrochloride-H2O 200 209.6 209.6
L-Isoleucine 802 131.2 526.1
L-Leucine 802 131.2 526.1
L-Lysine hydrochloride 798 146.2 583.3
L-Methionine 201 149.2 149.9
L-Phenylalanine 400 165.2 330.4
L-Proline 67 115.13 38.569
L-Serine 400 105 210
L-Threonine 798 119 474.8
L-Tryptophan 78 204.2 79.6
L-Tyrosine disodium salt dihydrate 398 181.2 360.6
L-Valine 803 117.2 470.6
Vitamins
Choline chloride 28 139.62 19.55
D-Calcium pantothenate 8 238.27 9.53
i-Inositol 40 180.2 36
Niacinamide 30 122 18.3
Pyridoxine hydrochloride 20 206 20.6
Thiamine hydrochloride 10 337 16.9
Inorganic Salts Ferric Nitrate 0.25 404 0.5
Potassium Chloride 5360 74.55 1997.9
Sodium Bicarbonate 880 84 369.6
Sodium Chloride 89000 58 25810
Sodium Phosphate dibasic 906 120 543.6
Zinc sulfate 0.67 287.56 0.9633
Other Components D-Glucose (Dextrose) 25000 180.2 22525
Sodium Pyruvate 227 110.04 124.9
MOPS 10000 269.3 13465
Table 2.2 Formulation of isolation medium (HALF; Hibernate A Low Fluorescence)
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2.3.2 Magnetic Activated Cell Sorting (MACS)
Cells were counted using a regular hemocytometer and 2.5µg mouse-anti-rat-A2B5-
IgM antibody (Millipore; cat#MAB312) were added for every 10 million cells (all
antibodies used for MACS are listed in table 2.3). Cells were incubated in 4°C for 25
minutes. After incubation, solution was topped up to 8ml of Miltenyi Washing Buffer
(MWB; 2mM EDTA, 2mM Na-Pyruvate, 0.5% BSA in PBS, pH 7.2-7.4) in order to
wash unattached antibodies. Solution was centrifuged (300g, 5 minutes) and the pellet
was re-suspended in 80µl of HALF WB supplemented with 20µl rat-anti-mouse-IgM
magnetic beads (Miltenyi; cat#130-047-302) per 10 million cells. Cells were incubated
in 4°C for 15 minutes. Secondary antibody was washed with 8ml of MWB and solution
was centrifuged (300g, 5 minutes). Cell pellet was resuspended in 1ml of HALF WB
and MACS was performed according to supplier instructions (Miltenyi). In short, MS
column was placed on a magnet, pre-wet with 500µl of MWB. Cell suspension was
then loaded to the column. The column was then washed three times using 500µl of
MWB (allowing each time the full amount of buffer to fully run through the column).
Finally, column was removed from the magnet allowing A2B5 positive cells to be
washed off the column using 1ml pre-warmed, CO2 pre-equilibrated OPC medium
(see table 2.4 for full components list). On average, 106 cells were isolated per rat
(young or aged).
2.3.3 Fluorescence Activated Cell Sorting (FACS)
Cells were re-suspended in 100µl of HALF WB per 10 million cells. The following
antibodies were then added:
• Mouse-anti-Rat-A2B5-IgM (Alexa 488 conjugated) (Millipore; cat#MAB312RX)
• Mouse-anti-CD11b-IgG2a (APC conjugated) (Biolegend; cat#201809)
For each antibody a single stain was made using a small fraction of the original
cell population (100K per single stain). Cells were incubated with antibodies for 25
minutes in 4°C. Antibodies were washed twice using 1ml of HALF WB. Second wash
included Hoechst 33342 (2µg/ml; Sigma) to detect live/dead cells. Cells were flowed
using BD AriaIII Cell Sorter.
Isolation strategy was as follows: Detect live/dead cells, isolate CD11b positive
cells (microglia), detect A2B5 positive cells (OPCs). Staining thresholds and aut-
oflourscences were set for each isolation using single stain samples. For all isolations,
cell viability was more than 90%. A illustration of the isolation strategy is shown in
chapter 4.
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Antibody Dilution Vendor Catalog#
Primary antibodies
Mouse anti-A2B5 (IgM) 2.5µg per 107 cells Millipore MAB312
Mouse anti-CD11b-Microbeads 10µl per 107 cells Miltenyi 130-105-634
Mouse anti-O4 (IgM) 2.5µg per 107 cells R&D Systems MAB1326
Goat-anti-Mouse-MOG-Biotinilated 2.5µg per 107 cells R&D systems BAF2439
Secondary antibodies
Mouse-anti-Biotin magnetic micro beads 20µl per 107 cells Miltenyi 130-105-637
Rat-anti-mouse-IgM magnetic beads 20µl per 107 cells Miltenyi 130-047-302
Table 2.3 Antibodies used for MACS
2.4 Adult OPC culture
Cells were plated onto 48 well plates (VWR) pre-coated with PDL (Sigma). OPC
medium (OPCM) was used for experiments unless stated differently. Cells were
plated in low density, 10K cells per well (48 well plate). After seeding, cells were
left to recover overnight in media supplemented with b-FGF and PDGF (Peprotech)
according to age of the animal (neonatal 20ng/ml; young adult and aged 30ng/ml).
For aged cells, after two days media was changed to promote proliferation (OPCM +
20ng/ml b-FGF and PDGF) or differentiation (OPCM + 40ng/ml T3). During both
differentiation and proliferation, media was changed every other day.
Table 2.4: OPC medium formulation. The medium was mixed, sterile filtered
and kept at 4°C.
Component Final Conc. Stock Conc. Vendor Catalog#
DMEM/F12 1X 1X Gibco 31330-038
NAC 60µg/ml 6mg/ml Sigma P4333
Insulin 10µg/ml 4mg/ml Gibco 12585014
Sodium pyruvate 100µM 100mM Gibco 11360070
Apo-Transferrin 50µg/ml 5mg/ml Sigma T2036-100MG
Putrescine 16.1µg/ml 1.61mg/ml Sigma P5780
Na-Selenite 40ng/ml 0.5µg/ml Sigma S5261E
Progesterone 60ng/ml 6µg/ml Sigma P8783
Table 2.4 OPC medium formulation
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2.5 Isolation of aged and young Mononuclear phago-
cytes (MNPs)
Following OPC (aged or young)MACS isolation, A2B5 negative cells were centrifuged
(300g, 5 minutes) and cell pellet was re-suspended in DMEM-F12 supplemented with
10% FBS (Fetal Bovine Serum) for ghost experiments, or OPC modified media for
conditioned media experiments. Cells were plated densely in untreated suspension
plates for overnight recovery. Next day, cells were detached from the suspension
plates using ice cold HBSS- supplemented with 5mM EDTA. Cells were incubated
in detachment solution in 4°C for 15-20 minutes and then removed using a pipette.
The cell suspension was then centrifuged (300g, 5 minutes) and re-suspended in 90µl
HALF WB with 10µl anti-Rat-CD11b magnetic micro beads (Miltenyi; cat#130-105-
634) for every 10 millions cells for 15 minutes in 4°C. Cells were washed using cold
8ml MWB and then pelleted again (300g, 5 minutes). Cells were then loaded to a MS
column as described above.
2.5.1 Ghost protocol
CD11b positive cells (microglia) were plated densely in 48 well plates, 40K cells
per well in microglia media (DMEM-F12 + 10% FBS). Cells were let to recover for
48 hours before media was completely removed and ddH2O. Plate was immediately
placed in dry ice for instant freeze. Plates were later kept for short term in -20°C,
or long term in -80°C. Before use, plates were defrosted and the water was removed
completely before new cells were plated on top of the ghosts.
2.5.2 Conditioned media
Cells were plated in density of 40,000 cells per well onto 24 well plates using OPCM.
After overnight recovery, media was completely removed and replaced with fresh
OPCM supplemented with either TGFb (Peprotech) or TGFb inhibitor (SB-431542,
Tocris). Cells were cultured for 48 hours, afterwards media was removed, filtered
using 22µ filters to remove any cell debris and was frozen immediately using dry ice.
Conditioned media was stored in -80°C until used.
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2.6 Isolating OL lineage cells
Single cell suspension was achieved as describe above. Cells were re-suspended in
100µl of HALF WB with 2.5µg of Goat-anti-Mouse-MOG-Biotinilated (RD systems;
cat#BAF2439) antibody for 25 minutes in 4°C. Cells were washed with 8ml of MWB
and centrifuged (300g, 5 minutes). Cell pellet was re-suspended in 80µl HALF
WB supplemented with 20µl Mouse-anti-Biotin magnetic micro beads (Miltenyi;
cat#130-105-637) for 15 minutes in 4°C. Cells were washed with 8ml of MWB
and centrifuged (300g, 5 minutes). MACS was executed as describe above. MOG
negative fraction was centrifuged (300g, 5 minutes) and MACS A2B5 was performed
as described above. A2B5 negative cells were centrifuged (300g, 5 minutes) and
cell pellet was re-suspended in 100µl of HALF WB with 2.5µl Mouse-anti-O4-IgM
(R&D systems; cat#MAB1326) and incubated in 4°C for 25 minutes. Cells were then
washed using 8ml of MWB and then centrifuged (300g, 5 minutes). Cell pellet was
re-suspended using 80µl HALF WB with 20µl rat-anti-mouse-IgM magnetic beads
(Miltenyi; cat#130-047-302) and incubated for 15 minutes in 4°C. Cells were washed
using 8ml of MWB and centrifuged (300g, 5 minutes). MACS was then performed
as describe above. Following MACS, cells were plated in 48 well plates (VWR) for
culturing (same conditions as for adult OPCs) or were lysed immediately for DNA and
RNA isolation. Number of cells isolated per animal changed according to the age of
the animal (see chapter 4), but for young adult rats (2-3 months old) which were used




Following A2B5 MACS sorting, cells were pelleted (1000g, 5 minutes) and immedi-
ately lysed using RLT Plus Lysis Buffer (Qiagen). For young and aged OPC isolation,
approximately 106 cells were used on average per sample. RNA isolation was per-
formed using Qiagen RNeasy Micro Kit (Qiagen), including on column DNA digestion
step. Following elution, RNA was frozen immediately using dry ice and was stored at
-80°C until library preparation.
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Fig. 2.2 RNA quality control Example for successful RNA QC, using a Bioanalyzer.
Before library preparation, each sample was subjected to QC using a Bioanalyzer
(Agilent). Minimal required RIN (RNA Integrity Number) was 8. (A) Electrophoresis
run of two samples and a ladder, showing high bands in 4000 and 2000 nucleotides
bands. (B) Graphs showing peak readings at 4000 and 2000 nucleotide for a young
and aged OPCs RNA samples.
2.7.2 Library preparation
RNA quality was assessed by Qubit measurement and posterior RNA nanochip/picochip
Bioanalyzer. Only high quality samples were used for library preparation and sequenc-
ing (RIN > 8, see figure 2.2). Ribosomal RNA was depleted with rat-specific oligos
(InDA-C technology). Sequencing libraries were prepared using 10-100ng total RNA
and the Nugen Ovation RNA-Seq Systems 1-16 for Model Organisms Kit (0349-32).
2.7.3 Full transcriptome sequencing and downstream analysis
Sequencing was performed on the Illumina HiSeq4000 in a pair-end 150 base pair
format. Adapter sequences were removed and reads were quality-trimmed using
TrimGalore. Trimmed reads were aligned to the rat reference genome (RGSC6.0/rn6)
by using TopHat2 (http://ccb.jhu.edu/software/tophat, version: 2.0.13) guided by
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Ensemble gene models. Raw counts per gene regions were obtained by featureCounts.
Replicates were evaluated, counts were normalised and differential expression of
transcripts was evaluated by the R Bioconductor DESeq2 package. Expression levels
were further normalised by transcript length (per kB). Transcript annotations were
based on Ensemble (Release 82). GO analysis was done using GOrrila (Eden, Navon,
Steinfeld, Lipson, & Yakhini, 2009). Ingenuity pathway analysis was done by IPA
(Qiagen). Principal Component Analysis was performed using Clustvis (Metsalu &
Vilo, 2015).
2.8 DNA methylation sequencing
2.8.1 DNA isolation
Following FACS isolation, A2B5 positive cells were pelleted (1000g, 5 minutes) and
DNA was extracted using Qiagen DNeasy Blood Tissue Kit, including RNA digestion
step, using Rnase A on column digestion, according to manufactures instructions.
2.8.2 Whole Genome Bisulfite Sequencing (WGBS) and downstream
analysis
Whole Genome Bisulfite Sequencing (WGBS) was performed on Illumina HiSeq4000.
Reads were trimmed with TrimGalore, with default parameters. Reads were aligned
and de-duplicated using bismark. Methpipe was used to calculate DNA methylation
levels in all regions (Song et al., 2013). Window size for promoter methylation analysis
was 1000bp. For aged and young OPCs, approximately 5⇥105 cells were used for
each sample.
2.9 qRT-PCR (OPCs, microglia)
RNA was isolated from acutely purified OPCs and microglia or from cultured OPCs
and microglia using Qiagen RNeasy Micro Kit, or Directzol RNA MicroPrep Kit
(Zymo Research; cat#R2061). Isolated RNA was immediately frozen using dry ice
and was further stored in -80°C. RNA quantities were measured using Nanodrop 2000
(Thermo Scientific). cDNA was generated using Qiagen QuantiTect Reverse Tran-
scription Kit according to the instructions of the manufacturer (Qiagen; 205310). For
RT-qPCR, primers were acquire from KiCqStart SYBR Primers (SIGMA-ALDRICH)
and used at a concentration of 300µM. cDNA, primers, and the Syber Green Master
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Mix (Qiagen; 204141) were mixed as instructed by the manufacturer, and RT-qPCR
and melting curve analysis were performed on Life Technologies Quantstudio 6 Flex
Real-Time PCR System. Fold changes in gene expression were calculated using the
delta delta Ct method in Microsoft Excel using TATA box binding protein (Tbp) as a
control gene. Statistical significance was determined using two-tailed unpaired t-tests
assuming equal variances.
2.9.1 Primers used for qRT-PCR
See table 2.5 for full list of primers used in this study.
Gene name Sequence
Ascl1 5’ - AAACAAGGGAAGAGGAAAAG - 3’
5’ - CATTGAATCTAAGTCCTGGTG - 3’
Cd44 5’ - AAGATTTTATCTCCAGCACC - 3’
5’ - CTGTCTATATCAGTCATCCTGG - 3’
Cspg4 5’ - ACAAGCTCAAGAATTTCCAC - 3’
5’ - TGAAGTTCCCTGTAGTGTAAG - 3’
Cnp1 5’ - TTTCAAGAAAGAGCTTCGAC - 3’
5’ - TAAGATCTCCTCACCACATC - 3’
Enpp6 5’ - AATTTGTCTCTCCTTTGACC - 3’
5’ - CTTTCTGGACATCAGATAGC - 3’
Fn1 5’ - AAGCCAATAGCTGAGAAATG - 3’
5’ - AAGTACAGTCCACCATCATC - 3’
Il10 5’ - TCTCCCCTGTGAGAATAAAAG - 3’
5’ - TAGACACCTTTGTCTTGGAG - 3’
Pdgfra 5’ - GAGATTATGAATGTGCTGCC - 3’
5’ - TTTCTCGTGAACAGAAATGC - 3’
Sox6 5’ - TCCCAATTTTTCCACATGAC - 3’
5’ - GTTATCACCTGGCTTGTATG - 3’
Tbp 5’ - CATCATGAGAATAAGAGAGCC - 3’
5’ - GGATTGTTCTTCACTTTGG - 3’
Tnf 5’ - CTCACACTCAGATCATCTTC - 3’
5’ - GAGAACCTGGGAGTAGATAAG - 3’
Table 2.5 List of primers
2.10 OL lineage sequencing
Following MACS isolation, cells were pelleted (1000g, 5 minutes) and DNA and
RNA was isolated using ZR-Duet DNA/RNA MiniPrep (Zymo Research, D7001)
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according to manufacture instructions. Thius, RNA and DNA were isolated from the
same cells. RNA isolation included on column DNA digestion using DNase I. Further
sequencing and analysis was performed as described above. Number of cells used
changed between cell types. Number of OLs and OPCs were approximately 106 cells
per sample, whereas for POLs only 3⇥105 cells were isolated from each sample.
2.11 Statistics
Statistical analysis was performed on GraphPad Prism (GraphPad Software, Inc.),
excluding one sample T-Tests which were performed using SPSS (IBM). Immunohis-
tochemical staining were counted using CellProfiler (as described above) and results
were compared using suitable statistical tests. If more than two groups were present, a
one-way analysis of variance (ANOVA) test was performed, followed by appropriate
post test in order to compare individual groups. For all statistical analysis, differences
between groups were considered significant at p-value < 0.05.
Graphs were produced using GraphPad Prism or RStudio.
2.12 Flow cytometry
Cells were collected immediately after MACS isolation, pelleted (1000g, 5 minutes)
an re-suspended in 500µl of 4% PFA. Solution was incubated on ice for 20 minutes.
Following incubation, cells were washed twice using PBS and finally re-suspended
in 100µl PBS. Before flow cytometry, cells were were blocked with 5% NDS for 20
minutes in RT. Primary antibodies were added according to table 2.1 for 30 minutes
in RT. Following primary incubation cells were washed twice using PBS and then
incubated for 20 minutes with appropriate secondary antibodies (see table 2.1). Cells
were washed twice using PBS, and re-suspended in MWB for flow cytometry analysis.
For every flow cytometry experiment, appropriate single stain controls were obtained.
Flow cytometry was performed on Attune NxT Flow Cytometer (Thermo Fisher
Scientific). Results were analysed using FlowJo (FlowJo, LLC).

Chapter 3
Transcriptomics and epigenetics of
OL lineage in the adult rat
3.1 Introduction
A key step in successful remyelination is the differentiation of OPCs to mature myeli-
nating OLs. OPC differentiation is a complex process, which includes both morpholog-
ical and transcriptomic changes. The morphological transition is characterised by the
transition from a bi-polar cell type, to a multi process cell, and eventually the creation
of multiple myelin sheaths. This morphological transition is accompanied by various
changes in gene expression, which ultimately lead to the expression of multiple myelin
proteins. Previous studies have characterised both the transcriptomic and methylomic
changes in the neonatal OL lineage (Moyon, Huynh, et al., 2016; Zhang et al., 2014).
Studying neonatal cells limits the ability to draw conclusions regarding adult cells
behaviour and biology. This is especially true for OPCs, as during the rodent neonatal
stage these cells are highly active, as myelination takes place in this time frame. This
is in contrast to OPCs which reside in the adult brain, where de novo myelination
is rare and might be restricted mainly to learning processes (Mckenzie et al., 2014;
Young et al., 2013). Therefore, similar to other tissue resident stem cells one would
expect cells to be in a more quiescence state, which will have different properties than
the activated neonatal state (Cheung & Rando, 2013).
As remyelination is usually studied in the context of the adult/ageing organism, I set
out to study the adult counterparts of the OL lineage. For that I developed a method
that can reproducibly isolate cells from distinct phases in OPC differentiation, and
then continued to perform a full transcriptome and methylome analysis in order to
explore the critical changes between OPCs and differentiated OLs, hopefully to shed
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more light of the distinct functions of adult OPCs, the mechanisms that govern their
differentiation in the adult CNS. Moreover, it is currently unknown what role do adult
OPCs play in normal brain function (if any). The dataset presented in this chapter
will perhaps enable researchers to begin exploring the specific roles OPCs might play
outside the remyelination paradigm.
3.2 Experimental strategy
Fig. 3.1OL lineage triple isolation method A summary of the method used to isolate
cells from the different stages of the OL lineage. (A) Schematic presentation sequential
MACS steps used for the isolation of OL lineage cells. (B) Set of images showing
the various markers used to discriminate between the various cell types within the
OL lineage. The sequential steps used in the isolation are also marked, as MOG+
cells were the first to be isolated, followed by A2B5+ cells and finally O4+ cells. (C)
Illustration of the expression levels of the markers used for the cell isolation within the
OL lineage cells.
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Fig. 3.2 OL lineage cells A summary of the the differences exhibited by the different
cells types isolated using the method described above (fig3.1). (A) Morphological
changes exhibited by the various cell types, all stained using O4 antibody (green).
This exemplifies the growing comlexity exhibited by more differentiated cells (right
hand side of the panel). (B) Set of images showing selected markers for each stage of
differentiation. Cells were cultured in vitro for 48 hours after isolation.
In order to develop a isolation strategy, I based my work on the adult OPC isolation
protocol previously developed in the lab (see Materials and methods). I decided to base
the isolation on sequential MACS sortings, each time removing a specific population
in the lineage. The distinction between the three populations are shown in figure 3.2, as
well as the isolation sequence. Panel A in figure 3.2 shows the changes in morphology
during OL differentiation and maturation in vitro, from a bi-polar cell to membranous
cells type. Panel B shows key markers which are associated with the various phases in
OL differentiation. Panel C identifies the markers used for the lineage isolation, which
was done as follows:
Oligodendrocytes (OLs) were isolated first using anti MOG antibody. OLs are
recognised both by the expression of MBP (a mature OL marker) after short time in cell
culture, as well as by exhibiting a distinct membranous morphology, expressed by O4
staining in the upper panel of the figure. MOG negative were then be sorted by A2B5
MACS to isolate OPCs (MOG-/A2B5+). OPCs were characterised by expressing
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progenitor markers and the lack of mature OL markers. A2B5 positive cells were
also distinct from the OLs, by the high percentage of bi-polar cells present in culture,
and the lack of mature membranous, sheath-like morphology (see section 3.3.1 for
more details). A2B5 negative cells were then labeled by O4 antibody to isolate cells
that are pre oligodendrocytes (POL; MOG-/A2B5-/O4+). O4 positive cells exhibit
mainly multi-polar morphology, and only few of them showed bi polar morphology or
membrane like morphology.
3.3 Results
3.3.1 Isolation and in vitro characterisation of OL lineage cells
To characterise the differences between the various cell population isolated in the
Triple MACS protocol, I cultured each cell type in identical conditions and assessed
their differentiation capabilities. All cells were plated in similar densities, and were
cultured in identical media. Following isolation, cells from P20-30 neonatal rats were
plated in PDL coated, 48 well plates, in a density of 10,000 cells per well. Juvenile
cells were used as they are easier to maintain in culture. As A2B5 is expressed in both
neonatal and aged OPCs and used for isolating OPCs in various ages (see chapter 4
as well as (Windrem et al., 2004)), I could use the same antibody for OPCs from all
ages. Cells were cultured for 24-36 hours in OPCM supplemented with 20ng/ml of
FGF and PDGF before switching to differentiation media (OPCM with 40ng/ml of
T3). Differentiation was assessed after a total of 72 hours in culture, from which 24
hours were in differentiation conditions (OPCM with 40ng/ml T3). I chose a short
time scale for assessment of differentiation for two main reasons: firstly, the media I
used was made in order to answer the specific needs of OPCs, a progenitor cycling cell,
and not OLs - a fully differentiated cell type which might require different culturing
conditions. Therefore, I did not want my results to be skewed by high proportions
of cell death. Secondly, from past experiments and the experience of other members
in the lab, I knew that OPCs do not significantly differentiate within 24 hours in
culture. Therefore, I could be certain that cells that show differentiated morphology
and appropriate markers were in fact freshly isolated OLs.
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Fig. 3.3 In vitro culture of cells from different phases of the OL lineage OL lineage
cells were isolated as described above and were cultured for 72 hours in OPCM. (A)
Proportions of NG2 positive cells out of all O4 positive cells (all cells in the OL
lineage) in order to assess progenitor proportions. Using this double labelling has
shown that almost none of the OLs expressed NG2 (2.05%), whereas approximately
50% (47.99%) of POL express both markers and 86.9% of OPCs expressed both
markers. These changes were highly significant (one way ANOVA, n = 4, p-value
< 0.0001). (B) Percentage of A2B5 positive cells (out of total cells). This staining
also revealed a significant difference (one way ANOVA, n = 2, p-value = 0.0001)
between the different populations, where OLs do not express the progenitor marker in
comparison to OPCs (36.44%) and POLs (37.66%). Supporting the notion that the
OL fraction contained very small number of contaminating progenitor cells. (C) To
test differentiation capacities of the different cells, I used CNPase staining to mark
differentiated OLs. The figure shows the percentage of CNPase positive cells out
of the total OLIG2 positive cells (total OL lineage). Differences between the cells
groups were significant (one way ANOVA, n = 2, p-value = 0.0029), as 88.95% of
the OLs were labeled double positive, in comparison to 14.66% of the POLs and only
2.25% of the OPCs. (D) O4 staining was used to further assess differentiation by
analysing cell morphology. Cells were identified as either having processes (marked in
red,’Processes’) or membranous sheaths (marked in blue, ’Sheaths’) using CellProfiler
software. This analysis yielded a significant difference in proportions between the
various cell groups 74.97% of O4 expressing OLs exhibited a cell morphology which
showed distinct sheaths, only 17.24% of the O4 positive OPCs have shown the same
morphology and 30.365% of the POLs (two-way ANOVA; interaction p-value = 0.017
and column factor p-value = 0.0482).
Cells from different phases in the OL lineage, can be defined according to expres-
sion of specific antigens and according to unique morphologies. Figure 3.3 summarises
in vitro experiments in which cells from all groups were cultured at the same conditions.
I observed significant differences in both gene expression as well as morphologies
between the different cell types. OPCs and POLs expressed higher degree of NG2 and
A2B5, both markers for early stages of OL lineage (fig3.3A-B), whereas, OLs showed
significantly higher percentage of CNPase positive cells (fig3.3C). Changes in mor-
phology (fig3.3D) were also significant, as cells in the OL group showed significantly
high proportion of membranous and sheath like morphology in comparison to cells
from the other groups.
The high percentage of CNPase positive cells in the OL cell group (88.95%), as
well as their complex morphology, implies that these are in fact acutely isolated
oligodendrocytes, and are not progenitors cells which differentiated rapidly in culture.
Using flow cytometry analysis of cell from the triple isolation, I could verify both
the purity of the samples, as well as the proportions of progenitor cells. Figure 3.4
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Fig. 3.4 Flow cytometry analysis of OL lineage cell types To acutely assess the
purity of the cells in the various groups, I used Flow Cytometry analysis. For flow
cytometry analysis cells from juvenile rats were used (P20). Cells were isolated accord-
ing to the triple isolation method described before and were then fixed immediately in
suspension. I used O4 to identify cells from the OL lineage and A2B5 to identify OPCs
specifically. (A) Percentage of O4 positive cells out of all cells in suspension. For all
cell groups, percentage of positive cells was above 80%, and this was significantly
higher than the percentage in the negative fraction (one way ANOVA, n = 4, p-value <
0.0001). (B)Measuring the intensity of the O4 staining revealed a significant higher
staining intensity in the OL fraction in comparison to the OPC and POL groups (one
way ANOVA, n = 4, p-value = 0.0034). (C) A representative histogram of intensities
used to calculate medians of O4 staining intensity. Intensity was calculated in arbitrary
units. (D) Using A2B5 antibody I tested the percentage of progenitor cells in each
cell group. Higher proportions of A2B5 positive cells were detected in both OPC and
POL groups in comparison to OLs (one way ANOVA, n = 2, p-value = 0.007). (E)
Comparing A2B5 intensity in all cell groups, revealed a decrease in intensity in POLs
and OLs in comparison to OPCs (one way ANOVA, n = 2, p-value > 0.05). (F) A
representative histogram of intensities used to calculate medians of A2B5 staining
intensity. Intensity was calculated in arbitrary units.
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describes these experiments. Cells from all groups show high proportion of O4 staining
(above 80%), a known marker for OL lineage. As expected, O4 intensity significantly
increases in OLs in comparison to OPCs/POLs, according to their position in the
lineage. Using A2B5 antibody, I could assess the percentage of progenitors in each
group. As expected, I observed a steady decline (yet not significant) in both the
percentage of positive cells (p-value = 0.07), as well as their intensities. Intensities for
both O4 and A2B5 were calculated using the median intensity of positive cells. OPCs
exhibited high levels of A2B5 positive cells (92.95%, 1.344%), supporting the this a
valid method to isolate OPCs.
3.3.2 Developmental changes in OL lineage ex vivo
Fig. 3.5 Changes in OL lineage cells in development Total cell number was counted
in each sample after percol gradient step, and in the end of each isolation step. (A) A
summary of each fraction percentage out of the total cells isolated. OLs are marked
in blue, POLs in green and OPCs in orange. There is a clear transition from a pre-
dominantly progenitor based population in early neonatal stages, to a more terminally
differentiated population in later developmental stages. (B-D) Linear plots describing
the change in proportion of each cell group with time. R2 values and p-value are
stated for each figure. The linear plots provide evidence for the changes within the OL
lineage, as the proportion of OLs significantly increases on the expense of the OPC
fraction.
Summarising the cell numbers from each triple isolation shows changes in in the
proportions of progenitor and differentiated cells within the OL lineage total population.
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I chose to calculate the changes in proportions as percentage of OL lineage cells
isolated, and not total cells in the brain (as counted at the beginning of each isolation
following the percol gradient), in order to avoid the data being skewed by changes in
total cell number which can sometimes change between isolations, irrelevant to the
final numbers. This calculation allowed me to assess the changes in relative ratios the
different cell populations.
As seen in figure 3.5A, the more developed the animal is, there is an increase in
the relative proportions of OLs in expense of OPCs. In order to further explore the
cause behind the changes in the cell proportions, I plotted the percentage of each cell
type across time, as seen in figure 3.5B-D. In these graphs, the Y axis represents the
change in cell percentage as a proportions of the total OL lineage isolated, while the
X axis shows the log age of the animal in days. Figure 3.5B shows the significant
increase in OL proportions as a percentage of the total OL lineage with development,
while figure 3.5D shows the opposite trend for OPCs.
3.3.3 Transcriptome analysis of adult OL lineage cells
After verifying that I was able to successfully isolate distinct populations of the
OL lineage which exhibit the correct characteristics of the various steps in OPC
differentiation (section 3.3.1), I moved on to isolate cells from adult rats (n = 4,
2 males, 2 females) aged 2-3 months old in order to isolate both RNA and DNA
for transcriptomic and epigenetic analysis. t-SNE analysis provided evidence for
successful separation of three distinct populations (fig3.6A). t-SNE is a machine
learning based algorithm which was developed specifically for dimensionally reduction
of high-dimensional datasets (developed by Geoffrey Hinton and Laurens van der
Maaten). Using this method, I was able to divide my samples according to two
components as determined by the analysis. Plotting changes in volcano plots (fig3.6B-
D) show multiple genes with expression change between the different phases of the
OL lineage. Comparing OLs and OPCs resulted in 1925 differentially expressed genes,
while comparing between OLs and POLs resulted in 1083 differentially expressed
genes. OPCs and POLs showed 1243 differentially expressed genes. This is expected,
as OPCs and OLs are the most ’distanced’ population on the OL lineage.
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Fig. 3.6 Transcriptomic analysis of adult OL lineage cells (A) Full RNA sequencing
of adult OL lineage cells, isolated into three distinct groups: OLs, POLs and OPCs
(n = 4 for each group). (A) A t-SNE analysis of the three groups according to their
gene expression profile. This resulted in a clear distinction between the three groups
according to two components. Each group marked in different colour, as specified.
(B-D) Volcano plots presenting changes in gene expression between the different cell
populations. In each plot, genes which show significant changes (adjusted p-value <
0.05) are marked in colour according to the cell type (OL -> red, POL -> purple, OPC
-> blue)
The following tables show the GO analysis of enriched processes in each cell
type in comparison to the other cells (GO analysis was generated using GOrrila). GO
analysis show the expected upregulation of myelin genes in the OL cell population in
comparison to the OPCs and POLs. OPCs show upregulation of processes related to
cell activation, detection of stimulus and immune system regulation. POL enriched
processes were mainly regarding the detection of stimulus.
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OL vs OPC
GO process Enrichment p-value
Axon ensheathment 1.25893E-11
Ensheathment of neurons 1.25893E-11
Myelination 3.16228E-11
Glial cell differentiation 1.58489E-06
Oligodendrocyte differentiation 1.51356E-05
OL vs POL
GO process Enrichment p-value
Myelination 0.00017378
TNFSF11 mediated signalling pathway 0.000190546
Axon ensheathment 0.000281838
Ensheathment of neurons 0.000281838
Ether lipid metabolic process 0.000316228
Table 3.1 Top GO processes enriched in OLs vs OPCs and POLs
POL vs OPC
GO process Enrichment p-value
Amino acid transport 0.000194984
POL vs OL
GO process Enrichment p-value
Regulation of response to stimulus 5.37032E-05
B cell chemotaxis 0.000204174
Positive regulation of cystein-type endopeptidase 0.000338844
Regulation of motor neuron apoptopic process 0.000691831
Regulation of response to external stimulus 0.000758578
Table 3.2 Top GO processes enriched in POLs vs OPCs and OLs
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OPC vs OL
GO process Enrichment p-value
Regulation of immune system process 3.16228E-15
Positive regulation of immune system 1.58489E-14
Cell activation 3.98107E-12
Regulation of immune response 6.30957E-12
Immune system process 7.94328E-12
OPC vs POL
GO process Enrichment p-value
Protein refolding 4.16869E-06
Detection of chemical stimulus 3.16228E-05
Negative regulation of inclusion body assembly 3.46737E-05
Detection of chemical stimulus involved 3.54813E-05
Regulation of inclusion body assembly 5.88844E-05
Table 3.3 Top GO processes enriched in OPCs vs OLs and POLs
3.3.4 Comparing adult and neonatal OL lineage transcriptomics
In order to validate my database, I compared it to a well established neonatal OL
lineage database published by Zhang et al., (Zhang et al., 2014). For comparing the
two datasets, I selected the top 100 upregulated genes (p-value < 0.05) for each two
cell type comparison (i.e. OL vs OPC, OL vs POL, POL vs OL, POL vs OPC, OPC
vs OL and OPC vs POL). The results are summarised in Venn diagrams in figure 3.7,
where in every figure, a list of common genes are shown.
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Fig. 3.7 Comparison of neonatal and adult OL lineage cells Top 100 significantly
expressed genes in each cell type when compared to to other cell types were compared
to top 100 enriched genes as was shown by Zhang et al., (Zhang et al., 2014). Genes
from adult cell comparison are marked in orange circles, wheareas neonatal genes are
marked by blue circles. For each comparison a venn diagram was created to show
how many genes are similar between the adult database generated by this study to
the database published by Zhang et al. For example, comparing the top 100 enriched
genes in OLs vs OPCs as described in both databases revealed 15 shared genes only.
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Comparing enriched genes in OLs versus OPCs yielded 15 common genes, includ-
ing mainly known myelin genes such asMbp, Mobp and Plp1. A similar comparison
of genes upregulated in OLs in comparison to POLs revealed only a single gene
in common Slc32a1, similar to the other comparisons which also yielded a single
common gene, with the exception of upregulated genes in OPCs versus POLs which
yielded no common genes.
Expression of quiescence markers in adult OPCs
Since the adult OPCs I isolated did not distinguish themselves by expressing ‘classical’
OPC markers (i.e. Pdgfra, Cspg4, Sox2) known from the literature (Zhang et al.,
2014), I decided to explore in depth which genes are differentially expressed between
OPCs and OLs. Since adult OPCs reside in quiescent like state, and exhibit low rate of
myelination (Young et al., 2013), I hypothesised that adult OPCs express quiescence
genes similar to quiescence stem cells from other tissues. Together with colleagues in
the lab (Neumann and Segel, personal correspondence) and recent literature (Barker,
Tan, & Clevers, 2013; Basak et al., 2017; Klempin, Marr, & Peterson, 2012; Cheung &
Rando, 2013), I identified multiple genes that are associated with quiescence stem cells
from various tissues and compiled a list of candidate genes that represent quiescence
cells in adult known stem cell niches.
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Fig. 3.8 Expression of quiescence genes in adult OPCs Comparison of quiescence
related genes (gene list was based on multiple publications, mainly (Barker et al.,
2013; Basak et al., 2017; Klempin et al., 2012; Cheung & Rando, 2013)) in OPCs
versus OLs. (A) Volcano plot describing the RNA expression (log2 of fold changes
in FPKM, x-axis) and p-value (-log10) of selected quiescence genes. Overexpressed
genes in OPCs are marked in red, while higher expressed genes in OLs are marked in
blue. For each group, significantly upregulated (adjusted p-value < 0.05) are labeled
with the corresponding gene name. (B) A heatmap listing all the genes chosen for
this analysis, and relative expression over all samples. Red colours represent higher
expression values, while blue colours represent lower expression.
Figure 3.8 illustrates the results of the analysis of pre-chosen quiescence related
genes. Although only three genes were significantly upregulated in OPCs in compar-
ison to OLs, it is clear that the overall trend is of more genes upregulated in OPCs,
rather in OLs. Out of 51 genes in total, 33 (64.7%) were upregulated in OPCs, with
only 3 genes (Hes1, Rnf167 and Lgr5) were significantly upregulated. Similar analy-
sis comparing POLs and OPCs revealed only a single gene which was significantly
different, Grb10, which was upregulated in POLs in comparison to OPCs, similar to
its status in OLs vs OPCs (data not shown).
I further explored specific pathways that might be upregulated in adult OPCs
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using Ingenuity Pathway Analysis (IPA, Qiagen). Figures 3.9 and 3.10 show the top
pathways selected as enhanced in OPCs in comparison to OLs and POLs, respectively.
Both pathways include genes which are mostly known for their role in immune cells
activity. This corresponds with the immune related GO terms that were identified by
the GOrrila analysis, described in table 3.3
Fig. 3.9 Expression of NfkB related pathway in adult OPCs vs OLs Genes signifi-
cantly upregulated in OPCs vs OLs (adjusted p-value < 0.05) were submitted to IPA.
Top pathway predicted was IL10 pathway (enrichment p-value = 3.63*10(-9)). (A)
Illustration of the relationship of the different molecules in the pathway. (B) Heatmap
illustrating the changes in expression in the genes composing the pathway between the
different cell types. The heatmap shows a clear separation between OLs and OPCs,
whereas, POLs show a mixture of expression between the two cell types. Red colours
represent higher expression levels, while blue colours represent lower expression
levels.
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Fig. 3.10 Expression of PPARa/RXRa related pathway in adult OPCs vs POLs
Genes significantly upregulated in OPCs vs POLs (adjusted p-value < 0.05) were
submitted to IPA. Top pathway predicted was PPARa/RXRa pathway (enrichment
p-value = 3.22*10(-5)). (A) Pathway illustration of the connections between the various
molecules detected in the analysis. (B) Heatmap illustrating the changes in expression
of the pathway genes. Gene expression reveals clear separation between cells types as
expected. As this pathway was detected as upregulated in OPCs vs POLs, but not vs
OLs, it is not surprising that expression pattern shows upregulation in OPCs and OLs,
while being downregulated in POLs. Red colours represent higher expression levels,
while blue colours represent lower expression levels.
3.3.5 Methylation changes across the adult OL lineage
The role of DNA methylation in OL lineage cells was studied recently (Moyon, Huynh,
et al., 2016; Moyon et al., 2017), but a full methylome was only constructed for
neonatal OL lineage cells (Moyon, Huynh, et al., 2016). The ablation of Dnmt1 in OL
lineage cells (Using an Olig1 promoter) resulted in inefficient OPC differentiation and
reduced OPC proliferation. In contrast, in adult animals, the ablation of DNMT3A in
differentiating OPCs (Plp1 promoter) resulted in reduced remyelination. This suggests
that DNA methylation plays an important role in OPC biology, both in developmental
and adult cells. I therefore set out to explore the methylome of adult OL lineage cells
using WGBS.
Promoter DNA methylation is considered to be an inhibitory mark for transcription,
so as a first step I wanted to test if that is correct in my dataset. Similar to the results
shown in chapter 5, I could not find this kind of correlation. Figure 3.11 illustrates
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this: highly methylated genes in OLs (red and yellow dots) show both increased and
decreased expression rates. This pattern is repeated for other cell type comparison, i.e.
OL vs POL and POL vs OPC (data not shown).
Fig. 3.11 The effect of changes in promoter DNAmethylation between OPCs and
OLs on RNA transcript expression For each gene, promoter DNA methylation was
calculated as the change in methylation between OLs and OPCs and was plotted
against log2 of the fold change in transcript expression. Coloured dots represent genes
of which their promoters had 5X coverage at least for methylation analysis, and fold
change was significantly different (adjusted p-value < 0.05).
Even though I could not point out a specific correlation between DNA methylation
and transcription rates, I decided to analyse the GO terms of differentially methylated
promoters between each cell type. The results are summarised in the tables below. The
GO terms are different than the ones detected by the analysis of the transcriptional
changes between the cell types and some of the GO terms are common for both
hypomethylated and hypermethylated changes. This is in line with the lack of direct
correlation between transcript expression and promoter DNA methylation shown in
figure 3.11, and suggests that DNA methylation play a more complex role in the
control of transcription. Nevertheless, it is clear that the methylation changes are
focused in components of the cells which are most likely to be monitored during OPC
differentiation and OL maturation. For example, OLs show changes in methylation
(hypo and hyper) mainly in membranous proteins. This is true when comparing to
POLs and OPCs.
OPCs on the other hand show hypermethylation in processes that are related to stimulus
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detection. A more in depth view revealed that many of the genes clustered to these
processes are olfactory related genes. This could be related to the inhibition of neuronal
fates in OPCs when transitioning to POLs.
3.3.6 Sex based differences in OL lineage cells
Using both males and females for the isolations (n = 2 for each sex) allowed me
further analysis in the potential effects of sex on OL lineage cells. Past published
work has shown that aged females show enhanced remyelination in comparison to
aged males (W. W. Li, Penderis, Zhao, Schumacher, & Franklin, 2006). Analysing the
data divided according to sex, could reveal whether this difference in aged OPCs are
already evident in the young adult OPCs.
As was shown previously in figure3.6A, all cells were clustered according to the cell
type using t-SNE analysis, and there was no evidence for clustering according to sex.
Figure 3.12A show the same t-SNE analysis, with labelling to distinguish the different
samples. Sample 1 and 2 were derived from male rats, while 3 and 4 were from female
rats. Samples did not seem to cluster according to the sex of the animal. In order
to study each cell type separately, I used PCA, but this did not reveal any clustering
according to sex (3.12B-D). I further tried to cluster the cells according to list of
nuclear receptor genes (Di Canio et al., unpublished). This list includes multiple genes
which encode to sex hormones receptors which I expected would be affected by the
sex of the animal. Using K-means clustering did not show clustering according to sex
either (fig3.13). This suggests that the sex of the animal has very little if no effect on
the transcriptome of OL lineage cells (in this age range of 2-3 months).
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OL vs OPC hypermethylation
GO component Enrichment p-value
Membrane part 1.58489E-16
Intrinsic component of membrane 2.24999E-14
Plasma membrane part 4.39997E-12
Plasma membrane 1.12001E-11
External side of plasma membrane 1.56E-09
OL vs OPC hypomethylation
GO component Enrichment p-value
plasma membrane bounded cell projection part 2.34E-06
Cell projection part 2.34E-06
leading edge membrane 1.76E-05
cell junction 5.62E-05
cell projection membrane 7.81E-05
OL vs OPC hypermethylation
GO process Enrichment p-value
Signal transduction 2.38E-15
G-protein coupled receptor signalling pathway 2.03E-13
Immune system process 3.17E-13
Immune response 3.50E-13
Positive regulation of immune system process 5.47E-13
OL vs OPC hypomethylation
GO process Enrichment p-value
Negative regulation of supramolecular fibre organisation 7.77E-05
Regulation of transport 8.14E-05
Negative regulation of chemokine production 1.24E-04
Regulation of cell projection organisation 1.71E-04
Cellular hyperosmotic response 1.81E-04
Table 3.4 Top GO term in differentially methylated promoters between OPCs and OLs
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OL vs POL hypermethylation
GO component Enrichment p-value
Membrane part 1.82E-16
Intrinsic component of membrane 1.14E-15
integral component of membrane 4.85E-15
Plasma membrane 1.32E-11
Plasma membrane part 4.27E-11
OL vs POL hypomethylation






OL vs POL hypermethylation
GO process Enrichment p-value
Immune system process 1.05E-12
Positive regulation of immune system process 2.82E-12
Regulation of immune response 4.84E-12
Signal transduction 3.83E-11
G-protein coupled receptor signalling pathway 4.99E-11
OL vs POL hypomethylation
GO process Enrichment p-value
Hyperosmotic response 1.83E-04
Cellular hyperosmotic response 4.40E-04
Response to osmotic stress 7.75E-04
Table 3.5 Top GO term in differentially methylated promoters between POLs and OLs
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POL vs OPC hypermethylation
GO component Enrichment p-value
Membrane part 2.63E-13
Intrinsic component of membrane 4.69E-13
Integral component of membrane 8.12E-13
Plasma membrane 2.20E-08
External side of plasma membrane 1.39E-06
POL vs OPC hypomethylation
GO component Enrichment p-value
membrane part 3.81E-07
Intrinsic component of membrane 3.19E-06
Integral component of membrane 5.22E-06
Proton-transporting two-sector ATPase complex, catalytic domain 4.77E-04
Cell projection membrane 5.86E-04
POL vs OPC hypermethylation
GO process Enrichment p-value
G-protein coupled receptor signalling pathway 3.39E-14
Detection of chemical stimulus 1.84E-11
Detection of chemical stimulus involved in sensory perception 2.73E-11
Detection of stimulus involved in sensory perception 8.99E-11
Detection of stimulus 1.04E-10
POL vs OPC hypomethylation
GO process Enrichment p-value
hyperosmotic response 1.83E-04
cellular hyperosmotic response 4.40E-04
response to osmotic stress 7.75E-04
Table 3.6 Top GO term in differentially methylated promoters between OPCs and
POLs
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Fig. 3.12 Transcriptome analysis according to sex in OL lineage cells (A) t-SNE
analysis of all samples. Male samples are labeled 1 and 2, while the female samples
are 3 and 4. No clustering according to sex is visible. (B-D) PCA analysis for each
cell type separately. None of the samples show clustering according to the sex of the
animal.
Fig. 3.13 Expression of nuclear receptors in OL lineage cells (A-C) Heatmaps
showing the clustering of each cell type using only nuclear receptor genes. In this
case cells were again clustered differently for each cell type, regardless of the sex of
the animal. This is despite using a smaller list of genes which includes sex hormones
receptors
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I next asked whether the sex of the animal affects the alternative splicing. As shown
in fig3.14B the total number of significant (adjusted p-value < 0.05) differentially
expressed exons between males and females is dramatically lower than the when
comparing cell types (53 vs 3218). This is also true when testing the changes between
each two cell types (fig3.14B, right hand graph). This is visualised in the volcano plots
shown in figure 3.14. When comparing the number of exons differentially expressed
between each two cell types, the most distant cell types (OPCs and OLs) have the
fewest significant differentially expressed exons (343), in comparison to the changes
between OLs and POLs (2411) or OPC and POLs (2912). This leads to the conclusion
that the main differences between distant cell types on the lineage are in expression
of specific full transcripts (genes turned on and off), while the subtle changes of
alternative splicing mainly differ between cells that are closer on the lineage.
Fig. 3.14 Differential exon expression in OL lineage cells (A) Volcano plot showing
differentially expressed exons between males and females. Coloured dots represent
exons which were significantly differentially expressed (adjusted p-value < 0.05).
(B) Bar plots summarising the difference in number of significantly expressed exons
according to gender and cell type (53 and 3218 respectively. The right hand plot shows
the number of differentially expressed exons within each comparison: OPC vs OL (343
exons), OPC vs POL (2912) and OL vs POL (2411). (C) Volcano plots visualising the
exons differentially expressed between the different cell types. Coloured dots represent
significantly (adjusted p-value < 0.05) differences.
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3.3.7 Differential exon usage in OL lineage
After analysing changes in full transcript expression between the the different cell
types in the adult OL lineage cells, I investigated the possible alternative splicing
events between the different cell types, that would lead to differential exon usage
between the various cell types. An overview of this analysis was presented in the
previous section, in figure 3.14.
I ranked the top genes that exhibit significantly differential exon usage between each
two cell types. The top 50 genes in each comparison are listed in figure 3.15A-B.
A further GO analysis of all of the genes is then listed in tables 3.7 and 3.8. Most
processes enriched between POLs and OLs are related to cell adhesion and cell surface
genes. This is not surprising as the maturation of oligodendrocytes involves connection
between the OL and axons. Thus, most of the genes were also located in the projection
components of the cell. This was true also for the genes which show differential exon
usage between OPCs and POLs. Although, the main enriched processes in these genes
were not as specific to cell adhesion as the ones mentioned before.
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Fig. 3.15 Top differential exon expression in OL lineage cells (A) Top 50 genes
which show highest number of significantly differential exon usage between OPCs
and POLs. (B) Top 50 genes which show highest number of significantly differential
exon usage between OLs and POLs. (C) Venn diagram of both comparisons described
above. It shows that approximately half of the genes that have differential exon usage
are similar in both comparisons.
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OL vs POL
GO process Enrichment p-value
Cell-cell adhesion 1.95E-05
Cell-cell adhesion via plasma-membrane adhesion molecules 3.89E-05
Cell projection organisation 1.89E-04
Single-organism cellular process 2.27E-04
Cell adhesion 3.30E-04






Table 3.7 GO analysis genes showing significant exon differential usage between OLs
and POLs
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OPC vs POL
GO process Enrichment p-value
Negative regulation of axonogenesis 3.35E-05
Single-organism cellular process 5.31E-05
Positive regulation of ion transport 8.62E-05
Regulation of cellular component movement 8.99E-05
Positive regulation of endocytosis 1.13E-04




Plasma membrane bounded cell projection 6.65E-06
Neuron part 8.09E-06
Table 3.8 GO analysis genes showing significant exon differential usage between OPCs
and POLs
3.3.8 Transposable elements in OL lineage cells
Using the deep RNA sequencing of multiple samples, I was able to research the
changes in transposable elements (TEs) in the OL lineage. Figures 3.16 and 3.17 show
the top 25 TE classes which are upregulated between each two cells types (OPC vs
POLs and OLs vs POLs, respectively). Reviewing these lists will reveal that many
of the classes are mutual in all comparisons. This is further illustrated by the Venn
diagram displayed in figure 3.18. This suggests that these TE classes do not play a
specific role in the differentiation along the lineage. In order to verify that no specific
single TEs are involved in OL lineage differentiation, I plotted the top 500 TEs for
each cell type. This time I have used each TE chromosomal address in order to identify
unique TEs for each cell type (TE signature). This is illustrated by the Venn diagram
in figure 3.19. This diagram illustrates that the number of unique TEs is the highest
in OLs, suggesting that TEs that were activated in previous differentiation stages
remained active throughout the lineage.
DNA methylation is usually considered one of the mechanisms used by cells to
suppress the unwanted activation of TEs. I therefore investigated whether that is the
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case in my dataset. Similar to the results shown in chapter 4 I could not establish a
correlation between TE expression and methylation levels. This was true for all cell
types (fig3.20A-C). I could not find any correlation, even when observing specific TE
families such Alu or L1 (fig3.20D and E respectively).
Fig. 3.16 Top 25 transposable elements classes expressed in OPCs and POLs (A)
Top 25 TE classes which are significantly upregulated in OPCs vs POLs. (B) Top 25
TE classes which are significantly upregulated in POLs vs OPCs.
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Fig. 3.17 Top 25 transposable elements classes expressed in OLs and POLs (A)
Top 25 TE classes which are significantly upregulated in OLs vs POLs. (B) Top 25 TE
classes which are significantly upregulated in POLs vs OLs.
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Fig. 3.18 Venn diagram of TE classes significantly expressed between OL lineage
cell types
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Fig. 3.19 Venn diagram of 500 top expressed TEs in the different OL lineage cell
types As expected the POLs have the least mount of unique TEs (27%), followed by
OPCs (37%) and finally OLs (60% unique TEs).
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Fig. 3.20 Expression and methylation levels of TEs in OL lineage cells All TEs in
this analysis were covered by at least 5X coverage for methylation analysis. (A-C)
Scatterplots illustrating the levels of of expression and methylation of specific TEs in
each cell type (OL, POL and OPC - from left to right) It is clear that no correlation can
be found between the expression levels of specific TEs and their methylation levels.
(D-E) Scatterplots showing the expression levels and methylation of Alu (D) and L1
(E) elements in OLs. Again, no correlation can be found between expression levels
and methylation levels.
3.4 Discussion
3.4.1 Adult OL lineage isolation
In this part of my project I successfully isolated three different cell type groups within
the OL lineage from adult rats. Even though my in vitro experiments show predictable
results regarding the function and activity of these cells as would have expected from
similar studies done in neonatal OL lineage cells, comparing the transcriptomes of
adult OL lineage cells yielded different changes between the cell populations compared
to the differences detected by previous studies,
For my experiments I decided to begin with MOG positive cells (will be termed OL
from here on) and not with A2B5 positive cells (will be termed OPC in this section
from now on). This is in oppose to the method used by Zhang et al (Zhang et al., 2014)
where OPCs were isolated prior to OLs. I chose to isolate OLs first as I believe there
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has to be an overlap between the population so there are cells in transition between
OPCs and OLs, which must express both markers. But, it is likely that cells that
express MOG, will not be able top revert back to progenitor state, and are already
destined to be in the OL fate. Thus, isolating OLs first, allowed me to isolate pure
uncommitted OPC population.
Figure 3.5 also support the method I chose, as it shows that proportions of the different
sub-populations of within the OL lineage (as represented by the numbers of cells I
isolated from each animal) show the developmental trend expected from these cells.
Thus, the proportion of mature OL rises with development, whereas the proportions of
OPCs declines. This is in line with other reports regarding developmental myelination
in rodents, which is known to take place during the first couple of months postnatally
(A. H. Crawford, Tripathi, Richardson, & Franklin, 2016).
My results show a distinction between the differences stages in the OL lineage, as seen
in figure 3.6. My data also allows a more in depth look into the differences between
adult OLs and adult OPCs than were observed before. For example, Moyon et al.,
(Moyon et al., 2015) compares adult OLs to adult OPCs and reveal changes in only
37 genes. This can stem from multiple differences between the two datasets. Firstly,
Moyon et al., used a microarray analysis in comparison to my database which is based
on full RNA sequencing. A second, and maybe a more important difference is the
method used to isolate the different cells. Moyon used FACS sorting to isolate their
cells, using PDGFaR::GFP mice to isolate OPCs, and PLP-GFP mice for OLs. In the
PDGFaR::GFP mice, the GFP construct is attached to the histone H2B. This can create
a state in which, even though Pdgfra expression has ceased, the GFP will linger on.
This way, cells which are supposedly PDGFRA positive, are not anymore in reality,
thus creating a mix population between OPCs and OLs. This is shown by the single cell
sequencing done by Marques et al., (Marques et al., 2016) which used the PDGFRA-
H2B-GFP mice to isolate cells from the full OL lineage. Moreover, according to my
dataset, unlike neonatal OPCs, which are in constant activation mode and therefore
express high levels of Pdgfra, adult OPCs are in a resting quiescence state and their
expression levels of Pdgfra are similar to those expressed by OLs. This again support
my original decision to begin with MOG isolation, as this included both mature OLs
as well as OPCs which are en route of differentiation. Another observation made by
Moyon et al., was that activated adult OPCs upregulate inflammatory mediators as part
of their response to demyelination, and specifically indicate the role of Il1b and Ccl2.
In similar fashion, I also found that OPCs and POLs upregulate the expression of both
genes, and mainly Il1b compared to OLs. This could also be due to the presence of
contaminating microglia, but I found this unlikely due to the high percentages of O4+
3.4 Discussion 85
and A2B5+ cells identified in flow cytometry (fig3.4).
The in vitro culturing experiments shown here only compared the cells differentiation
capacities. In the future, I would like to perform additional experiments using these
cells in order to define their proliferation potential and multipotency. For that I will test
what proportions of the cells in each group are proliferative as well as the proportions
of cells that can become astrocytes. According to the results I have obtained so far, I
would expect that OLs will show the lowest proliferation capacity as well as the lowest
astrocyte formation. POLs will show high proliferation capacity, but low number
of astrocytes and OPCs will show low proliferation (see quiescence cells in section
below) but high capacity for astrocyte formation as these cells are the only ones which
are not committed to the OL fate.
The method of isolation I present here can also be used to study the effects of ageing
on OLs biology. Using MOG isolation, aged and young OLs can be isolated and
their transcriptomes can be compared and analysed. It will interesting to investigate
whether there are changes in expression of key genes in aged OLs. I would expect
to see changes in the expression of genes related to myelin compaction, as myelin
integrity has been shown to deteriorate in normal ageing brains using MRI imaging
(Bartzokis et al., 2003). Another feature of OLs that could interesting to explore
would be changes in genes related to the tropic support provided by OLs to axons.
These changes could be due to changes in expression of full transcripts, or as shown in
chapter 5, can be due to changes alternative splicing.
3.4.2 Differences between adult and neonatal OL lineage cells
Comparing my results with those obtained by previous studies (figure 3.7, (Zhang
et al., 2014) ) revealed major differences in the gene expression signature between
cells that are suppose to represent similar stages in the OL lineage. There are several
possible explanations for this result:
1. Using different animals for cell isolation -
Even though mice and rats are both rodents and share many similar traits, it is
only reasonable that the main changes will be revealed when observing specific
changes in gene expression. Moreover, several studies conducted by various
members of my lab (Neumann, personal communication) have shown that rat
and mouse OPCs specifically differ considerably in their in vitro behaviour and
therefore they will harbour transcriptional differences as well.
2. Different isolation sequence -
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Zhang et al, used the following sequence of isolations: OPCs, OLs and finally
POLs. Whereas I have isolated OLs first and only then proceeded to isolate
OPCs and POLs from the remaining pool of cells. As discussed above, using
this method ensured that my OPCs do not contain any cells that are already
committed to the OL lineage, thus the population is composed mainly of true
progenitor/stem cells.
3. Inherent differences between neonatal and adult OL lineage cells -
Zhang et al., have used neonate mice (P7) for the isolation of cells from the OL
lineage. At this stage, most OPCs are highly activated and intense myelination
is carried out throughout the rodent CNS. This is in a striking contrast to the
CNS state in the adult CNS brain, from which I have isolated the cells. At the
age of 2-3 months, most developmental myelination in rats are completed, and
OPCs which reside in the brain are in a quiescence state (see next section) and
are definitely not in an activated state as their neonatal counterparts.
3.4.3 Adult OPCs are quiescent stem cells
Are OPCs adult stem cells? This has been questioned and debated before (A. Crawford
et al., 2014; Franklin & Ffrench-Constant, 2008). The main criteria for defining a
cell as a stem cell are their multipotency, ability to self-renewal, asymmetric division
and quiescence state, common to many other tissue specific stem cells. Even though
majority of OPCs usually differentiate to OLs both in normal conditions as well as
following lesions (Zawadzka et al., 2010), they posses multipotent abilities and can
differentiate into multiple other cell types including astrocytes (Raff et al., 1983),
neurons (Belachew et al., 2003) and even non-CNS cells, such as Schwann cells
(Zawadzka et al., 2010). Adult OPCs also show proliferation capabilities (Dawson et
al., 2003) and there is evidence that they can undergo asymmetrical division (Sugiarto
et al., 2011). But it has not been known whether or not adult OPCs can actually be
described as quiescence stem cells, similar to other tissue specific stem cells? (Cheung
& Rando, 2013)
The overexpression of known quiescence markers in my OPC isolated population
when compared to the OL population, suggests so. The list of genes I used to define
quiescence was according to genes expressed in other stem cells, mainly haematopoi-
etic stem cells (HSCs), muscle stem cells (MuSCs) and hair follicle stem cells (HFSCs)
(Cheung & Rando, 2013). To that list I added some known quiescence genes described
regarding other stem cell niches, such as Hes1/5 , Lgr5 and Pax5/6 (Barker et al.,
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2013). Even though most of the genes on the list were upregulated in OPCs, only a
few were significantly upregulated. From observing the individual sample data (figure
3.8B) I could infer that there was high variability within samples of each group in the
expression levels of these genes. This combined with low amount of mRNA in OPCs
in general (especially when compared to the amount in OLs) can explain the difficulty
in obtaining significant results. Moreover, many of the genes I used for comparison
were detected in other tissues, and are not widely expressed in CNS resident cells.
Therefore it is not surprising that the genes that are significantly expressed in OPCs
included genes that were detected in quiescence NSCs.
In this section I intend to explore some of the factors upregulated in OPCs and how
these factors promote quiescence as been described in other cell types.
• Lgr5 -
The Lgr5 gene encodes an orphan G-protein-coupled receptor. It is a downstream
target of the Wnt pathway, and was observed in several types of carcinomas.
In the colon and the small intestine, Lgr5 is expressed by cycling cells, as it is
expressed by the crypt base columnar cells. These cells are based in the bottom
of the crypt (as their name suggests) and are interspersed between differentiated
Paneth cells (Barker et al., 2007).
Similarly, Lgr5 is also expressed by cycling hair follicle stem cells (Jaks et al.,
2008). Interestingly, these are also the first cells to respond to anagen (formation
of hair follicle)-initiating signals. This is similar to the role of OPCs which also
responds to external stimuli. This is also in line with some of the GO terms that
are enriched in OPCs in comparison to OLs and POLs, including detection of
chemical stimulus and cell activation.
Moreover, as a downstream target of Wnt signalling, it is not surprising that
OPCs overexpress Lgr5 as Wnt inhibition is required for OPC differentiation.
• Hes1 -
Hes1 (mammalian hairy and Enhancer-of-split homologues) is a bHLH type
transcription factor which is a downstream of the NOTCH signalling pathway.
NOTCH signalling is required for the maintenance of of NSCs (Hitoshi et al.,
2002). More specifically, overexpression of Hes1 inhibits the differentiation of
neural stem cells (Ishibashi et al., 1994) and has been shown to control neuronal
differentiation (Nakamura et al., 2000).
In OPCs, HES1 expression is downregulated following cuprizone administration,
and when not inhibited, it blocks differentiation (Shen, Sandoval, et al., 2008).
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In summary, these two examples present genes which are known to be part of the
quiescence states in multiple stem cells resident cells, and therefore their upregulation
in adult OPCs further supports the notion that these are quiescence stem cells.
Ingenuity Pathway Analysis (IPA) further revealed interesting pathways which are
activated in adult OPCs when compared to POLs and OLs. These were NfkB and
PPARa pathways (figures 3.9 and 3.10). NfkB pathway was related to the maintenance
of pluripotency in both human embryonic stem cells (hES, (Armstrong et al., 2006))
as well as human induced pluripotent cells (IPS, (Takase et al., 2013)). In both cases,
NfkB expression was downregulated with the differentiation of the cells. Since NfkB
and its dimers have multiple targets in in the genome, only through ChiP-sequencing
experiments we will be able to elucidate its specific role in OPCs in particular and stem
cells in general. Therefore, I assume that NfkB plays a similar role in the maintenance
of the progenitor state in adult OPCs.
This observation regarding the ‘stemness’ of adult OPCs, raises the question whether
the cells I isolated weren’t actually neural stem cells (NSCs) and not OPCs? This notion
can be supported by the reports of several groups regarding the role of adult NSCs
in remyelination. For example, Xing et al., show that in the cuprizone model, NSCs
originating in the SVZ were responsible for a substantial amount of remyelination
and regeneration (Xing et al., 2014). The generation of OLs by NSCs and OPCs
was spatially segregated, and morphological differences were noticed as well. More
recently, Samanta and colleagues introduced the mechanism underlying the recruitment
of NSCs to remyelination, which included the inhibition of Gli1 (Samanta et al., 2015).
This is similar to the expression pattern of Gli1 shown in my dataset as Gli1 is
significantly upregulated in OPCs in comparison to OLs (fold change = 3.28, adjusted
p-value < 0.001). Thus, NSCs can participate in remyelination and can therefore
‘contaminate’ the OPC group presented here. I find this unlikely, due to the expression
pattern of Nes in my database. NSCs are characterised by high expression of Nestin ().
This was not evident in my database as OPCs did not display upregulation of Nestin in
comparison to OLs or POLs (adjusted p-value = 0.86 and 0.44 respectively). Therefore,
I do not believe that my results are due to contamination of the OPC pool by NSCs.
The lack of higher expression of Nes together with lack of neurons developing in any
of my in vitro cell culture experiments (data not shown) both support the notion that
adult OPCs and NSCs are in fact two distinct and separate cell populations.
In conclusion, using a novel technique to isolate and distinguish between the
various cells in the adult OL lineage allowed me to identify a unique signature of
the OPCs in the adult CNS, which was cannot be observed when studying neonatal
OPCs. This is due to extreme differences in the environments and roles OPCs between
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the neonatal and adulthood phases. The data I present here supports the notion
that similarly to other tissues in the mammalian body, the CNS also harbours a
resident quiescent stem cell population. Further experiments will be needed in order
to characterise more clearly the unique state of OPCs in adulthood. Open questions
include the spatial organisation of adult OPCs (do they have a niche much like other
stem cells?) and their role in normal conditions.
3.4.4 Transposable elements in OL lineage
Transposable elements (TEs) are usually mentioned in relation to DNA damage and
ageing, in which they have been shown to increase in expression (this topic is covered
extensively in chapter 4 in relation to ageing OPCs). The potential role of TEs in
cell differentiation and stem cell maintenance is currently unknown. In this chapter
I showed evidence for upregulation of multiple families of TEs in the different OL
lineage cell types. At a first glance this can support the notion of a novel role for TEs
in OL maturation (and maybe even in other cell types). Unfortunately, I do not think
this is the case here. The fact that same families of TEs show upregulation in all cell
types suggest that there is no specific role for a TE family in a specific cell type. Using
a Venn diagram I show that each cell type only has very few cell type specific TEs
uniquely expressed (Figure 3.19). Moreover, as the role of TEs in cell differentiation is
currently unknown, it is difficult to verify that these expression patterns are not solely
due to correlation with other genes, i.e. - TE which are adjacent to genes which are
upregulated can be upregulated as well just by proximity.
Figure 3.19 shows the common specific TEs between cells types. As expected, POLs
exhibit the least number of uniquely expressed TEs. I expected that since these cells
share most the most active TEs both OPCs (TEs that were activated did not get shut
down) and whatever new TEs have been activated in this state, are now shared with the
next phase of maturation - the OLs. Surprisingly though, OLs show the highest number
of uniquely expressed TEs (60% of the top 500 expressed TEs), which contradict
somewhat the theory I have just proposed. I would have expected that OPCs would
have higher ratio of expression of TEs as they are progenitor cells and it has been
shown that at least neural progenitor cells express higher ratios of TEs (Coufal et al.,
2009).
To further investigate the potential role of TEs in OL lineage cells, more specific
genomic studies and experiments must be conducted. For example, each significantly
upregulated TE should be verified not to be adjacent to other upregulation genes.
Furthermore, functional essays must be conducted in order to discover functional roles
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of TEs.
Figure 3.20 shows the relationship between TE expression levels and their methylation
levels. I could not find such correlation, in contrast to previous studies (Slotkin &
Martienssen, 2007; Woodcock, Lawler, Linsenmeyer, Doherty, & Warren, 1997). It is
possible that DNA methylation is not the main mechanism in which OL lineage cells
silence TE expression, and they employ other epigenetic mechanisms, such histone
modification and RNA silencing (Slotkin & Martienssen, 2007).
3.4.5 Differential exon usage in OL lineage cells
Alternative splicing is an elaborate mechanism that allows eukaryotic cells to enhance
the number of proteins they can produce from a smaller amount genes. In the OL
lineage, Moyon et al., have recently reported that knock out of Dnmt1 in OPCs led
to dysfunctional alternative splicing (Moyon, Huynh, et al., 2016). Therefore I set
fourth to examine which genes in the adult OL lineage could be affected by alternative
splicing. To examine this I isolated the genes which exhibited significant changes in
differential exon usage (adjusted p-value < 0.05) and submitted them to GO analysis
using the GOrrila web tool, in the same way I used it previously for analysing changes
in full transcripts (tables 3.7 and 3.8 and tables 3.1, 3.2 and 3.3 respectively). In both
comparisons (OLs vs POLs and POLs vs OPCs) most genes were identified to be part
of the membranous part of the cell, and were even identified into the same categories
exactly. This suggests that genes that exhibit alternative splicing in OPCs vs POLs,
also show significant changes in exon usage when POLs transition into OLs. This
is also evident when comparing the top 50 genes that show significant exon usage -
many of the genes are mutual in both comparison as illustrated by the Venn diagram
(fig3.15C).
It is therefore clear that these changes in alternative splicing are relevant to the correct
OPC differentiation. It yet unknown what are the specific mechanisms that control
these splicing events, as my attempts to correlate changes in DNA methylation to
differential exon did not yield a correlation (see chapter 5 for specific illustrations). It
is possible that further research will uncover the mechanisms that control alternative
splicing in OL lineage cells.
3.4.6 Sex based differences in OL lineage cells
One of the main advantages of the isolation method used in this chapter is the ability
to isolate all three OL lineage cell types from the same rat. This allowed me to retrieve
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multiple samples form both male and female young adult rats. Sex hormones receptors,
such as Estrogen receptors have been implicated to have a role in OPC differentiation
and remyelination (Gonzalez et al., 2016) as well as progesterone receptors (Hussain
et al., 2011). Moreover, pregnant females show decreased symptoms of EAE and
MS (Voskuhl & Palaszynski, 2001). This led me to compare my female and male
samples. Surprisingly, clustering of the samples was not according to the sex of the
animal, but seemed to be random (figure3.12). The lack of clustering according to sex
was evident when using different clustering methods, including t-SNE (figure3.12A) ,
PCA (figure3.12 B-D) and K-means (data not shown). This was also true for when
samples were clustered according to nuclear receptors which include multiple sex
hormone receptors (figure3.13). Males and females also exhibited a very small changes
in differential exon usage in comparison to the striking differences exhibited by the
different cell types (figure3.14). These results fall in line with evidences from toxin
induced demyelination study performed by Li and colleagues (W. W. Li et al., 2006).
In this study male and female rats showed differences in remyelination rates only in
advanced ages. Thus, sex based differences in OL lineage cells (and OPC specifically)
arise only in later ages than the ones I studied in this chapter. Clearly in order to study
these potential changes, the study described in this chapter is needed to be replicated
by using aged female and male rats. I expect that this will provide us with knowledge
regarding the changes in aged male and female OPCs. As to the studies exhibiting
differences in MS and EAE between males and females - one must remember that
these are autoimmune based diseases, and as such the adaptive immune system plays a
pivotal role in the advancement of the disease. Therefore, according to the results I
provide in this chapter, together with the conclusions from toxin induced demyelinating
studies, I assume that the underlying reasons for male/female differences in EAE/MS
are due to the changes in the immune system.

Chapter 4
Transcriptome and methylome of
aged OPCs
4.1 Introduction
One of the main obstacles for successful remyelination is the failure of OPCs to
differentiate into mature myelinating OLs following demyelination lesions(Kuhlmann
et al., 2008; Woodruff et al., 2004). This phenomenon increases with ageing and is a
feature of MS in the chronic stages. As patients usually reach this stage only in older
ages, it is sensible to assume that changes that occur with ageing are related to this
decline in remyelination and chronic deterioration. Although previous studies have
described the changes in remyelination with ageing in general (Shields et al., 1999;
Sim et al., 2002), and some have focused on the changes in the macrophage/microglia
population (Zhao et al., 2006), only few studies so far have described the intrinsic
changes that occur in the OPCs (Shen, Sandoval, et al., 2008).
In a study from 2015, Moyon et al., (Moyon et al., 2015) have described the
changes between neonatal and young adult OPCs. The authors specify that adult OPCs
exhibit a more differentiated phenotype in comparison to the neonatal counterparts.
They further report that during remyelination, activated OPCs are reverted back into
neonatal stage before fully differentiating into OLs. Since this study was limited to
neonatal and young adult OPCs, and did not include aged OPCs, it does not explain the
changes in aged OPCs which limit their differentiation capabilities. Previous studies
by Shen and colleagues (Shen, Liu, & Li, 2008; Shen, Sandoval, et al., 2008) show
that changes in HDAC activity in aged OPCs can explain at least partially the lack of
differentiation in aged OPCs. Therefore, there is reason to believe that aged OPCs are
internally different and exhibit transcriptional and epigenetic changes in comparison
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to young adult OPCs.
Using newly developed isolation methods recently established in the Franklin lab
(B. Neumann et al., n.d.) I was able to isolate OPCs from both young and aged adult
rats in order to study the changes in their transcriptome as well as methylome and
therefore establish a database that will enable research into potential new targets in
aged OPCs
4.2 Experimental strategy
OPCs were isolated using A2B5 magnetic sorting (MACS) (fig4.2) or fluorescent
activated (FACS) (fig4.1) from both young and aged male rats. Young adult OPCs
were isolated from rats who were 2-3 months old, as this is considered to be an age
where remyelination is highly efficient, while developmental myelination is considered
to be complete. This is similar to the age chosen by previous studies in order to
explore young adult OPCs (Moyon et al., 2015). Aged OPCs were isolated from
18-22 months old rats. Rats older than 24 months began developing tumours and
other health problems, which required them to be culled before use. OPCs used
for DNA isolation were isolated using FACS sorting, while RNA was taken from
MACS sorted cells. DNA / RNA were isolated immediately after cells isolation, using
Qiagen DNeasy and RNeasy kits respectively. FACS sorted OPCs were only used for
DNA isolation, as attempts to isolate high quality RNA from these samples were not
successful. Therefore, MACS isolated cells were used for RNA extraction.
A2B5 monoclonal antibody was used to isolate the OPCs, as this antigen has been
associated with OPCs for many years, and has been used previously used to label adult
OPCs (Shi, Marinovich, & Barres, 1998; Wolswijk, Riddle, & Noble, 1991). Cells
isolated in this method in my lab, stained 2 hours post plating show high percentages
of OLIG2 and PDGFRA expression (Neumann et al., 2017). Isolations for methylation
sequencing were done using FACS using A2B5-488 conjugated antibodies and CD11B-
APC conjugated antibodies to remove and isolate microglia (4.1A). Percentages of
OPCs between aged and young rats did not change significantly, in contrast to CD11B
numbers which have significantly increased in aged rats (fig4.1B-C). The increase in
CD11B in aged rats could be attributed to both increase in microglia numbers with
ageing, or an increase in infiltration of peripheral immune cells, which are also CD11B
positive (e.g. circulating monocytes, neutrophils, natural killer cells, granulocytes and
macrophages).
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Fig. 4.1 FACS isolation of A2B5 and CD11B positive cells from aged and young
rats (A) Illustration of the FACS strategy used to isolate both OPCs and microglia
from young and aged rats. Desired population is circled by magenta circle in all FACS
plots. Prior to FACS, single cell suspension was generated as previously described
(section 2.3.1). Cells were divided to live and dead by DAPI staining, as only dead
cells incorporate DAPI into their genome. Subsequently CD11B+ cells were removed,
before A2B5 cells were isolated. (B) Percentage of A2B5+ cells did not significantly
differ between aged and young rats (t-test, n=5, p-value = 0.2423). (C) CD11B+
percentages increased significantly with ageing (t-test, n = 5, p-value < 0.05)
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Fig. 4.2 MACS isolation of A2B5 positive cells from aged and young rats
Schematic description of MACS isolation used to isolate OPCs from young and
aged rats. Single cell suspension was generated in similar method as previously
described (see section 2.3.1). Cells were labelled using A2B5 antibody, and were




4.3.1 Age related changes in OPC transcriptome
Fig. 4.3 Changes in gene expression between aged and young OPCs Following the
acute isolation of aged and young OPCs (n = 3) using A2B5 MACS, total RNA was
isolated and RNA sequencing was performed. (A) Volcano plot visualising expression
data for genes sequenced. Coloured dots represent genes that were significantly
different between the two conditions (adjusted p-value < 0.05). Red dots represent
genes that are upregulated in young OPCs, while blue dots mark genes that are
upregulated in aged OPCs. Young OPCs show relative upregulation of progenitor
genes such as Ascl1, Hes1/5 and Pdgfra. Whereas, aged OPCs show the upregulation
of early differentiation genes such as Cnp and Enpp6 (adjusted p-value < 0.05 for
all genes). (B) IPA results of genes upregulated in aged vs young OPCs. Top five
significant pathways are shown, with their respective enrichment p-value (-log10).
As a first step to describe the intrinsic changes between aged and young OPCs, I used
the MACS A2B5 isolation method (see Materials and Methods, as well as Nuemann
et al., 2017) in order to isolate RNA from both young (2-3 months old) and aged
(20-24 months old) OPCs and perform a full RNA sequencing. The volcano plot view
(fig4.3A) illustrates that there are multiple genes which are significantly differentially
expressed between aged and young OPCs. Young OPCs showed increased expression
of progenitor and self renewal genes, such as Ptprz1, Pdgfra, Hes1, Hes5 and Ascl1.
This was in contrast to the aged OPC population which exhibited higher levels of
early differentiation markers, including Enpp6, Sirt2 and Cnp1, but no myelin genes
such as Mog, Mbp, Mag, Mobp. Aged OPCs also did not show a higher expression
of Wnt pathway inhibitors, such as Apc or Axin2, which are usually upregulated in
differentiating OPCs. Selected genes from this list were then confirmed using qRT-
PCR (Neumann et al., 2017). Using a recent single cell sequencing study (Marques
et al., 2016) I compiled list of genes which identify OPCs and OL lineage cells.
Plotting the expression of the 50 OPC signature genes using a heatmap presentation
(fig4.4A), shows that most genes are overexpressed in young OPCs, and not in aged
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ones. More detailed examination revealed that 56.25% of the genes were significantly
overexpressed in young OPCs in comparison to only 8.33% overexpressed in aged
OPCs (adjusted p-value < 0.05) (Neumann et al., 2017). This is illustrated in a pie
chart (fig4.4B). Moreover, using k-means clustering according to OL lineage signature
genes showed that aged OPCs cluster more closely to mature OLs in comparison to
young OPCs (fig4.4C), while still clustering closely to young OPCs.
Figure 4.3B shows the top pathways as predicted by Ingenuity Pathway Analysis
(IPA), when analysing the preferentially expressed genes in both aged OPCs. These
pathways include both metabolism related processes (such as mTOR) as well as protein
translation initiation pathways (EIF2 signalling and eIF4 signalling).
Genes involved in mTOR pathway and were found to be significantly upregulated in
aged OPCs in comparison to young ones are illustrated in their cellular compartments
in figure 4.5A. A visualisation of this can be observed using a heatmap (fig4.5B).
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Fig. 4.4 Upregulation of OL genes in aged OPCs (A) Heatmap showing the expres-
sion of OPC genes (according to recently published single cell sequencing database
(Marques et al., 2016)). Red colours represent high expression, whereas blue colours
represent low expression. It is clear that most genes show higher expression in young
OPCs in comparison to aged OPCs. (B) Pie chart illustrating the relative percentages
of significantly (adjusted p-value < 0.05) upregulated OPC signature genes in aged and
young OPCs. Whereas only 8.33% of the genes are upregulated in aged OPCs (marked
in blue), more than half of the genes are upregulated in young OPCs (56.25%, marked
in red), including key stem cell genes. 35.42% of the genes showed no significant
change in expression between aged and young OPCs. (C) Heatmap representing clus-
tering of young OPCs, aged OPCs and young OLs using OL lineage genes (Marques
et al., 2016). The heatmap shows that OPCs (regardless of their age) cluster tightly
together, but also that aged OPCs cluster closer to OLs than young OPCs, supporting
the claim that aged OPCs are more progressed in the OL lineage and lose some of their
progenitor markers. Red colours represent higher expression, whereas blue colours
represent lower expression levels.
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Fig. 4.5 Upregulation of mTOR pathway in aged OPCs Using Ingenuity Pathway
Analysis (IPA, by Qiagen) multiple pathways were shown to be upregulated in aged
OPCs in comparison to young ones (see fig4.3C for the full list). (A) mTOR pathway
related genes which show significant upregulation in aged vs young OPCs. The illustra-
tion presents the relationship between the molecules and their cellular compartments.
(B) Heatmap showing the mTOR related genes relative expression in young and aged
OPCs. Red colours represent higher expression, whereas blue colours represent lower
expression levels.
4.3.2 Changes in expression of nuclear receptors in ageing OPCs
Nuclear receptors, even though usually expressed in low copy number, play a pivotal
role in intracellular signalling pathways. In OPCs, it has been shown that the Retinoid
Acid (RA) receptor families are crucial for OPC differentiation, with emphasis on the
RXR-g receptor (Huang et al., 2011) and stimulation of of Vitamin D receptors (VDR;
known binding partner of RXR-g) can promote OPC differentiation (de la Fuente et
al., 2015). Recent work in my lab (Neumann 2017, unpublished) has shown that RXR
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agonists, as well as T3 do not enhance the differentiation of aged OPCs in vitro. I
therefore asked if there are changes in the expression of various nuclear receptors in
ageing OPCs in comparison to young ones, as this might serve as an explanation to
the recent results I have just mentioned.
To test the changes in nuclear receptor expression, I compiled a list according to known
literature that included 47 genes (Di Canio et al., unpublished), which many of are
known to play a role in OPC differentiation. Figure 4.6A summarises the differences in
gene expression, where coloured dots represent genes which are significantly changed
with age (adjusted p-value < 0.05). Red dots signify genes that are upregulated in
young OPCs, whereas blue dots represent genes upregulated in aged OPCs. Figure
4.6B summarises the percentage of genes which changed expression in aged and young
OPCs (22.92% of the genes are downregulated in aged OPCs, in comparison to a
single gene which is upregulated in aged OPCs).
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Fig. 4.6 Changes in nuclear receptors expression in ageing OPCs (A) Volcano
plot visualising transcriptome data from young and aged OPCs of selected nuclear
receptor genes. Significantly higher expressed genes in young OPCs are marked in
red dots, and significant higher expressed genes in aged OPCs are marked in blue
dots (adjusted p-value < 0.05). (B) Pie chart displaying the percentages of genes
differentially expressed between young and aged OPCs. 75% of the genes were not
significantly changed between young and aged OPCs (marked in grey in the doughnut
chart). When examining the 25% of the genes which exhibit significant changes in
expression, 96% are downregualted in aged OPCs in comparison to young OPCs
(marked in red). (C) Heatmap illustrating the changes in gene expression of nuclear
receptors genes in young and aged OPCs.
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4.3.3 Changes in DNA methylation in ageing OPCs
After observing the changes in the transcriptome of aged and young OPCs, I continued
to investigate more potential intrinsic changes between young and aged adult OPCs.
Knowing that epigenetic changes play a significant role in ageing ((Issa, 2014) and
chapter 1 for a full review), I decided to compare the methylome of aged and young
OPCs. For this, OPCs were FACS sorted from aged and young OPCs (n = 2 for
each age group), according to A2B5 positive expression and the lack of CD11B
expression (see fig4.1). DAPI staining was used to distinguish between live and dead
cells. Throughout the isolations, live cells accounted for more than 90% of the total
cells identified (according to SSC and FSA analysis). Freshly isolated cells were lysed
immediately, and total genomic DNA was extracted and Whole Genome Bisulfite
Sequencing (WGBS) was performed (see Materials and Methods for further details).
Global changes in aged OPCs methylome
Fig. 4.7 Global genome changes in methylation in ageing OPCs Following A2B5
FACS sorting, total genomic DNA was purified from aged and young OPCs (n = 2)
for WGBS. (A) Scatter plot including the methylation levels in CpGs in all promoters.
Coloured dots represent CpGs in which methylation change was higher than 10%.
Red dots represent CpGs which are hypermethylated in aged OPCs, while blue dots
represent CpGs which are hypermethylated in young OPCs. The darker the colour, the
greater the change in methylation between the samples. Only CpGs with a minimum
of 5X coverage were used for the analysis. (B-F) Violin plots showing methylation
rates in various genomic regions. As can be seen, there are no observable changes in
any of the examined regions.
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After obtaining WGBS results for both aged and young OPCs, I examined the data
to identify global changes in the methylome of aged OPCs. As can be observed in
figure 4.7, although there are many changes in CpGs in promoters (fig4.7A), there
was no overall genomic trend when observing specific functional genomic regions
(fig4.7B-F).
Specific changes in aged OPC promoter methylation
Since there were no significant global changes in the methylome of aged OPCs, I fo-
cused my analysis specifically on promoter methylation, as it thought be more closely
related to gene expression (A. P. Bird, 1985). Comparing the methylomes of aged and
young OPCs revealed multiple specific changes in methylation, but not global changes
(figure 4.7 A), in contrast to previous studies (Issa, 2014). Figure 4.8A plots all the
promoters which are differentially methylated between aged and young OPCs. Next, I
examined the same genes I used for defining young OPCs. Unlike the transcriptomic
results, which have shown a clear overexpression of OPC related genes in young OPCs,
this did not replicate in their methylome. Thus, most differentially methylated genes
were hypermethylated in young OPCs in comparison to aged ones (21 genes versus 7).
Including promoters of genes which were overexpressed in young OPCs and verified
by qRT-PCR (such as, Ptprz1). Similar results were observed when I performed the
same analysis for nuclear receptor genes (fig4.8B).
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Fig. 4.8Changes in OPC promoter methylation (A) Scatterplot shows the promoters
of OPC associated genes and their level of methylation in aged and young OPCs. Blue
dots represent promoters which are hypermethylated in aged OPC in comparison to
young OPCs, and red dots represent the opposite. Change in methylation was analysed
only for CpGs with at least 5X coverage, and methylation change of at least 10%. It
clear that most promoters lose their methylation marks with ageing, suggesting loss
of correct epigenetic landscape with ageing. (B) Another example for methylomic
changes with ageing is shown by focusing on promoter methylation changes in nuclear
receptors genes. This scatterplot shows loss of methylation mark in multiple promoters
of key nuclear receptor indicating an epigenetic drift with ageing.
Since there was not correlation between the expression of OPC genes and their
methylation (as well as for nuclear receptor genes), I then tested this correlation for
all promoters. Figure 4.9 shows both changes in gene expression as well as DNA
methylation for all genes. Hypo or hyper-methylation in the graph indicate the status
in aged cells (i.e. hypomethylated promoter, is a promoter which exhibits loss of
methylation markings in aged cells). Down or up-regulation of genes were also
calculated as compared to status in aged cells (i.e. upregulated genes are genes with
significantly increased expression in aged OPCs in comparison to young ones). In
contrast to previous studies, I could not identify a strong correlation between promoter
methylation levels and transcription levels. This is illustrated in fig4.9C pie chart
which summarises percentages of each category.
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Fig. 4.9 Correlation between DNA methylation and transcription levels in aged
and young OPCs (A) Scatterplot combining both methylation data and gene expres-
sion data in aged and young OPCs. Colourful dots represent genes which show
significant change in methylation and gene expression between aged and young OPCs.
Methylation and expression levels indicate aged OPC state. (B) Pie chart summarising
the percentages of each category of genes. This shows that majority of hypomethylated
genes in aged OPCs are also downregulated in aged OPCs, in contrast to previous
reports regarding the relation between methylation and transcription
Changes in DNA methylation in intragenic regions and their effect on transcrip-
tion
Since WGBS was used in my study, I was able to analyse the potential methylation
changes in gene bodies as well as promoters. This in contrast to previous studies
which examined methylation changes in OPCs and used more restricted methods such
Reduced Representation Bisulfite Sequencing (RRBS) (Moyon, Huynh, et al., 2016).
For this analysis, Differentiated Methylated Regions (DMRs) were chosen as ones
which include 3 CpGs at least, and a significant change was considered as one with
more than 3 CpGs showing a change in methylation status. Only 869 intragenic
regions answered these criteria. Since there are conflicting reports in the literature
regarding the effects of intragenic DMRs, I tested the expression levels of transcripts
regardless of the direction of change in methylation (hypo or hyper). The majority
of genes exhibiting DMR between aged and young OPCs, also showed a decrease in
expression in aged OPCs (fig4.10A). In fact 72.14% of these genes showed a significant
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downregulation with ageing (fig4.10B). These proportions did not change significantly
if only hypomethylated genes or hypermethylated genes were considered (fig4.10C-D
respectively). These results suggest that regardless of the change in methylation at
the gene bodies, the majority of these genes exhibit a decrease in expression in aged
OPCs, in comparison to young ones.
108 Transcriptome and methylome of aged OPCs
Fig. 4.10 Age related changes in intragenic methylation Intragenic regions were
chosen as ones which contain a minimum of 3 CpGs, and at least 3 CpGs exhibited
changes in methylation between aged and young OPCs. (A) Volcano plot showing
only genes which exhibit significant (more than 3 CpGs changed) aged related changes
in methylation in intragenic regions. Red coloured dots represent genes overexpressed
in young OPCs in comparison to aged OPCs. Blue dots represent genes which exhibit
overexpression in aged OPCs in comparison to young ones. (B) Pie chart summarising
the changes in gene expression between aged and young OPCs in genes which exhibit
significant changes in methylation in intragenic regions. A majority of these genes
(72.14%) showed an increase in expression in young OPCs (coloured in red), in
comparison to genes overexpressed in aged OPCs (coloured in blue). (C) Percentages
of genes overexpressed in young and aged OPCs (coloured red and blue respectively),
within genes which are hypomethylated in aged OPCs. (D) Percentages of genes
overexpressed in young and aged OPCs (coloured red and blue respectively), within
genes which are hypermethylated in aged OPCs.
4.3.4 Changes in alternative splicing in ageing OPCs
Alternative splicing has been studied in regards to ageing in general (Harries et al.,
2011; Witten et al., 2011a) and neurodegeneration specifically (Witten et al., 2011b),
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and so I asked if it can contribute to the ageing phenotype observed in aged OPCs.
Differential Exon Expression (DES) analysis was performed using the DEXseq R
package. Plotting genes which are overexpressed in young OPCs in comparison
to aged ones and testing whether they also show upregulation in changes in exons
expression (fig4.11A) revealed that there are almost no genes which are significantly
changed in both the full expression as well as in individual exons. Thus, there is no
connection between full transcript expression to changes in splicing. When examining
which genes show significant changes in splicing (fig4.11B) it was clear that young
OPCs exhibit higher rates specific exon expression. In order to focus on changes in
alternative splicing, that will not be contaminated by changes in whole gene expression,
I filtered out of the gene list all the genes that were differentially expressed between
aged and young OPCs (changes in full transcripts). This allowed me to add another
layer of observed changes between young and aged OPCs. GO analysis of the exons
which are differentially expressed between young and aged OPCs reveal that the top
processes which exhibit alternative splicing are involved in regulation of metabolic
processes (fig4.11C).
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Fig. 4.11 Differential exon expression in aged and young OPCs analysis (A) Scat-
ter plot showing Log2 fold changes in full transcript expression (X axis) plotted against
Log2 fold changes in exons of the same gene (Y axis). Red dots represent genes which
express significant (adjusted p-value < 0.05) upregulation full gene expression as well
specific exon upregulation in young OPCs versus aged OPCs. Blue dots represent
genes under the same criteria but only upregulated in aged OPCs versus young OPCs.
Only a handful of genes show the same trend in transcript expression and differential
exon expression. Thus, there is very little correlation between full transcript tran-
scription and differential exon expression. (B) Volcano plot showing all the exons
significant differential expression between young and aged OPCs. Blue dots represent
exons overexpressed in aged OPCs, while red ones represent exons over expressed
in young OPCs. Grey dots represent exons not significantly differentially expressed
(adjusted p-value > 0.05). This plot illustrates that young OPCs show a higher number
of unique spliced exons in comparison to aged OPCs. (C) Top 5 processes identified
in GO analysis in significantly changed exons. Only genes of which full transcripts are
not differentially expressed between young and aged OPCs were used for this analysis.
In order to investigate more specifically which genes show the most alternative
splicing, I plotted the top 50 genes that show significant splicing events (figure 4.12).
At the top of this list is Kif1b which exhibits 15 significant alternative splicing between
aged and young OPCs. Kif1b has been shown before to play a pivotal role in the
localisation of Mbp mRNA in OL processes during myelination (Lyons, Naylor,
Scholze, & Talbot, 2009). The list includes several more genes which has been show to
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be expressed in OPCs, such asMyrf (Emery et al., 2009) and C3 (Hosokawa, Klegeris,
Maguire, & McGeer, 2003). A visualisation of the differential exon usage of Kif1b
and Myrf is shown in figure 4.13. I also plotted the differential exon usage of Mbp, as
an example of a gene which expresses lower levels of significant change.
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Fig. 4.12 Top 50 genes exhibiting alternative splicing between aged and young
OPCs Top 50 genes which exhibit significant differential exons expression between
aged and young OPCs (adjusted p-value < 0.05). Genes are ranked according to
number of significantly differentiated exons expressed between young and aged OPCs.
4.3 Results 113
Fig. 4.13 Visual representation of differential exon usage in Kif1b, Myrf andMbp.
This visual presentation allows to view the differences between genes in the amount
of differentially expressed exons. Aged transcripts are marked in red, while young
transcripts are marked in blue. Significantly different expressed exons (adjusted p-
value < 0.05) are marked in magenta for each transcript. Note that Mbp exhibits a low
amount of significantly differential expressed exons, in comparison to Kif1b or Myrf
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Aged related alternative splicing inMyrf
Figure 4.13 illustrates the changes in exon expression in the Myrf transcript between
aged and young OPCs. SinceMyrf plays a crucial role in the regulation of many of the
myelin genes I asked what could be the results of this alternative splicing. Out of 27
exons in Myrf, 9 show significantly changed expression between aged and young, and
8/9 are downregulated in aged OPCs (adjusted p-value < 0.05). Using the ensemble
genome browser (fig4.14) I identified the protein domains that are potentially affected
by the loss of specific exons in agedMyrf transcript. Exons 1-3 are are significantly
downregulated in aged OPCs (log2 fold change = 0.28, 0.72, and 0.51, adjusted p-
value < 0.05, respectively) and comprise the PF13888 domain, which is part of MYRF
C-terminal domain. Exons 13-14 are also dowregulated in aged OPCs and are also
part of MYRF C-terminal domain (PF13887). Exon 14 is also downregulated in aged
OPCs and constitute a part of the ICA domain (PF13884) - Intramolecular chaperone
auto-processing domain. This domains enables the auto-proteolysis of the protein.
MYRF is translated as membrane bound protein, that in order to translocate to the
nucleus is auto-processed into two domains. This is done by the ICA domain. This
auto-processing is essential for the transcriptional activity of MYRF, and therefore is
required for the activation of multiple myelin genes (Z. Li, Park, & Marcotte, 2013).
Fig. 4.14 Genomic representation of Myrf exons Using ensemble genome
browser, protein domains in MYRF were identified according to the exons
that constitute them. Exons are numbered from left to right according to the
graph shown in figure 4.13. Exon marked in red are significantly downregu-
lated in aged OPCs, while blue ones are upregulated in aged OPCs (adjusted
p-value < 0.05). Full view of the genome browser is available in the fol-
lowing link: http://www.ensembl.org/Rattusnorvegicus/Gene/Splice?db =
core;g = ENSRNOG00000028274;r = 1 : 226260558   226292480; t =
ENSRNOT00000039133
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4.3.5 Transposable elements in ageing OPCs
Transposable elements (TE) are DNA sequences with the ability to change their lo-
cation within the genome. TEs constitute a considerable fractions of the eukaryotic
genome and are considered harmful to the host genome as their success in duplication
can come at the expense of the host genome stability. Eukaryotic cells have developed
epigenetic mechanisms in order to inhibit activation of TEs. One of the main mecha-
nisms involved in TE suppression, is DNA methylation (Slotkin & Martienssen, 2007).
Thus, I used the deep sequencing that was available to me from aged and young OPCs,
to investigate the possible changes in TE expression in these cells. The results of
this comparison are summarised in figure4.15. In total, 5877 TEs were significantly
differentially expressed between aged and young OPCs (adjusted p-value < 0.05). Out
of these TEs, 80.13% were upregulated in young OPCs in comparison to aged ones.
Only 19.87% of the TEs were overexpressed in aged OPCs. Figure4.15A-B lists the
the classes of TEs which are overexpressed in young and aged OPCs respectively.
Venn diagram analysis showed that most of the families expressed in aged OPCs
are also expressed in young OPCs (as expected), whereas young OPCs exhibit high
expression of 13 classes of TEs, not expressed in aged OPCs. These include DNA TEs,
LTRs, and SINE. This increased expression in TEs in young OPCs, included elements
which have been previously reported to increase in senescent aged cells, such as Alu
(De Cecco, Criscione, Peckham, et al., 2013).
In order to have a more detailed analysis of the different TEs expressed in aged and
young OPCs, I have plotted the top 500 expressed TEs in aged and young OPCs, as
well as in OLs. I could then test whether young and aged OPCs express different
TEs, and also see if aged OPCs show a pattern of TE expression more similar to OLs
than young OPCs do (similar to their gene expression profile described before). Venn
diagram in figure 4.16 shows that between young and aged OPCs more than half of the
top 500 expressed TEs are common. Moreover, it shows that young OPCs have more
TEs in common with OLs than aged OPCs (32 vs 10). Since young OLs were used for
this analysis this suggests that the age of the cells, has more effect on the expression
of the TEs than how mature the OPC is.
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Fig. 4.15 Differential expression of transposable elements in aged and young
OPCs (A-B) Classification of TEs significantly expressed in young and aged OPCs
(respectively). (C) Venn diagram illustrating the common classes of TEs between aged
and young OPCs.
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Fig. 4.16 Top 500 expressed TEs in aged/young OPCs and OLs Venn diagram
showing top 500 expressed TEs in OLs (green), aged (blue) and young (red) OPCs.
Out 500 TEs, 357 (71.4%) were common to both young and aged OPCs. OLs did
not share higher number of TEs with aged OPCs, unlike gene expression results (see
previous sections).
The changes in expression levels in TEs between aged and young OPCs did not
correspond to similar changes in DNA methylation. Aged and young OPCs show simi-
lar numbers of hyper and hypo methylated TEs, and when plotting expression levels
and methylation levels, no correlation was found in aged nor young OPCs (figure4.17).
The scatterplots shown in fig4.17 A-B illustrates that there is no correlation between
the methylation status of a specific TE to its expression levels.
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Fig. 4.17 Age related changes in methylation of TEs (A-B) Scatterplots of methy-
lation levels and expression levels of TEs in aged and young OPCs (respectively).
There is no correlation between the individual methylation levels of each TE, and
its expression levels. (C) Scatter plot of TEs which exhibit significant change in
expression (adjusted p-value < 0.05) and significant change in methylation (at least 5X
coverage; methylation difference > 10). There is no clear correlation between aged
related changes in expression and methylation.
Since I could not find global changes that support the notion that TE expression
increases with ageing, I decided to focus on two main types of TEs widely studied
Alu and L1. These elements were shown to increase in ageing and senescence cells
(De Cecco, Criscione, Peckham, et al., 2013; De Cecco, Criscione, Peterson, et al.,
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2013). I therefore filtered my data to include only these elements and examined both
their expression and methylation. Figure 4.18 shows the number of elements from
each family which are significantly increased in aged or young OPCs. It is clear that
both elements are highly enriched in young OPCs, in comparison to aged ones. Figure
4.19 shows the changes in methylation of Alu and L1 elements. Similar to the global
analysis shown above, there is no correlation in either of the TEs.
Fig. 4.18 Age related changes in expression of Alu and L1 elements (A) A bar plot
summarising the number of significantly upregulated Alu elements in aged (blue) and
young (red) OPCs. Whereas 760 Alu elements were significantly upregulated in young
OPCs, only 152 were upregulated in aged OPCs (adjusted p-value < 0.05). (B) A bar
plot summarising the number of significantly upregulated Alu elements in aged (blue)
and young (red) OPCs. Whereas 1147 Alu elements were significantly upregulated in
young OPCs, only 221 were upregulated in aged OPCs (adjusted p-value < 0.05).
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Fig. 4.19 Age related changes in methylation of Alu and L1 elements (A) A bar
plot and scatter plot summarising the number of Alu elements which exhibited methy-
lation changes (above 10% change between aged and young). Similar number of
elements exhibited hyper hypo methylation. (B) A bar plot and scatter plot summaris-
ing the number of Alu elements which exhibited methylation changes (above 10%
change between aged and young). Similar number of elements exhibited hyper hypo
methylation.
4.4 Discussion
4.4.1 Aged OPCs more differentiated than young counterparts
Using RNA sequencing I was able to obtain a full and complete transcriptional profile
of aged and young adult OPCs. This tool enabled me to begin exploring the internal
processes that underlie OPC ageing, and might lead to their reduced differentiation
capabilities in aged animals. One of the first things I noticed were the changes in
transcription of key OPC signature genes. These included Pdgfra, Cspg4, Hes1, Hes5
and Ascl1 (some of which have been confirmed in qRT-PCR by Neumann et al.,).
This is in line with previous studies which have compared neonatal and young adult
OPCs (Moyon et al., 2015) and have shown that when compared to neonatal OPCs,
adult OPCs have a more differential transcriptional signature. It is important to note
that additional studies which have used the same mouse line (PPDGFRa-GFP) to
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isolate OPCs, have shown that the GFP in this mouse line can also make mature OLs
(Marques et al., 2016). It could be argued that at least some of the adult OPCs isolated
in that study were in fact OLs. A similar claim can be made against my database, i.e.
my aged OPC sample is contaminated by OLs. As I would explain in the following
paragraphs, I believe this is highly unlikely. I used the recently published single cell
RNA sequencing database of OL lineage cells by Marques et al., (Marques et al.,
2016) to create signature gene lists for OPCs and OL lineage cells. When comparing
the expression of OPC signature genes in young and aged OPCs, it is clear that aged
OPCs show reduced expression of many of those genes (fig4.3B and fig4.4A). This
was further confirmed when I used the data collected from sequencing adult OLs (see
chapter 4). Figure 4.4C shows the clustering of aged young OPCs in relation to adult
OLs, using the transcriptional signature of OL lineage cells established by Marques
and colleagues (Marques et al., 2016). This heatmap supports two main claims: firstly,
aged and young OPCs cluster together; secondly, aged OPCs cluster closer to OLs
than young OPCs. This refutes a possible claim that the aged OPCs that were isolated
were in fact OLs, and shows that they are OPCs that are in a more advance stage of the
lineage. Moreover, the fact that the aged OPCs do not show upregulation of any of the
myelin genes (e.g. Mbp, Mog, Mag, Mobp and Plp1) supports this claim as well. The
upregulation of these genes in OLs is striking, as can be observed by data collected
by me (chapter 4) and others (Zhang et al., 2014). Thus, I would claim that the main
feature of aged OPCs is their loss of progenitor characteristics, which renders them
less prepared to be activated in states such as remyelination.
The upregulation of OL genes in aged OPCs could be seen as a advantage in
cases of demyelination, when OPCs are required to differentiate into OLs in order
to remyelinate nude axons. But during remyelination OPCs are required not only to
differentiate, but also to migrate and proliferate. This pre-mature differentiation profile
can be seen as rendering the aged OPCs as less flexible than their young counterparts.
Moyon et al., have shown that in an event of demyelination, young adult OPCs are
activated and revert to the neonatal transcriptional profile. One can assume that since
aged OPCs show even less expression of OPC genes they would be less capable to
revert back to neonatal activated state which is required for successful remyelination,
since this will require more dramatic changes in transcription and epigenetic states.
The premature differentiation of aged OPCs also renders them vulnerable to other
dangers of the ageing brain. For example, inflammation levels increase with ageing
(Norden & Godbout, 2013), and include the increase in expression of TNFa in the aged
brain. At the same time, studies have shown the mature OPCs are more vulnerable
to TNFa toxic effects (Cammer & Zhang, 1999). This increased sensitivity to TNFa
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levels is also supported by my data showing an increase in the expression of TNF
receptors (Tnfrsf1a) in aged OPCs. Moreover, ’late OL progenitors’ have also been
shown to be more vulnerable to hypoxia-ischemia conditions (S. A. Back et al., 2002).
Therefore, it seems that the pre-mature differentiation of aged OPCs renders them both
inadequate to efficiently address demyelination lesions, but also place them in more
vulnerable position when confronting other challenges the aged brain exhibit.
4.4.2 Nuclear receptors
Retinoic acid (RA) receptors (and specifically retinoid x receptors; RXR) have emerged
in recent years as a potential therapeutic target for enhancing remyelination. Early
study by Huang and colleagues from 2011, has shown that there is an upregulation
of RA receptors during remyelination by comparing microarrays of different stages
in remyelination (Huang et al., 2011). This study have focused on the role of RXR-g
as the main receptor that its activation can enhance remyelination. Another study
from 2015, has supported this notion by enhancing remyelination in the optic nerve by
specifically activating RAR receptors by using either all-trans retinoic acid (ATRA;
metabolised Vitamin A) or by using a synthetic agonist of RAR-a/b (Am80).
These two studies have shown that the beneficial effects of RA agonists relate
to both the immune system as well as the OPCs themselves. Moreover, RXR acti-
vation has been shown to reverse the age related decline in myelin phagocytosis by
macrophages/microglia (Natrajan et al., 2015).
It is important to note though that a recent study have concluded that even though
human NSCs upregulate RARs when they become OPCs, a long-term exposure to RA
isoforms can result in upregulation of differentiation inhibitors, such as Hes5 and Id4
(young Kim et al., 2017).
In contrast to the studies which have shown the beneficial effects of RXR activation
both in vivo and in vitro (de la Fuente et al., 2015; Huang et al., 2011), experiments
conducted in our lab (Neumann et al., 2017, Neumann, unpublished data) have shown
that treating aged OPCs RXR agonists do not enhance their differentiation capacity.
Exploring my RNA-seq data, I found that aged OPCs express lower levels of multiple
nuclear receptors related to RA pathway, including ones which have been specifically
important for OPC differentiation, such as Rar-a/b/g and Thr-a/b. As RXR are known
to work as hetrodimers (de la Fuente et al., 2015), it is clear that the downregulation of
many of RXR binding partners would reduced their activation and potential to enhance
differentiation.
Therefore, it possible that the failure of RA agonists to enhance aged OPCs
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differentiation in vitro, is due to the fact that these cells do not express sufficient levels
of these receptors and their essential binding partners. It is possible that higher doses
of RA would have been more efficient in enhancing OPC differentiation, and these
experiments should be conducted in order to assess properly the therapeutic effect of
these molecules.
Another known enhancer of OPC differentiation in vivo and in vitro is T3 (Thyroid
hormone) (B. A. Barres, Lazar, & Raff, 1994), which is used by many researchers
(including myself) to accelerate OPC differentiation in vitro. T3 acts on cells through
nuclear thyroid receptors, Thra/b to activate a set of genes that promote OPC differ-
entiation, mainly through the activation of Klf9. Similarly to the RA, the effect of
T3 on aged OPC differentiation is extremely limited (Neumann et al., 2017). The
RNA sequencing data I show here revealed that both thyroid receptors (Thra/b) are
significantly downregulated in aged OPCs (fig4.6). Similarly, the main target of T3
in OPC differentiation, Klf9, is also significantly downregulated in aged OPCs. This
can at least partially explain why T3 has such reduced effect on aged OPCs. The
lack of receptors for T3 reduces its ability to activate and promote the differentiation
programme in aged OPCs.
Exploring nuclear receptors expression in aged OPCs reveals important changes
between aged and young OPCs and highlights the significance of experimenting with
aged cells, when studying ageing. The encouraging results described by past papers
regarding the potential of RXR activation in the enhancement of OPC differentiation,
myelin debris removal and ultimately remyelination led to clinical trials being currently
conducted using RXR agonist bexarotene. The results I show in this chapter suggests
that these trials might encounter severe difficulties, due to the downregulation of key
genes in aged OPCs relevant for the activity of nuclear receptors. This could be true of
other potential therapeutic targets identified by in vitro and in vivo essays that were
performed using young and neonatal rodents, such as endothelin 2. This inflammatory
factor was identified by Yuen et al., (Yuen et al., 2013) as a one which is important in
promotion of OPC differentiation mainly through the activation of Endothelin Receptor
Type B (Ednrb). Similar to the RA and T3 receptors, Endothelin receptors Ednra/b
are both found to be significantly downregulated in aged OPCs (adjusted p-value <
0.05). This is similar to the situation found in chronically demyelinated lesions in
MS patients (Yuen et al., 2013). Thus, Ednrb low expression in aged OPCs precisely
exemplified the connection and relevance between the study of aged OPCs and chronic
MS patients.
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4.4.3 mTOR pathway is dysregulated in Aged OPCs
Using Ingenuity Pathway Analysis (IPA) to characterise the upregulated genes in
aged OPCs revealed multiple pathways which are upregulated in aged OPCs, one
of those is the mTOR pathway (figures 4.3 and 4.5). mTOR (mammalian target of
rapamycin) is a well studied pathway which is known to integrate extracellular signals
to induce many cell responses, such as cell differentiation and proliferation. mTOR
has also been studied extensively in relation to ageing in multiple cells and organisms
(Johnson, Rabinovitch, & Kaeberlein, 2013), as the inhibition of mTOR activity, either
by administering rapamycin or by mutating mTOR genes lead to extended life span
in multiple organisms, including mice (Roizen, 2010). Moreover, activation of Wnt
pathway in hair follicles stem cells, leads to hyper proliferation and depletion of the
stem cell pool. This process can be blocked by the administration of rapamycin,
again supporting the notion that inhibition of mTOR pathway in stem cells can protect
from stem cells exhaustion and senescence (Castilho, Squarize, Chodosh, Williams, &
Gutkind, 2009).
These reports, combined with the results shown in this chapter, suggest that aged
OPCs are no different than stem cells in other tissues, in which hyper activation of
mTOR pathway lead to stem cell exhaustion and cell senescence. It is therefore
not surprising that the addition of rapamycin to aged OPCs, prior to differentiation,
enhanced their differentiation abilities. (Neumann et al., 2017).
The relation between Wnt and mTOR pathways in regard to ageing stem cells
was suggested by a paper from Castilho et al., (Castilho et al., 2009), in which
mTOR signalling was activated by Wnt signalling pathway, and this led to stem
cells exhaustion. In OPCs, dysregulated Wnt signalling is known to inhibit OPC
differentiation (Fancy et al., 2009). Since mTOR signalling is necessary for OPC
differentiation, these results seem to contradict each other. I suggest that there is a
need to separate between the different states of OPCs and the effects of these pathways.
Thus, overexpression of mTOR can promote OPC differentiation and this explains
why aged OPCs are more differentiated than young ones. But at the same time, this
renders them less equipped for challenging situations which emerge in demyelinating
lesions, as well as can lead to stem cell exhaustion, similar to what has been describes
in other tissues.
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4.4.4 OPCs exhibit specific changes in methylation with ageing
One of the hallmarks of ageing is the changes in epigenetic landscape, which is also
referred to as an ’epigenetic drift’. Even though, epigenetic mechanisms and their
direct relation to transcription have yet to be fully understood, it clear that a specific
epigenome is required for a proper cell function. The importance of the epigenome is
even more relevant for progenitor cells, such as OPCs which are required to initiate
complex transcriptional programs in a timely manner.
Unlike past publications (Issa, 2014), I could not find marked global changes
between the epigenome of aged and young OPCs (figure 4.7). This could be due
to different cell types used, as well as differences in the methods used by different
researchers. Since no significant global changes were identified, I decided to explore
specific changes, by examining specific genes which hare known to play a role in
OPC biology. In both groups of genes (OPC genes and nuclear receptors), the same
pattern emerged: a marked decrease in promoter methylation. Examining the changes
in DNA methylation in aged and young OPCs in the promoters of nuclear receptors
revealed a surprising result. In contrast to what is described in previous literature,
where promoter hypermethylation is correlated with reduced mRNA expression, when
exploring the methylation of these promoters, most promoters lose their methylation
markings in aged OPCs. This can be a good example to loss of epigenetic memory
and actual ’epigenetic drift’. As was mentioned before, some studies do describe
DNA methylation as epigenetic memory marker rather than an actual inhibitor of
transcription. Thus, the loss of these markings with age leads to the loss of ’correct’
methylome in particular and epigenetic memory in general in ageing cells. This is
extremely relevant to cycling cells such as OPCs, as they are unable to properly inherit
their epigenetic landscape after proliferation. This is another aspect in which, my
database shown here differ from older studies: even though, ’classical’ notion of
promoter methylation suggests that promoter hyper methylation leads to decreased
gene expression. My data suggests that this is not the case, not only when assessing
all promoters but also when comparing specific groups of genes (figure4.8). I would
suggest that this supposed discrepancy is the result of differences in cell type, and
more likely differences in methods. Past studies have focused on specific, single genes,
but now, with advanced technology it is possible to sequence the whole genome in
sufficient depth to explore most if not all promoters.
These changes in methylome states between young and aged OPCs, resemble
findings from stem cells in other tissues. For example, Liu and colleagues (L. Liu et al.,
2013) show that muscle stem cells exhibit dramatic changes in chromatin formations in
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ageing. They further report reduction in histone expression with ageing, and increase
in H3K27me3 at the histone loci. This could be observed in similar manner in OPCs,
as they seem to lose methylation patterns in key gene sets, such as OPC genes and
nuclear receptors, both important to OPC biology (figure4.8).
Another set of evidence to the epigenetic drift exhibited by aged OPCs are the
changes in methylation within gene bodies (figure4.10). In similar fashion to what
have been shown by previous studies, methylation levels in intragenic regions is
not conclusively correlated to gene expression (P. a. Jones, 2012). This ambiguity
regarding the role of DNA methylation, makes it difficult to predict the transcriptional
results of the changes in methylation. In either case, there is clear change in methylation
patterns in hundreds of gene bodies. Interestingly, majority of these genes (⇠70%
of the genes) are downregulated in aged OPCs. GO analysis of these genes (data
not shown) show that these genes are involved in multiple cellular processes, mainly
specific metabolic processes.
These results support the notion of epigenetic drift in ageing cells. Even though
we cannot yet correlate specifically these changes in methylation to gene expression,
it can be added to an increasing set of evidence showing that aged OPCs, similarly
to other tissue specific stem cells, show dysregulated epigenome which could reduce
their capability to be activated in due time.
4.4.5 Alternative splicing in ageing OPCs
When analysing the changes in alternative splicing in aged and young OPCs, I used
several approaches. Firstly, I filtered the list of genes so it won’t include genes which
I previously detected to exhibit significant changes in transcript expression. GO
analysis of these genes showed enrichment in metabolic processes and regulation of
biological processes. This shows that alternative splicing alone can be accounted for
changes in aged OPCs, without showing effects in full transcript expression. For the
second analysis, I listed again all the genes which exhibit significantly differential exon
expression (adjusted p-value < 0.05) and plotted them according to their frequency of
appearance, i.e. how many significant splicing events occur in each gene. Interestingly,
the top gene which emerged was Kif1b. This gene showed significant differential
exon usage in 15 exons, but did not show significant change in transcript expression
(young/aged log2 fold change = 0.09, p-value = 0.633). Kif1b has been shown
previously to have an important role in myelination. Kif1b encodes for a kinesin
motor, and in OLs it is required for the localisation ofMbp mRNA transcripts in OL
processes (Lyons et al., 2009). Lyons and colleagues have shown that a mutation in this
4.4 Discussion 127
gene disrupts its interaction with microtubule, which leads to improper myelination
and CNS development. Since aged OPCs exhibit high ratios of alternative splicing
events in comparison to young ones, it is possible that this also explain some of the
phenotypes exhibit by aged OPCs in vitro, specifically their failure to differentiate to
fully mature, MBP positive oligodendrocytes.
Another gene which exhibited high rate of significant alternative splicing events
was Myrf (total of 9 significantly differentially expressed exons). Myrf is OL lineage
specific nuclear protein, which is required for OPC differentiation and myelination
(Emery et al., 2009). MYRF is DNA binding transcription factor which is responsible
to the activation of myelin genes in differentiating OPCs. Similar to Kif1b, Myrf
does not exhibit changes in full transcript expression between aged and young OPCs
(young/aged log fold2 change = -0.222, adjusted p-value = 0.387). Using the ensem-
ble genome browser, I was able to map the the exons which exhibit downregualted
expression, and show that they are part of two critical domains in Myrf. The main
part of MYRF that seemed to be affected is its C-terminal. This part of the protein
is left in the ER after auto-cleaving by the ICA domain. Even though it does not
translocate into the nucleus and act as a transcription factor, MYRF C-terminal seems
to have a role in expression of myelin genes, since MYRF lacking this part is not as
efficient as the full version in inducing myelin genes transcription in CG4 cells (Z. Li
et al., 2013). Moreover, disruptions in the ICA domain (which are also possible to
the downregualtion of exon 14) can lead to inefficient auto-cleavage of MYRF, and
will prevent it from translocating to nucleus. Lack of either of these domains renders
MYRF non functional (Emery et al., 2009; Z. Li et al., 2013). This is in line with the
differentiated phenotype of aged OPCs I have reported above. Aged OPCs show the
expression of several differentiation genes, but none of the myelin genes. This could
be explained by the lack of ’young’ version ofMyrf that is required to activate these
genes. This could be especially relvant for adult animals, as MYRF is required for
myelin maintenance in adult mice (Koenning et al., 2012).
Unfortunately, I could not specifically correlate between the methylation of intra-
genic regions to differential exon expression, in contrast to other reports (P. A. Jones,
2012; Moyon, Huynh, et al., 2016). This might be due to several technical reasons:
firstly, the fact that DNA was extracted from FACS A2B5 positive OPCs, in compari-
son to the RNA that was isolated from MACS A2B5 sorted OPCs. Secondly, It could
be that the potential relations between methylation and alternative splicing are very
subtle, and as such a very scrutinising view should be used to analyse methylation
rate. I.e. correlate specific splice sites methylation to splicing events. In this study
a more global approach was taken, and therefore these correlations might have been
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overlooked.
In summary, these examples show the potential of research into alternative splicing
as serving a role in the reduced capacity of aged OPCs to differentiate properly. Further
studies will be required in order to specifically investigate which splicing events are
actually relevant in the decreased differentiation ability of aged OPCs. This can be
done by artificially expressing ’young’ gene versions of specific target genes in aged
cells. Further research would need to be done in order to understand better what
are the underlying causes to these changes in exons expression. This can be done
by a thorough examination of methylation states of specific splice sites, as well as
expression of specific chromatin marks in those areas.
4.4.6 Transposable elements in OPCs
Transposable elements (TEs) are DNA sequences which have a capability of self
replication and insertion into the genomic DNA. There are two main types of TEs -
DNA transposons encode an enzyme named transposase. This allow them to be ’cut
and pasted’ within the genome. The other group of TEs, are are the retrotransposons.
These TEs use an intermediate RNA molecule to mobilise throughout the genome.
The RNA is reverse transcribed to cDNA and can therefore be ’copied and pasted’
in multiple sites in the genome. Both modes of mobilisation can lead to mutations
and genomic instability (Sturm, Ivics, & Vellai, 2015). Therefore, cells have devised
multiple mechanisms in order to inhibit TE activation. These include epigenetic
mechanisms, such as DNA methylation and RNA silencing (Sturm et al., 2015). In
ageing somatic tissues, there is evident that specific TEs become active, thus leading
to increased genomic instability (De Cecco, Criscione, Peterson, et al., 2013; Maxwell,
Burhans, & Curcio, 2011).
Therefore, it seems that exploring the behaviour of TEs in ageing OPCs could lead to
some insightful observations. Surprisingly, my results shown in this chapter are not in
line with some of the previous reports regarding the activity of TEs. Firstly, I observed
downregulation of multiple TEs in aged OPCs, when compared to young ones (4709
TEs). In comparison, only a 1168 TEs exhibited an increase in expression in aged
OPCs. A similar trend of increased expression of TEs in young OPCs in comparison
to aged ones was detected even when I have focused on specific TE families, such as
Alu and L1 (figure 4.18). I chose these two families since they have been specifically
indicated to increase in ageing cells (De Cecco, Criscione, Peckham, et al., 2013; De
Cecco, Criscione, Peterson, et al., 2013). Besides the technical differences between
these studies and mine, I can again point out to the difference in cell types, as previous
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studies used fully differentiated cells in comparison to stem cells which were used
in the current study (i.e., OPCs). These results are in line with a smaller number of
reports regarding the role of TEs in CNS cells, and specifically their role in neural
progenitor cells (NPC) (Coufal et al., 2009; Singer, McConnell, Marchetto, Coufal,
& Gage, 2010). A study from 2009 by Coufal et al., shows evidence that neuronal
progenitors activate L1 retrotransposons preferentially to other somatic cell types from
the same animal. Thus leading to a mosaic of somatic neural cells. The cells used for
that study were identified as SOX2, NESTIN, MUASASHI-1 and SOX1 cells. At least
two of these genes (Sox2 and Msi1) are significantly increased in my young OPCs
in comparison to the aged ones. SOX2 is especially interesting in this context, as
Coufal et al., show through immunoprecipitation, that it can bind to the 5’-UTR of L1
elements, and show similar pattern of expression to L1 (Coufal et al., 2009).
Furthermore, when trying to correlate methylation levels and TE expression, no
correlation was found (figure 4.17). This is again in contrast to previous reports
describing the relation between DNA methylation and TE expression (Slotkin &
Martienssen, 2007). I cannot fully explain these differences between previous studies
and the results presented here. The most obvious explanation regarding the lack of
relation between TE expression and methylation is that these analysis were done on
different cells. I.e. RNA was isolated from MACS sorted OPCs while DNA was
isolated from FACS sorted OPCs. Clearly, finding a link between the databases will be
difficult. Since I found similar relations when analysing changes in DNA methylation
and RNA expression in another dataset (chapter 4, OL lineage cells) where the DNA
and RNA were isolated from the same cells, I find that this explanation is insufficient.
It is possible that the relation between RNA expression and DNA methylation of TEs
(and other genomic elements) is much more complex than was previously thought to
be. It is possible that many correlations previously reported were due to the authors
tendency to focus on specific element at the genome. Thus, a more global genomic
view that I used might obscure these specific correlations.
In summary, my results suggest that TEs might play a crucial role in OPC biology
and maintenance, and are highly activated in these cells, similarly to what have been
shown in NPCs. This is in striking contrast to TEs in other tissues and cell types. This




Ageing Mononuclear Phagocytes and
their effects on OPC differentiation
5.1 Introduction
Microglia, the resident immune cells of the CNS play a pivotal role in both normal
as well as during pathological conditions. As described in chapter 1, previous studies
have been conducted in relation to role of microglia in ageing in general, and in
remyelination specifically. With regards of their role in remyelination, studies have
mostly focused on the decreased phagocytosis capability of aged microglia (Natrajan
et al., 2015; Ruckh et al., 2012). Other studies have shown that aged microglia
exhibit a delayed response to demyelination, and thus create a delayed and lingered
response to demyelinating lesion (Zhao et al., 2006). In parallel, the field of microglia
biology has advanced considerably, and now there are multiple transcriptomic studies
that reveal the changes between young and aged microglia (Hickman et al., 2013;
Holtman et al., 2015). Most studies though, have mainly focused on the changes in
the secretion profile (secretome) of aged microglia and did not focus on other aspects
of aged microglia, such as changes in their surface antigens and their contribution
to the ECM in the normal and pathological CNS. Study of microglia in the relation
of remyelination has also neglected the potential role of of various surface antigens
expressed by microglia, and focused only on a handful of secreted cytokines. The
effect of the ECM and surface antigens on OPC differentiation is evident from studies
which explored the various surface antigens on neurons in order to identify which cues
limit myelin wrapping to axons, such as JAM2 (Redmond et al., 2016). Moreover,
experiments using in vitro astrocytes and OPCs cultures show that proteoglycans
expressed by activated astrocytes inhibit OPC differentiation (Keough et al., 2016).
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Despite these findings, there has been very little research regarding the changes in
microglia surface antigen expression and its potential relation to OPC differentiation.
This is surprising, since in the early days of a demyelinating lesion, the main cell type
which populates the lesion is from a microglial origin. Thus, it will be reasonable to
assume that the main contributor to microenvironment and ECM in the lesion area will
be the microglial cells.
Another aspect of aged microglia which has not been fully explored in relation to
remyelination, is their changes in their secretome. Previous studies have only focused
on specific cytokines and the changes in their levels in remyelination. These usually
focus on the well studied pro and anti inflammatory cytokines. But these studies
overlook the complete secretome of microglia, and the fact that even though these cell
originated from primitive myeloid cells (Ginhoux et al., 2010), they are an integral
part of the CNS and perform multiple non-immune roles, by secreting various factors,
such as BDNF for promoting synapse formation (Parkhurst et al., 2013).
In light of the these findings and the knowledge gaps described above, I set out to
address the following questions:
1. Do microglia surface antigens directly affect OPC differentiation capacities?
2. Do microglia surface antigens change with ageing?
3. What is the driving factor behind the changes in microglia surface antigens?
4. Are the effects of microglia surface antigens identical to the effects of microglia
secreted factors?
5.2 Experimental strategy
In order to study microglia and their effects on OPCs, I first had to establish microglia
cultures. I have used the vast experience that our lab has in culturing aged OPCs and
put it into use in isolating and culturing microglia. I isolated microglia using anti
CD11B labeled magnetic beads (fully detailed protocol can be found in the Materials
and Methods chapter). Since CD11B does not identify microglia exclusively but can
be found on other phagocytic cells (Lavin et al., 2014) I cannot be certain that the
cells that were isolated were pure microglia population, and are not contaminated by
other macrophages. Since this does not alter the results or my interpretations of my
results, I will abbreviate the CD11B+ cells isolated in this method as mono-nuclear
phagocytes, or MNPs. In order to study the role of the MNP surface antigens separately
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from the roles of their secreted factors, I created MNP ’ghosts’, in a technique similar
to that used before with astrocytes (Keough et al., 2016) and with OPCs in my lab
(Segel 2017, unpublished). In short, MNPs were cultured for 48 hours, and then were
submerged in ddH2O and then immediately placed into dry ice. The short culturing
time allowed the attachment of most microglia to the plates on one hand, but also to
retain their age associated properties as much as possible. The addition of ddH2O
resulted in immediate death of the microglia, while maintaining their cell morphology
and surface antigens (which was evident by light microscopy). The ghosts were then
kept in -80°C for use at a later stage. Next, freshly isolated OPCs were plated on top
of these ghosts, and their differentiation capabilities were assessed. This protocol is
illustrated in figure 5.1.
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Fig. 5.1 Microglia ghost protocol Schematic illustration of the protocol used to
generate microglia ghosts. Following the generation of single cell suspension (as
described in section 2.3.1) A2B5 MACS was performed to remove OPCs. A2B5
negative cells were then cultured overnight in suspension plates. The next day, MNPs
were isolated using CD11B MACS. Cells were plated in PDL pre-coated plates, and
after 48 hours in vitro were lysed using dH2O. Plates were frozen immediately to
preserve the ghosts. When needed, plates were defrosted and OPCs (A2B5+) were
plated on top of the ghosts.
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5.3 Results
5.3.1 Isolating and culturing adult MNPs
Using the protocol described above, and in combination with the experience I gained
in isolating adult OPCs and other OL lineage cells (chapters 3 and 4), I used CD11B
MACS in order to isolate MNPs (mono0nuclear phagocytes). MNPs cells were isolated
after overnight recovery in suspension plates after A2B5 MACS was performed on the
cells.
Isolated MNPs usually recovered very quickly and assumed microglia-like typical cell
morphology within a few hours (Fig5.2). Following culturing, in order to test the purity
and health of the culture, I stained the cells using CD11B and IBA1 (known markers
for microglia and macrophages (Zhang et al., 2014)). In all conditions tested, cultures
were composed of mainly MNPs (>80%) (Fig5.2). This was expected, as FACS
sorting using CD11B conjugated antibody (see Fig5.4) yielded very clear population
separation, suggesting this is a suitable antibody.
Following 48 hours of culture, MNPs were ‘ghosted’ as described before or media
was collected to be used for conditioned media experiments. Microglia used as ghosts
were cultured on top of PDL (figures 5.3 and 5.5) coated wells, while those used for
conditioning media were cultured on non coated wells (figure 5.8). Cells that were
treated with ddH2O show very little nuclear staining, and do not regrow when fresh
media is added later on. This eliminated the possibility that the results observed in
later stages of the experiments were due to live microglia and not due to OPCs plated
on top of the ghosts. Moreover, as the first step in the ghost protocol was to isolate
A2B5+ cells, it is unlikely that the ghosts were composed out cells which are not
MNPs (Fig5.1).
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Fig. 5.2 In vitro culture of adult MNPs Following CD11B MACS sorting, MNPs
cells (young and aged) were plated in high density plating (50,000 cells per 1cm2). (A)
After 48 hours in serum free media (OPCM), majority of cells were positive for either
CD11B and/or IBA1 staining (>80%) and exhibited microglia-like cell morphology.
This did not change between ages, and TGFb1 treatment. (B-D) Representative images
of MNPs of different ages, treated or untreated with TGFb and/or SB-431542 (scale
bar represents 100µm).
5.3.2 OPCs cultured on aged MNPs ghosts alter their differentia-
tion fate
Following A2B5 MACS isolation, neonatal A2B5 positive cells were plated on either
PDL coated wells, or on top of ghost microglia (prepared as illustrated in figure 5.1).
Following overnight recovery in proliferation conditions (OPCM supplemented with
20ng/ml b-FGF and PDGF), media was changed completely into differentiation media
(OPCM + 40ng/ml T3). Cells were cultured in differentiation media for 6 days (media
was changed every second day), then fixed and stained. To assess the fate of the
differentiating cells, I used GFAP to mark astrocytes, and NG2 to mark OPCs. OLIG2
was used to mark cells of the OL lineage.
OPCs which were cultured on aged microglia ghosts showed an increase in astrocyte
formation, as well as changes in NG2 cells to more astrocytic form, characterised by
long processes in comparison to normal NG2 cells, which usually show short and
branched processes.
138 Ageing Mononuclear Phagocytes and their effects on OPC differentiation
Fig. 5.3 Culturing OPCs on aged MNPs ghosts Neonatal OPCs were cultured on
either control PDL or on top of aged microglia ghosts in serum free media (OPCM)
for 6 days in vitro before fixed and stained. (A) OPCs cultured on top of aged MNPs
ghosts have show significant increase in astrocyte formation, marked by percentage of
GFAP positive cells (p-value < 0.05, n = 4). These OPCs also show reduced percentage
of NG2 positive cells (p-value < 0.05, n = 4) and OLIG2 positive cells (p-value =
0.0513, n = 2) in comparison to cells cultured on PDL. (B) Representative images of
cells grown either on aged ghosts or control PDL. The lower panel shows a digital
magnification in which changes in cell morphology can be spotted in NG2 positive
cells (marked by cyan arrows) (scale bar represents 100µm).
5.3.3 Changes in aged MNPs surface antigens
Following the results described in figure 5.3 I investigated potential candidates for
molecules on the surface on aged MNPs that could explain part of the effect. Using
a published RNA sequencing data base (Hickman et al., 2013) I identified multiple
matrix associated molecules that are known to affect OPC differentiation and also show
an increase in expression with ageing microglia (fig5.4A). One of the upregulated
genes I identified was Cspg4, which encodes the NG2 proteoglycan. Using FACS
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analysis, I confirmed that in aged animals a higher percentage of MNPs (labeled by
CD11B) are also NG2 positive (fig5.4C). FACS analysis also revealed an increase
in the total percentage of microglia cells in animals (fig5.4B). This indicates that
any changes that is observed within the aged MNPs population could have important
effects due to the total increase in MNPs cell numbers with ageing.
Fig. 5.4 Changes in aged MNPs surface antigens (A) Data adapted from published
RNA sequencing (Hickman et al., 2013) showing an array of surface antigens which
are upregulated in aged microglia. Data is shown in log fold change normalised to
expression levels in young microglia. Young microglia expression levels are marked in
orange, while aged microglia levels are marked in blue. Significant changes (p-value <
0.05) are marked. (B) Results of FACS analysis using CD11B antibodies showing a
significant increase in percentage of MNPs in aged rats (p-value < 0.05, n = 7). (C)
FACS results showing percentage of MNPs which are double positive for NG2 and
CD11B. Aged MNPs showed a significant higher proportion of NG2 positive cells
than young ones (p-value < 0.005, n = 3). (D-E) Representative FACS plots of both
CD11B separation (D) and NG2 (E) expression exemplifying the results described in
above graphs.
5.3.4 AgedMNPs ghost effect can be recapitulated by TGFb-treated
neonatal MNPs
Following the findings described in figure 5.3 using aged MNPs, I wondered if this
effect is due to the age of the MNPs or any type of microglia will elicit the increase
in astrocyte formation. In order to test wether or not this effect is due to MNPs
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ageing, I repeated the ghost experiments with neonatal MNPs. As shown in figure 5.5,
there was no significant increase in astrocyte formation when OPCs were cultured on
top of neonatal MNPs ghost. In order to test if there are factors that could alter the
surface antigens of young microglia I decided to treat neonatal microglia with TGFb
in increasing concentrations. TGFb was chosen as it has previously been shown to
promote the expression of NG2 in microglia (Sugimoto et al., 2014). Moreover, TGFb
levels have been shown to increase with ageing in both humans and mice (Carlson et
al., 2009). Treating neonatal MNPs with TGFb1 (0-20 ng/ml) for 48 hours prior to the
ghost protocol have resulted in a steady and significant increase in astrocyte formation
by cultured OPCs. This led me to hypothesise that TGFb might be one of the driving
forces behind the changes in microglia surface antigens.
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Fig. 5.5 Culturing OPCs on neonatal MNPs ghosts Neonatal OPCs were plated
on either control PDL, or on top of P21 MNPs ghosts. Prior to the ghost protocol,
MNPs were cultured for 48 hours in 10% FBS media with increasing concentrations
of TGFb1 (0-20 ng/ml). (A) Astrocyte formation (measured by GFAP staining) by
OPCs is increased when cultured on top of microglia ghosts treated with TGFb in
a concentration dependent manner (one-way ANOVA, p-value < 0.05, n = 2). (B)
Representative images of OPCs cultured on top of neonatal ghost MNPs with different
concentrations of TGFb. Cells were fixed and stained for GFAP (red), NG2 (white)
and O4 (green) (scale bar represents 100µm).
5.3.5 Treating young MNPs with TGFb enhances the expression
of multiple surface antigens
To identify a factor that could be responsible to the changes in aged MNPs surface
antigens, I identified TGFb as a possible candidate. TGFb levels has been shown to
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increase with ageing in both mice and humans (Carlson et al., 2009). Furthermore,
TGFb has been shown to enhance the expression of multiple surface molecules which
are known to be related to OPC differentiation, such as fibronectin in multiple cell
types, including astrocytes, (Ignotz & Massagué, 1986; Laping et al., 2002; Yu, Wang,
Katagiri, & Geller, 2012) and NG2 in microglia (Sugimoto et al., 2014) . Moreover, in
order to inhibit the production of CSPGs in astrocytes (which as described before are
inhibitory to OPC differentiation) Keough and colleagues also used a TGFb inhibitor
(Keough et al., 2016). Therefore, I set out to test whether TGFb can play a role in the
modification of MNPs extracellular markers. In order to to do so, I cultured neona-
tal MNPs in the presence of rising concentrations of TGFb (0-20ng/ml). As shown
in figure 5.6. The addition of TGFb to MNPs culture resulted in the upregulation
of mRNA of multiple surface antigens, specifically of Cspg4, Fn1 and Cd44. This
upregulation in transcription was reversed in the presence of a small molecule TGFb
inhibitor (SB-432542, (Laping et al., 2002)). This is in line with transcriptional data I
gathered from published RNA sequencing of aged and young microglia, which shows
an increase in these antigens with ageing. In order to eliminate any global effect of
transcription up-regulation by TGFb, I tested the effect of TGFb on the expression
of several cytokines, which yielded no change in expression, in oppose to the global
effect of LPS, which resulted in up-regulation of multiple genes in a global effect (data
not shown).
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Fig. 5.6 Upregulation of aged MNPs surface antigens in neonatal MNPs treated
with TGFb In order to recapitulate the ageing effects, neonatal MNPs were cultured in
presence of TGFb (0, 10, 20 ng/ml) with or without 5uM of SB-431542 (i) for 48 hours.
(A)MNPs (IBA1 positive, red) treated with TGFb (right image) show co-localisation
with NG2 (stained in green) in contrast to non treated MNPs (left image) (scale bar
represents 100µm). (B) Summary of qRT-PCR results for three selected surface antigen
genes, show significant increase in the expression of Cspg4 and Cd44, which was
blocked in the presence of TGFb inhibitor SB-431542 (one-way ANOVA, p-value
< 0.005, n = 2). Similar trend was shown for Fn1, albeit not significant (one-way
ANOVA, p-value = 0.06, n = 2).
5.3.6 TGFb directly affects OPC differentiation
After observing the effects of TGFb on MNPs, I asked whether TGFb can affect
OPC differentiation directly. Past papers have claimed that TGFb promotes OPC
differentiation, but after reviewing this in more depth, I realised that no direct evidence
was shown in these papers (McKinnon, 1993).
In order to test the effects of TGFb, neonatal OPCs were isolated using MACS
(as described before, chapter 4) and were kept in differentiation media with rising
concentration of TGFb1 and SB-431542 (TGFb pathway inhibitor), or LDN-193189
(BMP pathway inhibitor). I used two types of inhibitors in order to clarify more
144 Ageing Mononuclear Phagocytes and their effects on OPC differentiation
precisely the pathway in which TGFb might affect OPC differentiation (fig5.7D).
When cultured with TGFb, OPCs showed reduce differentiation capacity, exhibited
by lower percentages of CNPase positive cells. This effect was blocked completely
when SB-431542 was added to the culture together with TGFb (fig5.7B). TGFb effect
was not blocked by the addition of LDN-193189 (fig5.7C), which suggests that the
effects of TGFb is through its canonical pathways, and more specifically through
the activation of ALK4/5/7 and their downstream targets, SMAD2/3 as described in
fig5.7D.
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Fig. 5.7 Direct effects of TGFb on OPC differentiation in vitro Neonatal OPCs
were isolated using A2B5 MACS and plated in PDL coated plates. After 24 hours
recovery in proliferation media, differentiation media was introduced with TGFb1
+/- SB-431542 or +/- LDN-193189. (A) OPC differentiation in vitro is inhibited by
the addition of TGFb1 (one way ANOVA, n = 3, p-value = 0.0007). (B) effects of
TGFb1 were ameliorated by the addition of 5µM of TGFb pathway small molecule
inhibitor, SB-431542 (one way ANOVA, n = 3, p-value = 0.728). (C) Addition of
BMP pathway inhibitor (LDN-193198, 200nM) does not replicate the effects of TGFb
pathway inhibition, as TGFb still inhibited OPC differentiation rate (t-test, p-value <
0.05, n = 2). (D) Diagram illustrating the different targets of SB-431542 and LDN-
193198, and the different SMADs activated in both pathways. (E-F) Representative
images of differentiating OPC with or without the addition of TGFb1. Cells were fixed
and stained for OLIG2 (red) and CNP (cyan).
5.3.7 OPCs cultured with aged MNPs-conditioned media do not
increase astrocyte production
After establishing that microglia surface antigens affect OPC differentiation, I tested
whether molecules secreted from MNPs are related to this effect, or was the effect only
due surface antigens expressed on the cell bodies of the MNPs ghosts and deposited in
the plate matrix. To test this, I cultured aged microglia in serum free media (OPCM,
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similar to the one I used to culture the OPCs) and collected the media after 48 hours. I
then used the different conditioned media to culture OPCs, by mixing the conditioned
media with fresh media in a 50/50 ratio.
Neonatal OPCs were cultured for 6 days with conditioned media supplemented with
T3 (40ng/ml). Cells were then fixed and differentiation capabilities were assessed
using CNPase and GFAP.
Unlike the clear changes expressed by the OPCs cultured on top of ghost MNPs,
OPCs cultured in presence of conditioned media did not show a significant increase in
astrocyte numbers (fig5.8A). No difference was detected when OPC differentiation
into OLs (marked by CNPase expression) was tested.
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Fig. 5.8 OPCs cultured with aged microglia MNPs media Neonatal OPCs were
cultured in media containing 50% media previously conditioned by aged MNPs.
The 1:1 ratio was chosen according to previously published studies which have also
experimented with MNPs conditioned media (Miron et al., 2013). OPCs were cultured
for 6 days in conditioned media before stained for astrocyte and oligodendrocyte
markers. (A-B) OPCs cultured with MNPs conditioned media with or without the
presence of SB-431542 TGFb inhibitor. No significant change was observed in
both astrocyte (A) or oligodendrocyte (B) numbers (p-value > 0.05, n = 3). (C-D)
Representative images of young adult OPCs cultured with or without conditioned
media. Cells were fixed and stained for GFAP (green), OLIG2 (red) and CNP (cyan).
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5.4 Discussion
5.4.1 Changes in microglia surface antigens lead to OL inhibitory
environment
Usually, culturing OPCs in vitro in relatively low densities (10,000 cells / cm2) on
PDL coated cell culture plates, results in low numbers of astrocytes (figure 5.3 and
5.5). In contrast, when I cultured OPCs on MNPs ghosts (especially aged ones), I
observed a significant increase in the number of astrocytes. As this phenomena was
not replicated by using media conditioned with aged MNPs, one can assume that the
increase in astrocytes was due to the direct effects of the microglia surface antigens on
the OPCs.
The effect of direct cell-to-cell contact on OPCs has been shown in relation to other
cell types. For example, neurons control their own myelination, both by secreting
neurotransmitters, but also by expressing specific antigens that inhibit OLs from
wrapping them with myelin. For example, recent paper published by Redmond and
colleagues (Redmond et al., 2016) show that expression of JAM2 on neuronal dendrites
play a role in inhibiting myelination of these parts in the neuron. Similarly, experiments
with astrocytes show that ghost activated astrocytes prevent OPC differentiation in
vitro (Keough et al., 2016). In this paper, astrocytes activated by LPS were ghosted
and OPCs were plated on top. This resulted in decreased OPC differentiation which
was attributed to upregulation of multiple surface antigens by the activated astrocytes,
especially various CSPGs. Inhibiting the production of these antigens neutralised this
effect. In this chapter, I show that MNPs surface antigens can also influence and play a
role in OPC differentiation. More importantly, I show that this effect is more profound
in aged MNPs than in young ones. This adds another layer to how aged MNPs inhibit
OPC differentiation, and contribute to the failure of remyelination in ageing.
The results described in figures 5.3 and 5.5 suggest that the formation of astrocytes
by OPCs is a result of the matrix components deposited by the MNPs cultured in the
same well and are now ghosts. There could multiple other explanations for my results,
which I will present, and will try to refute:
Firstly, the ghost MNPs might not be dead. This way, aged MNPs (and TGFb treated
neonatal MNPs) could influence the OPCs through active secretion of different factors.
I find that the possibility for this is extremely low. During the ghost protocol, cells
are fully submerged in ddH2O. Due to the osmotic pressure, the cells die immediately.
Moreover, cells were immediately frozen using dry ice. Imaging plates of ghosts with
no OPCs on them showed only very faint nuclear staining, if any. This also eliminates
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the second possible explanation: the original cells I plated included astrocytes which
have survived the ghost protocol and then took over the culture once ’revived’. Staining
for GFAP on ghosts with no OPCs on top did not show any positive cells (data not
shown). This explanation is also highly unlikely, as prior to CD11B isolation, A2B5+
cells were removed using MACS, making it unlikely to have contamination of non
MNPs (especially OPCs). A third explanation could be that leftover ingredients from
the microglia media, especially the serum which was used to culture microglia, affected
the OPCs. This is unlikely for three main reasons: firstly, control wells had media
in them and did not produce any effect. Secondly, if the effect was mainly due to
serum components lingering on, then young MNPs would have had the same effect,
regardless of the TGFb treatment (fig5.5). Thirdly, during the ghost protocol, all media
was removed, and then 300µl of ddH2O was added, thus washing off any leftover
components of the serum.
My experiments with aged MNPs conditioned media (fig5.8) did not seem to
yield any effects, in contrast to the effects shown by aged MNPs ghosts. This result
was not expected, as according to published datasets, aged MNPs harbour many
differences in their secretome (Hickman et al., 2013), and some of genes which have
been shown to change with ageing are known to affect OPC differentiation, including
pro-inflammatory cytokines. This surprising lack of effect could be due to multiple
reasons. Firstly, in order to perform the experiments, I used conditioned media in
1:1 ratio with fresh media. Although Miron et al., (Miron et al., 2013) have used
similar ratio in previous study with microglia/macrophages conditioned media, the
conditioned media might have been too diluted to elicit effects in my experiments.
The difference could stem from the fact that Miron et al., used media conditioned
by activated microglia/macrophages. At an activated state, the cells are prone to
secrete higher amount of various factors, especially in comparison to non activated
cells (which I have used). Secondly, in order to prepare the conditioned media, I have
cultured microglia in OPCM for 48 hours. It is possible that this was not enough
time for substantial concentration of factors to be released into the media (especially
as the media was then diluted in a factor of 2 as explained above). Preliminary
experiments with adult OPCs (isolated from 7 months old rat) show that OPCs cultured
in conditioned media show less complex branches when stained for CNPase (fig5.8C-
D), but this was not quantified and needs to be repeated. However these experiments
do support my initial conclusions regarding the origin of the effects observed in the
ghost experiments, i.e. that it is the deposition of aged MNPs matrix that affects the
differentiation of OPCs into astrocytes and not secreted molecules.
Future experiments will have to address the issues raised above, i.e. testing higher
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ratios of conditioned media and longer conditioning times by the microglia. I have also
begun a set of experiments using neonatal MNPs conditioned media. I would expect
that conditioned media by young/MNPs microglia will promote the differentiation
of OPCs, as one of the roles of MNPs during remyelination is the secretion of pro
differentiation factors. Moreover, I would also expect that media conditioned by young
MNPs would especially be useful in promoting the differentiation capacities of aged
OPCs. As was described before, heterochronic parabiosis studies which involved
young and aged mice, revealed that invasion of young macrophages to the aged CNS
enhances remyelination (Ruckh et al., 2012). This effect was explained as mainly
stems from enhanced myelin debris clearance by the young macrophages (compared
to the resident old ones). This does not rule out other potential beneficial effects that
could have been exerted by the young macrophages population, including enhanced
secretion of differentiation factors, which can be similar in young microglia due to the
similarities between these two cell types.
Exploring previously published RNA sequencing data (Hickman et al., 2013),
revealed to me that aged microglia upregulate multiple surface antigens. Analysing
the surface antigens which are upregulated in aged microglia, reveal that they include
a variety of CSPGs, as well as other molecules which are known to affect OPC differ-
entiation. The effect of the MNPs surface antigens as seen in the ghost experiments is
most likely due to a unique combination of surface molecules, and does not stem from
a single factor. Despite that, I would describe some specific effects of a few of the
upregulated molecules and how they might affect OPCs according to known literature.
Fibronectin, a glycoprotein, has been shown to play multiple roles in remyelina-
tion and MS. In toxin induced demyelinating lesions, fibronectin is upregulated in
the first 3-5 days post lesion (the main demyelination time period) and then cleared
during later stages (10 and 15 days post lesion) (Stoffels et al., 2013). In demyelinated
MS lesions, fibronectin is visible in the form of aggregates (Stoffels et al., 2013), and
these aggregates can inhibit OPC differentiation in vitro. Further experiments using
fibronectin coated plates will be required in order to assess if this is enough to elicit
the production of astrocytes by OPCs in vitro.
Another matrix molecule upregulated in aged microglia is NG2 (encoded by the
Cspg4 gene). NG2 is mainly known to be expressed by OPCs and is not commonly
expressed by microglia. Despite this, there are multiple reports showing that in
certain conditions, microglia can express NG2 (Pouly, Becher, Blain, & Antel, 1999).
Following stroke, microglia express NG2 and this is due to effects elicited by TGFb.
(Sugimoto et al., 2014). These cells were considered helpful for recovery from
stroke, as they seem to present important phagocytosis abilities that aid in removal
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of debris and dead cells. In contrast, directly testing the phagocytosis capacities of
NG2 microglia by Zhu et al., (Zhu et al., 2012) revealed that NG2 microglia show
reduced phagocytic abilities. Moreover, a recent study have shown that inhibiting
the upregulation of NG2 in microglia after LPS induction promotes the expression of
multiple neurotrophic factors, such as GDNF and NGF (Zhu et al., 2016).
Considering that aged microglia upregulate NG2, and at the same time show decreased
phagocytosis capabilities (Natrajan et al., 2015), it is likely that the conversion of
more and more microglia into NG2 positive microglia is part of their phenotype that
inhibits their regenerative aspects, including efficient phagocytosis and secretion of
pro regenerative molecules. Thus aged microglia exert a less effective support for
the remyelination process in multiple levels: firstly, as NG2 microglia they exhibit
decreased myelin phagocytosis capabilities. Secondly, shifting their expression of
multiple matrix associated molecules supports a less pro regenerative ECM in the
lesion site. According to this theory, treating neonatal microglia with TGFb should
render them less efficient in phagocytosis, as it promotes the expression of NG2
(fig5.6).
Despite the results I describe in this chapter, I cannot completely rule out that other
changes in ageing MNPs can also contribute to the effects I observed. Aged microglia
upregulate various pro-inflammatory cytokines, including IL1b and TNFa (Hickman
et al., 2013). Both of these cytokines have shown to promote OPC proliferation and
migration, but not necessarily differentiation (Arnett et al., 2001; Moyon et al., 2015).
Thus, it can be proposed that aged microglia in culture deposit higher amount of these
cytokines in the culture matrix. These cytokines are then detected by the OPCs seeded
on top of the culture matrix, thus inhibiting their differentiation into OLs.
5.4.2 Rising levels of TGFb with ageing alters MNPs expression
of surface antigens
After observing the effects aged microglia exert on OPCs, I turned to explore what
could be the underlying cause to these changes witnessed in aged MNPs surface
antigens. I have focused on TGFb, a well known and potent cytokine. I have decided
to focus on TGFb for multiple reasons:
1. TGFb levels have been shown to increase with ageing in both mice and humans
(Carlson et al., 2009). Secondly, TGFb is known to play a pivotal role in
microglia biology (Butovsky et al., 2014) and microglia highly express TGFb
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receptors in comparison to other type of macrophages (Lavin et al., 2014), as
well as in comparison to other cell types in the CNS (Zhang et al., 2014).
2. TGFb has been shown to promote fibronectin and other matrix related proteins
expression in other cells (Ignotz & Massagué, 1986; Laping et al., 2002; Roberts
et al., 1988)
3. microglia have been shown to upregulate NG2 after stroke as a response to
elevated TGFb levels.
This positions TGFb a major candidate to affect microglia and change its matrix
associated molecules.
Figure 5.5 supports the role of TGFb in the effects seen by aged OPCs, as culturing
neonatal microglia (P21) in the presence on rising concentrations of TGFb prior to
ghost protocol, results in an increase in of astrocyte formation by OPCs. My qRT-PCR
results (as shown in fig5.6) also supports the claim that TGFb is sufficient to induce
changes in microglia matrix related proteins expression. Culturing microglia in the
presence of TGFb resulted in the upregulation of multiple surface genes, and as this
was blocked by using specific small molecule inhibitor, it suggests that this is a specific
effect unique to TGFb.
Therefore, I suggest the following mechanism of action: with ageing, there is an
increase in both microglia numbers (due to repeating inflammation incidents), as well
as an increase in TGFb levels. Elevated TGFb levels elicit changes in the expression
profile of aged microglia, and specifically alter their expression of matrix related
molecules. This chronic exposure to TGFb renders the aged microglia to express
multiple anti regenerative surface molecules which contribute to the formation of an
anti regenerative matrix in aged animals lesion sites. This process is summarised and
illustrated below in figure 5.9.
Further experiments would be needed to test other possible effects of TGFb on mi-
croglia, starting from the effect of TGFb on myelin phagocytosis by microglia, i.e.
TGFb transforms microglia to NG2+ microglia which are less efficient in debris clear-
ance. Moreover, I’m currently in the process of assessing the potential of using TGFb
inhibitor (SB-431542) on the neonatal microglia treated with TGFb ghosts in order
to prevent the unwanted effects of TGFb. Similar experiments will be conducted
with aged microglia ghosts, in which using SB-431542 could potentially block the
expression of anti regenerative surface antigens.
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Fig. 5.9 Schematic summary illustrating the effects of TGFb on OPC differentia-
tion This schematic illustration shows the ways in which TGFb affects the potential of
OPC to differentiate, both directly and indirectly.
5.4.3 TGFb inhibits OPC differentiation in vitro
Following the results obtained by adding TGFb to MNPs, and the reports that TGFb
levels rise with ageing, I tested the potential direct effects of TGFb on OPC differen-
tiation, as this can also give an alternative explanation for the effects seen by TGFb
treated neonatal MNPs ghosts. I.e., treating MNPs with TGFb enhances the expression
of TGFb (Butovsky et al., 2014), it is possible that this lead to increased deposition of
TGFb in the culture matrix, and in turn affected OPC differentiation.
Surveying current the literature revealed a consensus that TGFb enhances OPC differ-
entiation. Exploring the references that led to this conclusion revealed only a single
report by McKinnon et al., that shows a direct connection between TGFb and OPC
differentiation (McKinnon, 1993). A more scrutinising view of this paper revealed that
no differentiation assay was actually conducted. Only proliferation assays were done,
and TGFb was only shown to inhibit OPC proliferation. Other studies, such as (Hinks
& Franklin, 2000) rely on indirect evidence. For example, delay in TGFb expression
in aged animals leads to decreased OPC differentiation. In summary, it seems that
the evidence for the supportive roles of TGFb in OPC differentiation is lacking, and
following my own experiments (fig5.7) I would propose a different effect for TGFb in
OPC differentiation.
As shown in figure 5.7, addition of TGFb1 inhibits OPC differentiation in vitro, while
blocking TGFb signalling pathway using small molecule inhibitor, SB-431542, cancels
this effect. SB-431542 is a direct inhibitor of Alk4/5/7 (Inman et al., 2002), and thus
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prevents the phosphorylation of SMAD2/3 (Laping et al., 2002). This prevents the
downstream activation of genes usually activated by phosphorylated SMAD2/3.
These results are in contrast to results shown by Palazuelos and colleagues (Palazuelos,
Klingener, & Aguirre, 2014). They show opposite results for the effects of TGFb on
OPCs, both in vitro and in vivo, as the addition of TGFb OPCs in their cultures accel-
erated OPC differentiation, and administering TGFb in vivo promoted myelination.
As I did not test the effects of TGFb in vivo, I cannot say for certain what will be the
systematic effects of TGFb administration to animals. I believe that the main reasons
for the differences in the in vitro results stem from two main factors: the identity of the
cells and the concentration/duration of the TGFb administration. Firstly, Palazuelos et
al., used CNP-EGFP in order to sort OPCs. This is in contrast to the A2B5+ cells I
used. CNP+ cells are at best pre-myelinating OLs, and cannot be considered real pro-
genitors cells. Secondly, Palazuelos et al., administered TGFb1 in a concentration of
5ng/ml, which is half of the concentration I used. As TGFb pathway are complex and
include multiple feedback loops, I would expect that different doses will have different
effects. As shown with the MNPs experiments, only at 10 ng/ml a significant change
was achieved in MNPs gene expression. The role of TGFb in stem cells biology is
not yet fully known. Several reports have shown that inhibiting TGFb pathway results
in induction and maintenance of pluripotency. For example, Ichida and colleagues
show that TGFb inhibition can replace Sox2 overexpression in reprogramming adult
fibroblasts (Ichida et al., 2009), while Tan et al., show that inhibiting TGFb pathway in
combination with inhibiting HDACs (using Valporic Acid, VPA) can substitute Oct4
overexpression in reprogramming (Tan, Qian, Tang, Abd-Allah, & Jing, 2015).
In the OL lineage, Schultz and colleagues have shown that TGFb and Activin A induce
cell death in OL cell line (OLI-neu) (Schulz, Vogel, Dressel, & Krieglstein, 2008;
Schuster et al., 2002). I cannot rule out that cell death was the reason behind the
decline of differentiation in my experiments, but unlike the studies with OLI-neu I
could eliminate the effects of TGFb on OPCs by using small molecule inhibitors. This
is also in contrast to the effect of TGFb1 administration by Palazuelos et al. (Palazuelos
et al., 2014). It is also noteworthy to point out that more recent studies by Miron
et al., have pointed out that Activin A secreted by microglia/macrophages promotes
OPC differentiation in vitro, and adding Activin A blocking antibody eliminated the
effect of the microglia conditioned media (Miron et al., 2013). These latest results cast
doubts on the results shown by Schuster et al.
TGFb favourable role in OPC differentiation was further enhanced by studies
that claimed that at least part of the delay in OPC differentiation in aged animals is
due to changes in TGFb expression by microglia/macrophages. Hinks and Franklin
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(Hinks & Franklin, 2000) described the delayed kinetics of several growth factors
(including TGFb) during remyelination in aged animals and concluded that this leads
to delayed remyelination. According to the results I show in this chapter I would
suggest a different mechanism for the delayed OPC differentiation in relation to TGFb
kinetics in aged animals. In aged animals, the duration of exposure to TGFb is longer
and delays OPC differentiation. According to this paper, in young animals, who
exhibit successful remyelination, TGFb levels peak very early after the lesion (10
days post lesion), but then also decline very rapidly. In contrast, in aged animals
TGFb levels peak later on, but also remain high for a longer duration. A similar
phenomena is described by Doyle and colleagues when investigating stroke in aged
and young animals, where aged animals show a higher baseline of TGFb levels before
and after stroke. This is thought to lead to enhanced astrogliosis, which in turn inhibits
regeneration (Doyle, Cekanaviciute, Mamer, & Buckwalter, 2010).
Therefore, I suggest that in aged animals, delayed appearance and more importantly
delayed removal of TGFb, result in direct inhibition of OPC differentiation.
In summary, I show here results that suggest that TGFb actually plays an inhibitory
role in OPC differentiation, both directly and indirectly (through microglia surface
antigens). This adverse effect is only enhanced with age, as TGFb levels rise.
This situates TGFb as a potential therapeutic target for enhancement of remyelina-
tion in aged patients. To test this, aged animals would be subjected to demyelinating
lesion while being treated with a TGFb pathway inhibitor. A good candidate for this
could be the FDA approved compound Losartan. Losartan, which is mainly known
as Angiotensin type receptor 1 (Agtr1, AGTR1) antagonist, has been shown to be
effective in blocking TGFb signalling in multiple pathological conditions, including
Marfan syndrome models where it has been shown to inhibit TGFb dependent activa-
tion of signal regulated kinase (ERK) (Holm et al., 2011; Habashi et al., 2011). Even
tough Agtr1a is not highly expressed in microglia (Zhang et al., 2014), a report from
2008 by Miyoshi and colleagues showed that Losartan can attenuate the activation of
microglia by LPS, measured by reduced expression of IL1B and NO (nitric oxide)
(Miyoshi, Miyano, Moriyama, Taniguchi, & Watanabe, 2008). Furthermore, Losartan
has been shown to be an effective suppressor of TGFb related epilepsy (Bar-Klein et al.,
2014). Most importantly, in the study from 2014, although Losartan was administered
intraperitoneally and orally, it was successful in affecting epileptic processes in the
CNS, suggesting it can cross the BBB. Future studies would involve the direct effects




Final discussion and conclusions
6.1 DNA methylation in adult and aged OPCs
The epigenetic landscape and DNA methylation in particular, has been studied for
many decades. In recent years, with the emergence of new genomic tools, it has been
clear that the original notions regarding the role of DNA methylation were at best
simplistic, and even incorrect in some respects. One of the most repeated statements
relates to the inhibitory role of DNA methylation in transcription (A. P. Bird, 1985;
A. Bird, 2002). This inhibition can act in two main ways - firstly, direct effects of
DNA methylation on the affinity of the transcription machinery to the promoter sites;
secondly, through recruitment of histone modifiers which inhibit transcription (Fuks,
2005).
In this research I studied the potential connection between DNA methylation and
transcription in OL lineage cells, in both young adult and aged cells. In both cases, I
could not find a strong correlation between changes in DNA methylation and changes
in transcription. This was true when exploring full transcripts expression, differential
exon usage and expression of transposable elements (TEs). In all these cases, no direct
correlation was detected. I would like to explain this discrepancy by looking at the
following aspects:
1. Technical differences in comparison to past papers -
My research included Whole Genome Bisulfite Sequencing (WGBS). This al-
lowed me to observe changes in methylation in specific CpGs in a global genome
view. Many of the older studies regarding DNA methylation function used more
limited techniques (such as Reduced Representation Bisulfite Sequencing -
RRBS) that focus on specific locations in the genome and thus enable the view
of patterns more easily. Moreover, as recently reviewed by Tirado-Magallanes
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et al., (Tirado-Magallanes, Rebbani, Lim, Pradhan, & Benoukraf, 2017) identifi-
cation of correlation between DNA methylation and gene transcription is greatly
influenced by the window size chosen when analysing the methylation state. For
this study promoters were analysed with a window size of 1000bp (-900...+100),
which might not be the optimal window size, especially as there are no big
changes between the samples. This correlation can also be influenced by the
exact region that is analysed (i.e. different parts of the transcription start site).
This being said, exploring a recent publication regarding DNA methylation in
developmental OPCs (Moyon, Liang, & Casaccia, 2016) I could identify similar
patterns detected in my results and theirs. In both cases, the correlation between
DNA methylation and transcription was not perfect. Moyon et al. focused only
on the genes which showed the expected behaviour. Focusing only on promoters
that show correlation in methylation-transcription restricts the data that can be
inferred. For example, most of the genes identified in the Moyon paper as being
hypomethylated in OLs were myelin related. This could have also been inferred
by just observing the transcriptional data as OLs increase the expression of
myelin genes.
2. Novel role for DNA methylation in OL lineage cells - As opposed to the orig-
inal role set out for DNA methylation as an inhibitory cue for gene transcription,
my data suggests that DNA methylation plays a much more complex role in
in gene transcription than a binary state, at least in the OL lineage cells. A
publication by Raynal et al., (Raynal et al., 2012) supports this notion, as they
show that treating cells with HDAC inhibitors is sufficient for activation gene
transcription without altering DNA methylation states.
Thus, when observing promoter methylation levels of several key OPC genes in
aged cells, it is possible to hypothesise that DNA methylation acts more as a fine-
tuner than as a simple inhibitor. This loss of methylome landscape observed in
key genes in aged OPCs (some of which show significant changes in expression
as well) might be a contributing factor to the changes in transcriptome and cell
maintenance in aged OPCs. In order to fully investigate these changes, further
experiments will need to be conducted. This could include the comparison of
aged dietary restricted OPCs to young ones, similarly to the effects shown for
the transcription of key genes (Neumann et al., 2017),
In conclusion, my results show that the relation between DNA methylation and
gene transcription is more complex then a simple binary switch. Therefore, further
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research will need to be conducted in order to fully understand the role of DNA
methylation in gene transcription in general and in adult OPCs in particular.
6.2 Adult OL lineage cells are inherently different from
their neonatal counterparts
To date, the majority of in vitro studies involving OPCs have used neonatal OPCs. This
has generated substantial amounts of data regarding the developmental myelination
occurring in the early weeks postnatally in rodents. It is still unknown how much of this
is relevant to adult OPC biology and the transition they undergo during remyelination
(Fancy, Chan, Baranzini, Franklin, & Rowitch, 2011). Using a newly developed
isolation method I was able to isolate OLs and OPCs from adult rats in order to
further study the unique transcriptome of adult OPCs. When comparing my results to
previously published studies comparing neonatal OPCs and OLs (Zhang et al., 2014)
I found very few similarities. I believe that the main reason for this is the extensive
differences between neonatal and adult OPCs.
While the role of neonatal OPCs is to facilitate the developmental myelination
process, thus being in a constant state of activation, adult OPCs are not constantly
activated. Adult OPCs seems to reside in a quiescent state, characterised by a slow
cycling of the cells (Young et al., 2013). The differences between neonatal and adult
OPCs raise two main questions - are adult OPCs in fact adult stem cells residing in the
adult CNS? And what is the main role of adult OPCs in CNS homeostasis?
The discussion regarding the question whether or not OPCs can be considered
adult stem cells has been reviewed previously (A. Crawford et al., 2014; Franklin
& Ffrench-Constant, 2008). When examining the criteria for stem cells, one would
point out multipotency, self-renewal, asymmetric division and quiescence state when
not activated. Adult OPCs show multipotency both in vitro as well as in vivo, as
they can differentiate into oligodendrocytes, astrocytes, neurons and schwann cells
(Belachew et al., 2003; Raff et al., 1983; Zawadzka et al., 2010). OPCs can also
undergo asymmetrical division (Sugiarto et al., 2011) and can self renew themselves
(Neumann, unpublished). Using the transcriptional data presented in this study I can
add further evidence to this argument by pointing out that adult OPCs express specific
quiescence markers shared by other stem cells, such as Lgr5 (Jaks et al., 2008). Adult
OPCs also upregulate the expression LKB1 (Stk11 (fold change = 4.39, p-value =
0.051). LKB1 is a master regulator which maintains homeostasis in haematopoietic
stem cell (HSC), and its deletion leads to their depletion (Gan et al., 2010). Therefore,
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OPCs seems to activate quiescence genes similar to other adult quiescence stem cells.
This raises another question - if OPCs are quiescent stem cells, what is their stem
cell niche? OPCs are usually described as spread across the CNS following their
initial migration waves (A. H. Crawford, Tripathi, Richardson, & Franklin, 2016),
and do not seem to encompass any specific niche beyond the original blood vessels
they follow in their initial stages of development (Tsai et al., 2016). This will have to
be investigated in future studies. My data presents future researchers with some key
findings for identifying quiescent adult OPCs. As mentioned in chapter 3, adult OPCs
do not upregulate ‘classical’ markers in comparison to adult OLs, including Pdgfra
(fold change = 0.956, adjusted p-value = 0.937). Therefore, I suggest that in order to
accurately study quiescent adult OPCs, new markers should be used, such as Lgr5,
which is used to identify quiescent stem cell in other niches (Barker et al., 2007; Basak
et al., 2017; Jaks et al., 2008) and Hes1 which is a known marker for neural stem
cells (Nakamura et al., 2000). Discovering the stem cell niche of OPCs is essential
to combat the external effects of ageing, as it has been shown in other tissues that the
ageing niche can inhibit the function of young stem cells (Carlson & Conboy, 2007).
Another question that arises from the distinct differences between neonatal and
adult OPCs involves the role of adult OPCs in CNS homeostasis. In the adult CNS,
OPCs comprise 5-10% of the cells and the majority of the dividing cells (BrdU positive)
(Dawson et al., 2003; Horner et al., 2000); yet their role remains unknown. As yet, the
function of adult OPCs has been investigated mainly in the relation of remyelination
following pathological demyelinating events (Franklin & Ffrench-Constant, 2008).
Adult OPCs also play a role in de novo myelination in learning processes (Mckenzie
et al., 2014) and modulate myelin in the adult CNS (Young et al., 2013). Both of these
behaviours are to be expected by the nature of OPCs, as oligodendrocyte progenitors.
But both of these examples are primarily instances of OPC differentiation into OL
in order to facilitate their functions (remyelination and myelination). These do not
account for the activity of OPCs in their progenitor state. Do OPCs have an active
function while still in their progenitor state? In other tissues, the reason for the
existence of quiescence stem cells is to maintain a pool of cells ready to differentiate
when needed. The quiescent state is thought to protect the cells from genomic damages
that will occur if these cells divide rapidly (Richmond, Shah, Carlone, & Breault,
2016). But unlike the stem cells of the haematopoietic or intestinal systems, in which
large numbers of new differentiated cells need to be generated daily, adult OPCs do not
differentiate rapidly every day, but mainly proliferate and differentiate in response to
injury or outside stimulation (as described above). Future research would be required
to determine if adult OPCs participate in normal brain homeostasis (similar to the
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part played by astrocytes, for example), or if they only play a role when needed to
differentiate (similar to stem cells in the hair follicle, for example (Ito et al., 2005)).
Fig. 6.1 Summary of differences between adult and neonatal OPCs Schematic
illustration describing the differences between neonatal and young adult OPCs. Neona-
tal OPCs (green) are in activated state, characterised by the high expression of Pdgfra
and Cspg4. As developmental myelination ends, OPCs transform into a more quies-
cent state (red cells) which is characterised by the expression of quiescent stem cell
genes such as Hes1 and Lgr5. Once activated, either in vitro by PDGF or following
demyelinating lesion, adult OPCs are activated and revert to a more neonatal state, in
similar way to what has been described in previous studies (Moyon et al., 2015).
6.3 Transcriptional changes in agedOPCs inhibit their
differentiation capabilities
Remyelination is a regenerative process which is essential for the restoration of myelin
sheaths onto demyelinated axons. This enables adequate saltatory conduction, as well
as providing essential trophic support to axons, thus preventing axonal degeneration
(Franklin & Ffrench-Constant, 2008). This process seems to play a critical role in
the relapsing remitting phases of Multiple Sclerosis (MS) in humans (Compston &
Coles, 2008). Unsuccessful remyelination is usually thought to result from the failure
of OPCs to differentiate in the lesion site (Kuhlmann et al., 2008), and not due to
insufficient numbers of OPCs in ageing (Woodruff et al., 2004). In demyelinating
animal models, there is a marked decrease in the remyelination rate, making this
process virtually unsuccessful (Shields et al., 1999). Since age is correlated to the
transition to progressive phase in MS patients, it is clear that ageing must be considered
as a factor in remyelination therapies being developed. Unfortunately, due to technical
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limitations, most studies regarding the enhancement of OPC differentiation capabilities
up to this day have used in vitro neonatal OPCs.
In line with recent reports from the Franklin lab (Neumann et al., 2017), I show
here transcriptional and epigenetic evidence to support the notion that aged OPCs are
inherently different to neonate and young adult OPCs. This difference is extremely
relevant to the decrease in differentiation capacities of aged OPCs. Aged OPCs exhibit
decreased expression levels of several nuclear receptors previously shown to enhance
OPC differentiation, including Thyroid hormone receptors and Retinoic Acid receptors
(B. A. Barres et al., 1994; Huang et al., 2011). These results raise concerns that drugs
developed to enhance OPC differentiation in aged MS patients might be of limited
efficacy.
Furthermore, I show here evidence that aged OPCs lose their progenitor state when
compared to young OPCs. This includes the upregulation of several OL markers
(Cnp and Enpp6) but none of the myelin genes. This state is even more evident when
considering the fact that downregulation of multiple OPC genes are tightly connected
to maintaining the cell’s progenitor status (including Pdgfra, Hes1, Hes5, Ptprz1,
Sox2 and Ascl1). When recruited to demyelinating lesions, adult OPCs revert back to
neonatal activated state (Moyon et al., 2015). Aged OPCs, which show downregulation
of many progenitor genes, are therefore less likely to be able to revert back to neonatal
progenitor state. Moreover, expression of progenitor genes is essential in order to
maintain the quiescence state of OPCs. Mainataing cells in a quiescence state is key in
protecting cells from DNA damage as forced exit from quiescence can lead to extensive
DNA damage (Beerman, Seita, Inlay, Weissman, & Rossi, 2014) and maintaing pool
of stem cells for lineage differentiation (Cheung & Rando, 2013).
Using WGBS I was able to study change in methylation status in aged OPCs. Al-
though no global changes were found, when observing specifically OPC related genes
(which are necessary for the progenitor phenotype of OPCs) I detected a significant
loss of methylation in many promoters. This suggests a loss of epigenetic memory
in aged OPCs and an epigenetic drift. Mechanisms behind epigenetic inheritance are
still unknown, but DNA methylation presents a good candidate since it is transmitted
in a semi-conservative way during DNA replication and hence can be fully copied to
daughter cells. DNMT1 is responsible for this cellular inheritance, and, as expected,
is downregulated in aged OPCs (log2 fold change = 0.4, adjusted p-value < 0.05).
This provides the basis for the reduction of methylation observed in several key OPC
gene promoters. It is not yet known how these changes directly affect the biology of
aged OPCs and their ability to differentiate and respond to external stimuli. Since
calorie restriction results in restoration of expression of key genes in aged OPCs to
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similar levels as those exhibited by young OPCs (Neumann et al., 2017), similar results
might be shown by performing WGBS on aged OPCs derived from calorie restricted
animals. Changes in multiple genes reduces the chances that interventions which are
based on specific DNA methylation alterations, including using CRISPR mediated
DNA methylation (McDonald et al., 2016), will be effective in correcting the aged
methylome, as it includes multiple targets. Therefore, a more global approach that will
reverse the epigenetic landscape of aged OPCs in a global way should be favoured, as
described below.
Ingenuity Pathway Analysis (IPA) has revealed that one of the main pathways
which is upregulated in aged OPCs is the mTOR (mammalian target of rapamycin)
pathway. mTOR has been described as a major effector in ageing related processes
(Johnson et al., 2013). Inhibition of the mTOR pathway leads to increased life span
in multiple organisms, ranging from yeast, nematode Caenorhabditis elegans, fruitfly
Drosophila and mice (Roizen, 2010; Johnson et al., 2013). More specifically, upregu-
lation of mTOR has been detected in aged HSCs, and inhibiting mTOR activation in
these cells using rapamycin restored their function and improved the overall immune
system activity of aged mice (C. Chen, Liu, Liu, & Zheng, 2009). Besides mTOR
inhibition, the only other mechanism that has been shown to increase life expectancy
throughout the animal kingdom is calorie restriction (CR) (Johnson et al., 2013). CR
rejuvenation effects are thought to be mediated, partially, through the inhibition of
mTOR activation (specifically mTORC1 inhibition), and have been shown to enhance
aged stem cell function (Cerletti, Jang, Finley, Haigis, & Wagers, 2012). mTOR is
inhibited by AMPK (AMP-activated protein kinase). As expected, one of the catalytic
sub units of AMPK, encoded by Prkaa2, is downregulated in aged OPCs (log2 fold
change = 0.745, adjusted p-value = 0.005). Therefore, this could at least partially
explain the dysregulation in mTOR signalling. Similar to what have been shown in
HSCs, aged mice which have been subjected to CR show enhanced remyelination
capacities, and OPCs isolated from these mice show enhanced differentiation capabil-
ities (Neumann et al., 2017). This rejuvenation of aged OPCs can also be achieved
by inhibiting mTOR directly using rapamycin. Unfortunately, this probably cannot
be used as therapeutic strategy for two main reasons: firstly, mTOR activation is
also needed for OPC differentiation (Tyler et al., 2009). Secondly, chronic exposure
to rapamycin can inhibit mTORC2 activity, impairing glucose tolerance and insulin
function (Lamming et al., 2012). Therefore, the use of metformin in order to activate
AMPK was favoured, and has been shown to reproduce the effects of CR (Neumann et
al., 2017). I expect that by altering major pathways in aged OPCs as described here, it
will be possible to reverse at least some of the changes I observed in the methylation
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patterns in aged OPCs.
In conclusion, aged OPCs show dramatic changes in their transcriptional landscape.
These changes render them less equipped to address challenges posed by demyelinating
lesions in the aged CNS. Therapeutic interventions can potentially rejuvenate aged
OPCs, and these will be most effective if done in a global, systematic fashion.
Fig. 6.2 Summary of intrinsic changes in aged OPCs Schematic summary of intrin-
sic changes in aged OPCs described throughout this study. Young adult OPCs (labelled
in green) are an homegenous population stem cells which are capable to self renew
and differentiate once activated. During ageing, these cells exhibit several intrinsic
changes, as illustrated. This results in heterogeneous population which is less effective
in responding to injury and activation cues. Red text boxes describe changes which
include downregualtion of elements, whereas blue text box exhibit upregulations. The
green text box describe changes which include and up and down-regulation. Each text
box includes a few specific examples of the process which is mentioned.
6.4 Microglia ECM molecules affect OPC differentia-
tion
OPC differentiation is a complex process which is governed by both internal and
external factors. In the previous sections I focused on the internal gene networks in
6.4 Microglia ECM molecules affect OPC differentiation 165
play in adult OPCs and how they are affected by the process of ageing. In this final
section I will focus on some external effectors which mediate OPC differentiation,
focusing on microglia and their contribution to the lesion microenvironment, with
emphasis on their effect on the extracellular matrix. The microenvironment has a
profound role on the function of stem cells, and this has been shown for multiple tissue
and cell types (Carlson & Conboy, 2007).
Previous studies have explored the ways in which the microenvironment can affect
OPC differentiation, with emphasis on the inhibitory effects of CSPGs (chondroitin
sulfate proteoglycans), myelin debris and more. CSPGs are known to be inhibitory
for axonal regeneration in general and OPC differentiation in particular (Lau et al.,
2012; Pendleton et al., 2013). More recent investigations have focused on the role
astrocytes play in demyelinating lesions, by the expression of inhibitory CSPGs, and
how the mere presence of these molecules can ameliorate all effects OPC differentiation
drugs might exert (Keough et al., 2016). These studies emphasise the pivotal part
the lesion substrate plays in the dynamics of OPC differentiation. In contrast to
astrocytes which encompass the rim of the demyelinating lesion, the core of the lesion
- where remyelination will eventually take place - is mainly populated by microglia
and macrophages. These cells are usually the first to arrive at the lesion, and are
responsible for the clearance of inhibitory myelin debris and the recruitment of OPCs
to the site lesion using specific chemokines (McMurran, Jones, Fitzgerald, & Franklin,
2016).
The results I show in chapter 5 describe (for the first time to my knowledge) an
additional role for microglia in remyelination as they shape the extracellular matrix
(ECM) of the lesion by the expression of multiple surface antigens that in turn affect
OPC differentiation. Aged microglia upregulate multiple surface antigens, including
NG2 and fibronectin (Hickman et al., 2013), which in turn can affect OPC differentia-
tion. Using in vitro cultures, I show that aged microglia antigens can alter the fate of
OPCs, and promote astrogenesis. I can further show that this process can reproduced
in neonatal microglia by adding TGFb, similarly to what have been shown in other
cell types (Ignotz & Massagué, 1986).
In vivo experiments have shown that microglia in demyelinating lesions express
fibronectin and this can potentially inhibit remyelination (Stoffels et al., 2013). There-
fore, I suggest here that elevated levels of TGFb in aged animals alters the expression
of surface antigens on microglia to a phenotype which does not supports OPC differ-
entiation, and might even inhibit it.
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6.5 Conclusions
This thesis presents novel methods and new data regarding the transcriptome of adult
OPCs, and the changes they encounter during ageing. The discussion also emphasises
the differences between neonatal and adult progenitor cells, and the importance of
studying adult and aged cells in order to develop therapeutic targets in human diseases.
I provide here evidence for multiple changes in the aged OPC transcriptome which
can lead to inefficient differentiation; these include alterations in full gene expression
as well as changes in alternative splicing. I also supply transcriptional evidence to
support the notion that OPCs are in fact similar to other tissue resident adult stem cells.
Furthermore, the data reveals a previously undiscovered contribution of microglia to
the ageing ECM, and its effect on OPC differentiation. I go on to explore the possible
mechanism behind the changes in microglia ECM molecules, and identify TGFb as a
potential therapeutic target in aged animals and humans. Collectively, these findings
will provide a framework for further research that will unravel the biology of adult and
aged OPCs, aiding in the pursuit of new strategies to enhance remyelination in adult
and aged human patients.
In summary, all great work is the
fruit of patience and perseverance,
combined with tenacious
concentration on a subject over a
period of months or years.
Santiago Ramon y Cajal
Advice for a Young Investigator
References
Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F.,
. . . Zuhlke, L. J. (2017). Global, regional, and national under-5 mortality, adult
mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic
analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100),
1084–1150. doi: 10.1016/S0140-6736(17)31833-0
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007). Local
self-renewal can sustain CNS microglia maintenance and function throughout
adult life. Nature neuroscience, 10(12), 1538–43. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/18026097 doi: 10.1038/nn2014
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G.,
& Probert, L. (1998). Oligodendrocyte apoptosis and primary demyelination
induced by local TNF/p55TNF receptor signaling in the central nervous system
of transgenic mice: models for multiple sclerosis with primary oligoden-




Albrecht, P. J., Murtie, J. C., Ness, J. K., Redwine, J. M., Enterline, J. R., Arm-
strong, R. C., & Levison, S. W. (2003). Astrocytes produce CNTF dur-
ing the remyelination phase of viral-induced spinal cord demyelination to
stimulate FGF-2 production. Neurobiology of Disease, 13(2), 89–101. doi:
10.1016/S0969-9961(03)00019-6
Armstrong, L., Hughes, O., Yung, S., Hyslop, L., Stewart, R., Wappler, I., . . . Lako, M.
(2006). The role of PI3K/AKT, MAPK/ERK and NFkb signalling in the main-
tenance of human embryonic stem cell pluripotency and viability highlighted by
transcriptional profiling and functional analysis. Human Molecular Genetics,
15(11), 1894–1913. doi: 10.1093/hmg/ddl112
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., . . .
Stiles, C. D. (2004, dec). bHLH transcription factor Olig1 is required to repair
demyelinated lesions in the CNS. Science (New York, N.Y.), 306(5704), 2111–
5. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15604411 doi:
10.1126/science.1103709
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y.
(2001, nov). TNFa promotes proliferation of oligodendrocyte progenitors




Arnett, H. A., Wang, Y., Matsushima, G. K., Suzuki, K., & Ting, J. P.-Y. (2003). Func-
tional genomic analysis of remyelination reveals importance of inflammation
168 References
in oligodendrocyte regeneration. Journal of Neuroscience, 23(30), 9824–32.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14586011 doi:
23/30/9824[pii]
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N., & Lovell-Badge, R.
(2003). Multipotent cell lineages in early mouse development on SOX2 function.
Genes Dev., 17, 126–140. doi: 10.1101/gad.224503
Awatramani, R., Scherer, S., Grinspan, J., Collarini, E., Skoff, R., O’Hagan, D., . . .
Kamholz, J. (1997). Evidence that the homeodomain protein Gtx is involved in
the regulation of oligodendrocyte myelination. The Journal of neuroscience :
the official journal of the Society for Neuroscience, 17(17), 6657–6668.
Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J.,
. . . Holtzman, D. M. (2002). Selective vulnerability of late oligodendrocyte
progenitors to hypoxia- ischemia. Journal of Neuroscience, 22(2), 455–63.
Back, S. a., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., . . .
Sherman, L. S. (2005). Hyaluronan accumulates in demyelinated lesions
and inhibits oligodendrocyte progenitor maturation. Nature medicine, 11(9),
966–972. doi: 10.1038/nm1279
Bannister, A. J., & Kouzarides, T. (2011, mar). Regulation of chro-




Barker, N., Tan, S., & Clevers, H. (2013). Lgr proteins in epithelial stem cell biology.
Development, 140(12), 2484–2494. Retrieved from http://dev.biologists
.org/cgi/doi/10.1242/dev.083113 doi: 10.1242/dev.083113
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen,
M., . . . Clevers, H. (2007). Identification of stem cells in small intestine
and colon by marker gene Lgr5. Nature, 449(7165), 1003–1007. Retrieved
from http://www.nature.com/doifinder/10.1038/nature06196 doi:
10.1038/nature06196
Bar-Klein, G., Cacheaux, L. P., Kamintsky, L., Prager, O., Weissberg, I., Schoknecht,
K., . . . Friedman, A. (2014). Losartan prevents acquired epilepsy via TGF-b
signaling suppression. Annals of Neurology, 75(6), 864–875. doi: 10.1002/
ana.24147
Barres, B. A., Lazar, M. A., & Raff, M. C. (1994, may). A novel role for thyroid
hormone, glucocorticoids and retinoic acid in timing oligodendrocyte develop-
ment. Development (Cambridge, England), 120(5), 1097–108. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/8026323
Barres, B. a., & Raff, M. C. (1993). Proliferation of oligodendrocyte precursor cells
depends on electrical activity in axons. Nature, 361(6409), 258–260. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/8093806{%}5Cnhttp://
www.nature.com/doifinder/10.1038/361258a0 doi: 10.1038/361258a0
Bartzokis, G., Cummings, J. L., Sultzer, D., Henderson, V. W., Nuechterlein, K. H.,
& Mintz, J. (2003, mar). White Matter Structural Integrity in Healthy Aging
Adults and Patients With Alzheimer Disease. Archives of Neurology, 60(3), 393.
Retrieved from http://archneur.jamanetwork.com/article.aspx?doi=
10.1001/archneur.60.3.393 doi: 10.1001/archneur.60.3.393
Basak, O., Beumer, J., Wiebrands, K., Seno, H., van Oudenaarden, A., & Clevers,
H. (2017). Induced Quiescence of Lgr5+ Stem Cells in Intestinal Organoids
Enables Differentiation of Hormone-Producing Enteroendocrine Cells. Cell
References 169
Stem Cell, 20(2), 177–190.e4. Retrieved from http://dx.doi.org/10.1016/
j.stem.2016.11.001 doi: 10.1016/j.stem.2016.11.001
Beerman, I., Seita, J., Inlay, M. A., Weissman, I. L., & Rossi, D. J. (2014). Quiescent
hematopoietic stem cells accumulate DNA damage during aging that is repaired
upon entry into cell cycle. Cell Stem Cell, 15(1), 37–50. Retrieved from
http://dx.doi.org/10.1016/j.stem.2014.04.016 doi: 10.1016/j.stem
.2014.04.016
Belachew, S., Chittajallu, R., Aguirre, A. A., Yuan, X., Kirby, M., Anderson, S.,
& Gallo, V. (2003). Postnatal NG2 proteoglycan-expressing progenitor cells
are intrinsically multipotent and generate functional neurons. Journal of Cell
Biology, 161(1), 169–186. doi: 10.1083/jcb.200210110
Bennetta, M. L., Bennetta, C., Liddelowa, S. A., Ajami, B., Zamanian, J. L., Fernhoff,
N. B., . . . Barres, B. A. (2016). New tools for studying microglia in the mouse
and human CNS. Pnas, 1525528113–. Retrieved from http://www.pnas
.org/content/early/2016/02/10/1525528113.abstract doi: 10.1073/
pnas.1525528113
Bieber, A. J., Kerr, S., & Rodriguez, M. (2003). Efficient central nervous system
remyelination requires T cells. Annals of Neurology, 53(5), 680–684. doi:
10.1002/ana.10578
Bird, A. (2002, jan). DNA methylation patterns and epigenetic memory. Genes &
Development, 16(1), 6–21. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/11782440http://www.genesdev.org/cgi/doi/10.1101/
gad.947102 doi: 10.1101/gad.947102
Bird, A. P. (1985). CpG-rich islands and the function of DNA methylation. Nature.
Retrieved from http://europepmc.org/abstract/MED/2423876 doi: 10
.1038/321209a0
Blakemore, W. (1974, may). Remyelination of the superior cerebel-
lar peduncle in old mice following demyelination induced by cupri-




Blakemore, W. F., & Keirstead, H. S. (1999). The origin of remyelinating cells in
the central nervous system. Journal of Neuroimmunology, 98(1), 69–76. doi:
10.1016/S0165-5728(99)00083-1
Bond, A. M., Bhalala, O. G., & Kessler, J. A. (2012). The dynamic role of bone
morphogenetic proteins in neural stem cell fate and maturation. Developmental
Neurobiology, 72(7), 1068–1084. doi: 10.1002/dneu.22022
Boulanger, J. J., & Messier, C. (2014). From precursors to myelinating oligo-
dendrocytes: Contribution of intrinsic and extrinsic factors to white mat-
ter plasticity in the adult brain. Neuroscience, 269, 343–366. Retrieved
from http://dx.doi.org/10.1016/j.neuroscience.2014.03.063 doi:
10.1016/j.neuroscience.2014.03.063
Boyd, A., Zhang, H., & Williams, A. (2013, jun). Insufficient OPC mi-
gration into demyelinated lesions is a cause of poor remyelination in




Branco, M. R., Ficz, G., & Reik, W. (2012, jan). Uncovering the role of 5-
170 References
hydroxymethylcytosine in the epigenome. Nature reviews. Genetics, 13(1),
7–13. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22083101
doi: 10.1038/nrg3080
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G.,
. . . Weiner, H. L. (2014). Identification of a unique TGF-b -dependent molecular




Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., . . .
Schwartz, M. (2006, jan). Microglia activated by IL-4 or IFN-gamma differen-
tially induce neurogenesis and oligodendrogenesis from adult stem/progenitor
cells. Molecular and cellular neurosciences, 31(1), 149–60. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/16297637 doi: 10.1016/
j.mcn.2005.10.006
Cai, J., Qi, Y., Hu, X., Tan, M., Liu, Z., Zhang, J., . . . Qiu, M. (2005). Generation
of oligodendrocyte precursor cells from mouse dorsal spinal cord independent
of Nkx6 regulation and Shh signaling. Neuron, 45(1), 41–53. doi: 10.1016/
j.neuron.2004.12.028
Cai, J., Zhu, Q., Zheng, K., Li, H., Qi, Y., Cao, Q., & Qiu, M. (2010). Co-localization
of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating
oligodendrocytes. Glia, 58(4), 458–468. doi: 10.1002/glia.20937
Caillava, C., Vandenbosch, R., Jablonska, B., Deboux, C., Spigoni, G., Gallo, V., . . .
Evercooren, A. B. V. (2011). Cdk2 loss accelerates precursor differentiation
and remyelination in the adult central nervous system. Journal of Cell Biology,
193(2), 397–407. doi: 10.1083/jcb.201004146
Calvanese, V., Lara, E., Kahn, A., & Fraga, M. F. (2009, oct). The role of epigenetics
in aging and age-related diseases. Ageing research reviews, 8(4), 268–76.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19716530 doi:
10.1016/j.arr.2009.03.004
Cammer, W., & Zhang, H. (1999, jun). Maturation of oligodendrocytes is more
sensitive to TNFa than is survival of precursors and immature oligodendro-
cytes. Journal of Neuroimmunology, 97(1-2), 37–42. Retrieved from http://
linkinghub.elsevier.com/retrieve/pii/S0165572899000454 doi: 10
.1016/S0165-5728(99)00045-4
Carlson, M. E., & Conboy, I. M. (2007). Loss of stem cell regenerative capacity within
aged niches. Aging Cell, 6(3), 371–382. doi: 10.1111/j.1474-9726.2007.00286
.x
Carlson, M. E., Conboy, M. J., Hsu, M., Barchas, L., Jeong, J., Agrawal, A., . . .
Conboy, I. M. (2009). Relative roles of TGF-b1 and Wnt in the systemic
regulation and aging of satellite cell responses. Aging Cell, 8(6), 676–689. doi:
10.1111/j.1474-9726.2009.00517.x
Castilho, R. M., Squarize, C. H., Chodosh, L. A., Williams, B. O., & Gutkind, J. S.
(2009). mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and
Aging. Cell Stem Cell, 5(3), 279–289. Retrieved from http://dx.doi.org/
10.1016/j.stem.2009.06.017 doi: 10.1016/j.stem.2009.06.017
Cedar, H., & Bergman, Y. (2009). Linking DNA methylation and histone modification:
patterns and paradigms. Nature reviews. Genetics, 10(5), 295–304. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/19308066 doi: 10.1038/
nrg2540
References 171
Cerletti, M., Jang, Y. C., Finley, L. W. S., Haigis, M. C., & Wagers, A. J. (2012).
Short-term calorie restriction enhances skeletal muscle stem cell function. Cell
Stem Cell, 10(5), 515–519. Retrieved from http://dx.doi.org/10.1016/
j.stem.2012.04.002 doi: 10.1016/j.stem.2012.04.002
Cervoni, N., & Szyf, M. (2001). Demethylase Activity Is Directed by Histone
Acetylation. Journal of Biological Chemistry, 276(44), 40778–40787. doi:
10.1074/jbc.M103921200
Chan, W. Y., Kohsaka, S., & Rezaie, P. (2007). The origin and cell lineage of
microglia-New concepts. Brain Research Reviews, 53(2), 344–354. doi: 10
.1016/j.brainresrev.2006.11.002
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002). Premyelinating
oligodenrocytes in chronic lesions of multiple sclerosis. N Engl J Med, 346(3),
165–173.
Chen, C., Liu, Y., Liu, Y., & Zheng, P. (2009, nov). mTOR Regulation and Thera-
peutic Rejuvenation of Aging Hematopoietic Stem Cells. Science Signaling,
2(98), ra75–ra75. Retrieved from http://stke.sciencemag.org/cgi/doi/
10.1126/scisignal.2000559 doi: 10.1126/scisignal.2000559
Chen, T., Ueda, Y., Dodge, J. E., Wang, Z., & Li, E. (2003, aug). Establishment and
maintenance of genomic methylation patterns in mouse embryonic stem cells by




Cheng, X., Wang, Y., He, Q., Qiu, M., Whittemore, S. R., & Cao, Q. (2007). Bone
morphogenetic protein signaling and olig1/2 interact to regulate the differen-
tiation and maturation of adult oligodendrocyte precursor cells. Stem cells
(Dayton, Ohio), 25(12), 3204–14. Retrieved from http://onlinelibrary
.wiley.com/doi/10.1634/stemcells.2007-0284/full doi: 10.1634/
stemcells.2007-0284
Cheung, T. H., & Rando, T. A. (2013, may). Molecular regulation of stem cell





Compston, A., & Coles, A. (2008). Multiple sclerosis. The Lancet, 372(9648),
1502–1517. Retrieved from http://dx.doi.org/10.1016/S0140-6736(08)
61620-7 doi: 10.1016/S0140-6736(08)61620-7
Cortese, R., Lewin, J., Bäckdahl, L., Krispin, M., Wasserkort, R., Eckhardt, F., &
Beck, S. (2011). Genome-wide screen for differential DNA methylation asso-




Coufal, N. G., Garcia-Perez, J. L., Peng, G. E., Yeo, G. W., Mu, Y., Lovci,
M. T., . . . Gage, F. H. (2009). L1 retrotransposition in human neu-





Crawford, A., Stockley, J., Tripathi, R., Richardson, W., & Franklin, R.
(2014, oct). Oligodendrocyte progenitors: Adult stem cells of the cen-




Crawford, A. H., Tripathi, R. B., Foerster, S., McKenzie, I., Kougioumtzidou, E., Grist,
M., . . . Franklin, R. J. M. (2016). Pre-existing mature oligodendrocytes do not
contribute to remyelination following toxin-induced spinal cord demyelination.
American Journal of Pathology, 186(3), 511–516. Retrieved from http://
dx.doi.org/10.1016/j.ajpath.2015.11.005 doi: 10.1016/j.ajpath.2015
.11.005
Crawford, A. H., Tripathi, R. B., Richardson, W. D., & Franklin, R. J. M. (2016).
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response
to Demyelination and Susceptibility to Age-Associated Functional Decline.
Cell Reports, 15(4), 761–773. Retrieved from http://dx.doi.org/10.1016/
j.celrep.2016.03.069 doi: 10.1016/j.celrep.2016.03.069
Cross, S. H., & Bird, A. P. (1995, jun). CpG islands and genes.




Cuadros, M. A., & Navascués, J. (1998). The origin and differentiation of microglial
cells during development. Progress in Neurobiology, 56(2), 173–189. doi:
10.1016/S0301-0082(98)00035-5
Cunliffe, V. T., & Casaccia-Bonnefil, P. (2006). Histone deacetylase 1 is essential for
oligodendrocyte specification in the zebrafish CNS.Mechanisms of Development,
123(1), 24–30. doi: 10.1016/j.mod.2005.10.005
Dawson, M. R. L., Polito, A., Levine, J. M., & Reynolds, R. (2003). NG2-expressing
glial progenitor cells: An abundant and widespread population of cycling cells
in the adult rat CNS. Molecular and Cellular Neuroscience, 24(2), 476–488.
doi: 10.1016/S1044-7431(03)00210-0
De Cecco, M., Criscione, S. W., Peckham, E. J., Hillenmeyer, S., Hamm, E. A.,
Manivannan, J., . . . Sedivy, J. M. (2013). Genomes of replicatively senescent
cells undergo global epigenetic changes leading to gene silencing and activation
of transposable elements. Aging Cell, 12(2), 247–256. doi: 10.1111/acel.12047
De Cecco, M., Criscione, S. W., Peterson, A. L., Neretti, N., Sedivy, J. M., & Kreiling,
J. A. (2013). Transposable elements become active and mobile in the genomes
of aging mammalian somatic tissues. Aging, 5(12), 867–883. doi: 10.18632/
aging.100621
Deaton, A. M., & Bird, A. (2011, may). CpG islands and the regulation of transcription.
Genes & Development, 25(10), 1010–1022. Retrieved from http://genesdev
.cshlp.org/cgi/doi/10.1101/gad.2037511 doi: 10.1101/gad.2037511
de la Fuente, A. G., Errea, O., van Wijngaarden, P., Gonzalez, G. A., Kerninon, C.,
Jarjour, A. A., . . . Franklin, R. J. (2015). Vitamin D receptor–retinoid X receptor
heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
The Journal of Cell Biology, 211(5), 975–985. Retrieved from http://www.jcb
.org/lookup/doi/10.1083/jcb.201505119 doi: 10.1083/jcb.201505119
Di Ruscio, A., Ebralidze, A. K., Benoukraf, T., Amabile, G., Goff, L. a.,
Terragni, J., . . . Tenen, D. G. (2013, oct). DNMT1-interacting
References 173
RNAs block gene-specific DNA methylation. Nature, 503(7476),





Ding, X., Liu, S., Tian, M., Zhang, W., Zhu, T., Li, D., . . . Guan, J.-S. (2017).
Activity-induced histone modifications govern Neurexin-1 mRNA splicing and
memory preservation. Nature Neuroscience, 20(5). Retrieved from http://
www.nature.com/doifinder/10.1038/nn.4536 doi: 10.1038/nn.4536
Dombrowski, Y., O’Hagan, T., Dittmer, M., Penalva, R., Mayoral, S. R., Bankhead, P.,
. . . Fitzgerald, D. C. (2017). Regulatory T cells promote myelin regeneration
in the central nervous system. Nature Neuroscience, 20(5), 674–680. Re-
trieved from http://www.nature.com/doifinder/10.1038/nn.4528 doi:
10.1038/nn.4528
Doyle, K. P., Cekanaviciute, E., Mamer, L. E., & Buckwalter, M. S. (2010). TGFb
signaling in the brain increases with aging and signals to astrocytes and innate
immune cells in the weeks after stroke. Journal of neuroinflammation, 7(1),
62. Retrieved from http://www.jneuroinflammation.com/content/7/1/
62 doi: 10.1186/1742-2094-7-62
Dugas, J., Cuellar, T., Scholze, A., & Ason, B. (2010). Dicer1 and miR-219 Are
Required for Normal Oligodendrocyte Differentiation and Myelination Jason.
Neuron, 65(5), 597–611. Retrieved from http://www.sciencedirect.com/
science/article/pii/S089662731000053X doi: 10.1016/j.neuron.2010.01
.027.Dicer1
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009). GOrilla: a
tool for discovery and visualization of enriched GO terms in ranked gene lists.
BMC bioinformatics, 10(1), 48. Retrieved from http://bmcbioinformatics
.biomedcentral.com/articles/10.1186/1471-2105-10-48 doi: 10
.1186/1471-2105-10-48
Emery, B., Agalliu, D., Cahoy, J. D., Watkins, T. A., Dugas, J. C., Mulinyawe,
S. B., . . . Barres, B. A. (2009). Myelin Gene Regulatory Factor Is a Critical
Transcriptional Regulator Required for CNSMyelination. Cell, 138(1), 172–185.
Retrieved from http://dx.doi.org/10.1016/j.cell.2009.04.031 doi:
10.1016/j.cell.2009.04.031
Esteller, M. (2008, mar). Epigenetics in cancer. The New England journal of medicine,
358(11), 1148–59. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
24413145 doi: 10.1056/NEJMra072067
Fancy, S. P. J., Baranzini, S. E., Zhao, C., Yuk, D. I., Irvine, K. A., Kaing, S.,
. . . Rowitch, D. H. (2009). Dysregulation of the Wnt pathway inhibits timely
myelination and remyelination in the mammalian CNS. Genes and Development,
23(13), 1571–1585. doi: 10.1101/gad.1806309
Fancy, S. P. J., Chan, J. R., Baranzini, S. E., Franklin, R. J. M., & Rowitch, D. H.
(2011). Myelin regeneration: a recapitulation of development? Annual review of
neuroscience, 34, 21–43. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/21692657 doi: 10.1146/annurev-neuro-061010-113629
Fancy, S. P. J., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini,
S. E., . . . Rowitch, D. H. (2011). Axin2 as regulatory and therapeutic target
in newborn brain injury and remyelination. Nature Neuroscience, 14(8),





Fancy, S. P. J., Zhao, C., & Franklin, R. J. M. (2004). Increased expression of Nkx2.2
and Olig2 identifies reactive oligodendrocyte progenitor cells responding to
demyelination in the adult CNS. Molecular and Cellular Neuroscience, 27(3),
247–254. doi: 10.1016/j.mcn.2004.06.015
Feigenson, K., Reid, M., See, J., Crenshaw III, E. B., & Grinspan, J. B.
(2011). Canonical Wnt signalling requires the BMP pathway to in-




Ffrench-Constant, C., & Raff, M. C. (1986, feb). Proliferating bipotential glial




Fraga, M. F., Agrelo, R., & Esteller, M. (2007, apr). Cross-Talk between Aging and
Cancer: The Epigenetic Language. Annals of the New York Academy of Sciences,
1100(1), 60–74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
17460165http://doi.wiley.com/10.1196/annals.1395.005 doi: 10
.1196/annals.1395.005
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L.,
. . . Esteller, M. (2005). Epigenetic differences arise during the life-
time of monozygotic twins. Proceedings of the National Academy of




Franklin, R. J. M., & Ffrench-Constant, C. (2008, nov). Remyelination in the CNS:
from biology to therapy. Nature Reviews Neuroscience, 9(11), 839–855. Re-
trieved from http://www.ncbi.nlm.nih.gov/pubmed/18931697http://
www.nature.com/doifinder/10.1038/nrn2480 doi: 10.1038/nrn2480
Fuks, F. (2005, oct). DNA methylation and histone modifications: teaming up
to silence genes. Current opinion in genetics & development, 15(5), 490–5.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16098738 doi:
10.1016/j.gde.2005.08.002
Fuks, F., Burgers, W. a., Brehm, A., Hughes-Davies, L., & Kouzarides, T. (2000). DNA
methyltransferase Dnmt1 associates with histone deacetylase activity. Nature
genetics, 24(1), 88–91. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/20331964 doi: 10.1038/71750
Gan, B., Hu, J., Jiang, S., Liu, Y., Sahin, E., Zhuang, L., . . . Depinho, R. a. (2010).
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem
cells. Nature, 468(7324), 701–704. doi: 10.1038/nature09595
Garbern, J. Y., Yool, D. A., Moore, G. J., Wilds, I. B., Faulk, M. W., Klugmann,
M., . . . Griffiths, I. R. (2002). Patients lacking the major CNS myelin protein,
proteolipid protein 1, develop length-dependent axonal degeneration in the
absence of demyelination and inflammation. Brain : a journal of neurology,
125(Pt 3), 551–61. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
References 175
11872612 doi: 10.1093/brain/awf043
Gensert, J. M., & Goldman, J. E. (1997). Endogenous progenitors remyelinate
demyelinated axons in the adult CNS. Neuron, 19(1), 197–203. doi: 10.1016/
S0896-6273(00)80359-1
Gibson, E. M., Purger, D., Mount, C. W., Goldstein, A. K., Lin, G. L., Wood, L. S.,
. . . Monje, M. (2014, may). Neuronal Activity Promotes Oligodendrogenesis
and Adaptive Myelination in the Mammalian Brain. Science, 344(6183),




Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., . . . Merad, M.
(2010). Hematopoietic Waves of Microglial Recruitment and Differentiation
Occur in the Central Nervous. Science, 330(2009).
Gonzalez, G. A., Hofer, M. P., Syed, Y. A., Amaral, A. I., Rundle, J., Rahman, S.,
. . . Kotter, M. R. N. (2016). Tamoxifen accelerates the repair of demyelinated
lesions in the central nervous system. Scientific Reports, 6(August), 31599.
Retrieved from http://www.nature.com/articles/srep31599 doi: 10
.1038/srep31599
Griffiths, I., Klugmann, M., Anderson, T., Yool, D. A., Thomson, C., Schwab, M. H.,
. . . Nave, K.-A. (1998, jun). Axonal Swellings and Degeneration in Mice
Lacking the Major Proteolipid of Myelin. Science, 280(5369), 1610–1613.
Retrieved from http://www.sciencemag.org/cgi/doi/10.1126/science
.280.5369.1610 doi: 10.1126/science.280.5369.1610
Grippo, P., Iaccarino, M., Parisi, E., & Scarano, E. (1968, sep). Methylation of DNA in
developing sea urchin embryos. Journal of molecular biology, 36(2), 195–208.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/5760538
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014, jan). Glial
response during cuprizone-induced de- and remyelination in the CNS:




Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., . . . Dietz,
H. C. (2011, apr). Angiotensin II Type 2 Receptor Signaling Attenuates Aortic
Aneurysm in Mice Through ERK Antagonism. Science, 332(6027), 361–365.
Retrieved from http://www.sciencemag.org/cgi/doi/10.1126/science
.1192152 doi: 10.1126/science.1192152
Harries, L. W., Hernandez, D., Henley, W., Wood, A. R., Holly, A. C., Bradley-Smith,
R. M., . . . Melzer, D. (2011). Human aging is characterized by focused changes
in gene expression and deregulation of alternative splicing. Aging Cell, 10(5),
868–878. doi: 10.1111/j.1474-9726.2011.00726.x
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-c.,
Means, T. K., & El Khoury, J. (2013, oct). The microglial sensome revealed




Hinks, G. L., & Franklin, R. J. (1999). Distinctive patterns of PDGF-A, FGF-2,
IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-
176 References
induced spinal cord demyelination. Molecular and cellular neurosciences, 14(2),
153–168. doi: 10.1006/mcne.1999.0771
Hinks, G. L., & Franklin, R. J. (2000). Delayed changes in growth factor gene
expression during slow remyelination in the CNS of aged rats. Molecular and
cellular neurosciences, 16, 542–556. doi: 10.1006/mcne.2000.0897
Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A. J., Nye, J. S., . . . Van Der
Kooy, D. (2002). Notch pathway molecules are essential for the maintenance,
but not the generation, of mammalian neural stem cells. Genes and Development,
16(7), 846–858. doi: 10.1101/gad.975202
Holm, T. M., Habashi, J. P., Doyle, J. J., Bedja, D., Chen, Y., van Erp, C., . . . Dietz,
H. C. (2011). Noncanonical TGFbeta signaling contributes to aortic aneurysm




Holtman, I. R., Raj, D. D., Miller, J. a., Schaafsma, W., Yin, Z., Brouwer, N., . . .
Eggen, B. J. L. (2015). Induction of a common microglia gene expression
signature by aging and neurodegenerative conditions: a co-expression meta-
analysis. Acta Neuropathologica Communications, 3(1), –. Retrieved from
http://www.actaneurocomms.org/content/3/1/31 doi: 10.1186/s40478
-015-0203-5
Horner, P. J., Power, A. E., Kempermann, G., Kuhn, H. G., Palmer, T. D., Winkler,
J., . . . Gage, F. H. (2000). Proliferation and differentiation of progenitor cells
throughout the intact adult rat spinal cord. J Neurosci, 20(6), 2218–2228.
Hornig, J., Fröb, F., Vogl, M. R., Hermans-Borgmeyer, I., Tamm, E. R., & Wegner,
M. (2013). The Transcription Factors Sox10 and Myrf Define an Essential Reg-
ulatory Network Module in Differentiating Oligodendrocytes. PLoS Genetics,
9(10). doi: 10.1371/journal.pgen.1003907
Hosokawa, M., Klegeris, A., Maguire, J., & McGeer, P. L. (2003). Expression of
complement messenger RNAs and proteins by human oligodendroglial cells.
Glia, 42(4), 417–423. doi: 10.1002/glia.10234
Huang, J. K., Jarjour, A. A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel,
W., . . . Franklin, R. J. M. (2011). Retinoid X receptor gamma signaling




Huidobro, C., Fernandez, A. F., & Fraga, M. F. (2013). Aging epigenetics: causes
and consequences. Molecular aspects of medicine, 34(4), 765–781. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/22771540 doi: 10.1016/
j.mam.2012.06.006
Hussain, R., El-Etr, M., Gaci, O., Rakotomamonjy, J., Macklin, W. B., Kumar, N.,
. . . Ghoumari, A. M. (2011). Progesterone and nestorone facilitate axon
remyelination: A role for progesterone receptors. Endocrinology, 152(10),
3820–3831. doi: 10.1210/en.2011-1219
Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., . . . Eggan,
K. (2009). A Small-Molecule Inhibitor of Tgf-b Signaling Replaces Sox2 in
Reprogramming by Inducing Nanog. Cell Stem Cell, 5(5), 491–503. Retrieved
from http://dx.doi.org/10.1016/j.stem.2009.09.012 doi: 10.1016/
j.stem.2009.09.012
References 177
Ignotz, R. a., & Massagué, J. (1986). Transforming growth factor-beta stimulates
the expression of fibronectin and collagen and their incorporation into the
extracellular matrix. The Journal of biological chemistry, 261(9), 4337–4345.
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith,
A. D., . . . Hill, C. S. (2002). SB-431542 is a potent and specific inhibitor of
transforming growth factor-beta superfamily type I activin receptor-like kinase
(ALK) receptors ALK4, ALK5, and ALK7. Molecular pharmacology, 62(1),
65–74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12065756
doi: 10.1124/mol.62.1.65
Ishibashi, M., Moriyoshi, K., Sasai, Y., Shiota, K., Nakanishi, S., &
Kageyama, R. (1994). Persistent expression of helix-loop-helix
factor HES-1 prevents mammalian neural differentiation in the cen-
tral nervous system. The EMBO journal, 13(8), 1799–805. Re-
trieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi
?artid=395019{&}tool=pmcentrez{&}rendertype=abstract
Issa, J.-p. (2014, jan). Aging and epigenetic drift: a vicious cycle. Journal of
Clinical Investigation, 124(1), 24–29. Retrieved from http://www.jci.org/
articles/view/69735 doi: 10.1172/JCI69735
Ito, M., Liu, Y., Yang, Z., Nguyen, J., Liang, F., Morris, R. J., & Cotsarelis, G.
(2005). Stem cells in the hair follicle bulge contribute to wound repair but not
to homeostasis of the epidermis. Nature medicine, 11(12), 1351–1354. doi:
10.1038/nm1328
Jaks, V., Barker, N., Kasper, M., van Es, J. H., Snippert, H. J., Clevers, H., & Toftgård,
R. (2008). Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Na-
ture Genetics, 40(11), 1291–1299. Retrieved from http://www.nature.com/
doifinder/10.1038/ng.239 doi: 10.1038/ng.239
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013, jan). mTOR is a key mod-




Jones, P. A. (2012). Functions of DNA methylation: islands, start sites, gene
bodies and beyond. Nature reviews. Genetics, 13(7), 484–92. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/22641018 doi: 10.1038/nrg3230
Jones, P. a. (2012, jul). Functions of DNA methylation: islands, start sites, gene
bodies and beyond. Nature reviews. Genetics, 13(7), 484–92. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/22641018 doi: 10.1038/nrg3230
Jordan, A. R., Racine, R. R., Hennig, M. J. P., & Lokeshwar, V. B.
(2015). The Role of CD44 in Disease Pathophysiology and Tar-




Káradóttir, R., Cavelier, P., Bergersen, L. H., & Attwell, D. (2005).
NMDA receptors are expressed in oligodendrocytes and activated








Keough, M. B., Rogers, J. A., Zhang, P., Jensen, S. K., Stephenson, E. L.,
Chen, T., . . . Yong, V. W. (2016, apr). An inhibitor of chon-
droitin sulfate proteoglycan synthesis promotes central nervous sys-




Kettenmann, H., & Verkhratsky, A. (2008, dec). Neuroglia: the 150 years af-
ter. Trends in Neurosciences, 31(12), 653–659. Retrieved from http://
linkinghub.elsevier.com/retrieve/pii/S0166223608002130 doi: 10
.1016/j.tins.2008.09.003
Kirkwood, T. B. L. (2005, feb). Understanding the Odd Science of Aging.
Cell, 120(4), 437–447. Retrieved from http://www.sciencedirect.com/
science/article/pii/S0092867405001017 doi: http://dx.doi.org/10.1016/
j.cell.2005.01.027
Kirkwood, T. B. L., & Austad, S. N. (2000). Why do we age? Nature, 408(6809),




Klempin, F., Marr, R. A., & Peterson, D. A. (2012). Modification of Pax6 and Olig2
expression in adult hippocampal neurogenesis selectively induces stem cell fate
and alters both neuronal and glial populations. Stem Cells, 30(3), 500–509. doi:
10.1002/stem.1005
Koenning, M., Jackson, S., Hay, C. M., Faux, C., Kilpatrick, T. J., Willingham,
M., & Emery, B. (2012). Myelin Gene Regulatory Factor Is Required for
Maintenance of Myelin and Mature Oligodendrocyte Identity in the Adult
CNS. Journal of Neuroscience, 32(36), 12528–12542. Retrieved from http://
www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.1069-12.2012 doi:
10.1523/JNEUROSCI.1069-12.2012
Kondo, T., & Raff, M. (2000). The Id4 HLH protein and the timing of oligo-




Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. (2006, jan). Myelin Impairs
CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differen-
tiation. Journal of Neuroscience, 26(1), 328–332. Retrieved from http://
www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.2615-05.2006 doi:
10.1523/JNEUROSCI.2615-05.2006
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M.
(2001). Macrophage depletion impairs oligodendrocyte remyelination fol-
lowing lysolecithin-induced demyelination. Glia, 35(3), 204–212. doi:
10.1002/glia.1085
Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I., & Wegner, M.
(1998). Sox10, a novel transcriptional modulator in glial cells. The Journal
of neuroscience : the official journal of the Society for Neuroscience, 18(1),






Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008,
jul). Differentiation block of oligodendroglial progenitor cells as a cause
for remyelination failure in chronic multiple sclerosis. Brain, 131(7),
1749–1758. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
18515322https://academic.oup.com/brain/article-lookup/doi/
10.1093/brain/awn096 doi: 10.1093/brain/awn096
Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., . . .
Baur, J. a. (2012, mar). Rapamycin-Induced Insulin Resistance Is Mediated by
mTORC2 Loss and Uncoupled from Longevity. Science, 335(6076), 1638–1643.
Retrieved from http://www.sciencemag.org/cgi/doi/10.1126/science
.1215135 doi: 10.1126/science.1215135
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez,
M. G., . . . Rivest, S. (2015). Inefficient clearance of myelin debris by microglia
impairs remyelinating processes. Journal of Experimental Medicine, 212(4),
481–495. Retrieved from http://jem.rupress.org/content/212/4/481
.full{%}5Cnhttp://www.jem.org/lookup/doi/10.1084/jem.20141656
doi: 10.1084/jem.20141656
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., . . .
Olson, B. a. (2002). Inhibition of transforming growth factor (TGF)-beta1-
induced extracellular matrix with a novel inhibitor of the TGF-beta type I
receptor kinase activity: SB-431542. Molecular pharmacology, 62(1), 58–64.
doi: 10.1124/mol.62.1.58
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., . . .
Nave, K.-A. (2003). Disruption of Cnp1 uncouples oligodendroglial functions in
axonal support and myelination. Nature genetics, 33(3), 366–74. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/12590258 doi: 10.1038/ng1095
Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G., & Yong, V. W. (2003,
dec). Matrix metalloproteinase-9 facilitates remyelination in part by processing
the inhibitory NG2 proteoglycan. The Journal of neuroscience : the official
journal of the Society for Neuroscience, 23(35), 11127–35. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/14657171
Lau, L. W., Keough, M. B., Haylock-Jacobs, S., Cua, R., Döring, A., Sloka, S., . . .
Yong, V. W. (2012). Chondroitin sulfate proteoglycans in demyelinated lesions
impair remyelination. Annals of Neurology, 72(3), 419–432. doi: 10.1002/
ana.23599
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M.,
. . . Amit, I. (2014). Tissue-resident macrophage enhancer landscapes are
shaped by the local microenvironment. Cell, 159(6), 1312–1326. Retrieved
from http://dx.doi.org/10.1016/j.cell.2014.11.018 doi: 10.1016/
j.cell.2014.11.018
Lee, S., Chong, S. Y. C., Tuck, S. J., Corey, J. M., & Chan, J. R. (2013). A
rapid and reproducible assay for modeling myelination by oligodendrocytes
using engineered nanofibers. Nature Protocols, 8(4), 771–782. Retrieved from
http://www.nature.com/doifinder/10.1038/nprot.2013.039 doi: 10
.1038/nprot.2013.039
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N.,
180 References
. . . Rothstein, J. D. (2012, jul). Oligodendroglia metabolically support ax-




Levine, J. M., & Reynolds, R. (1999). Activation and proliferation of endogenous
oligodendrocyte precursor cells during ethidium bromide-induced demyelination.
Experimental neurology, 160(2), 333–347. doi: 10.1006/exnr.1999.7224
Levine, J. M., Reynolds, R., & Fawcett, J. W. (2001). The oligodendrocyte precursor
cell in health and disease. Trends in neurosciences, 24(1), 39–47. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/11163886
Li, W. W., Penderis, J., Zhao, C., Schumacher, M., & Franklin, R. J. M. (2006).
Females remyelinate more efficiently than males following demyelination in the
aged but not young adult CNS. Experimental Neurology, 202(1), 250–254. doi:
10.1016/j.expneurol.2006.05.012
Li, Z., Park, Y., & Marcotte, E. M. (2013). A Bacteriophage Tailspike Domain
Promotes Self-Cleavage of a Human Membrane-Bound Transcription Factor,
the Myelin Regulatory Factor MYRF. PLoS Biology, 11(8), 1–14. doi: 10.1371/
journal.pbio.1001624
Liu, J., Magri, L., Zhang, F., Marsh, N. O., Albrecht, S., Huynh, J. L., . . . Casaccia,
P. (2015, jan). Chromatin Landscape Defined by Repressive Histone Methyla-
tion during Oligodendrocyte Differentiation. Journal of Neuroscience, 35(1),
352–365. Retrieved from http://www.jneurosci.org/cgi/doi/10.1523/
JNEUROSCI.2606-14.2015 doi: 10.1523/JNEUROSCI.2606-14.2015
Liu, L., Cheung, T. H., Charville, G. W., Hurgo, B. M. C., Leavitt, T., Shih, J., . . .
Rando, T. A. (2013). Chromatin Modifications as Determinants of Muscle Stem
Cell Quiescence and Chronological Aging. Cell Reports, 4(1), 189–204. Re-
trieved from http://dx.doi.org/10.1016/j.celrep.2013.05.043 doi:
10.1016/j.celrep.2013.05.043
Liu, Z., Hu, X., Cai, J., Liu, B., Peng, X., Wegner, M., & Qiu, M. (2007). Induction of
oligodendrocyte differentiation by Olig2 and Sox10: Evidence for reciprocal
interactions and dosage-dependent mechanisms. Developmental Biology, 302(2),
683–693. doi: 10.1016/j.ydbio.2006.10.007
Lopez-Anido, C., Sun, G., Koenning, M., Srinivasan, R., Hung, H. A., Emery, B., . . .
Svaren, J. (2015). Differential Sox10 genomic occupancy in myelinating glia.
Glia, 63(11), 1897–1914. doi: 10.1002/glia.22855
López-Otín, C., Blasco, M. a., Partridge, L., Serrano, M., & Kroemer, G.




Lu, Q. R., Yuk, D., Alberta, J. a., Zhu, Z., Pawlitzky, I., Chan, J., . . . Rowitch, D. H.
(2000). Sonic hedgehog–regulated oligodendrocyte lineage genes encoding
bHLH proteins in the mammalian central nervous system. Neuron, 25(2), 317–
329. doi: 10.1016/S0896-6273(00)80897-1
Lucchinetti, C. (1999, dec). A quantitative analysis of oligodendrocytes in multiple
sclerosis lesions: A study of 113 cases. Brain, 122(12), 2279–2295. Re-
trieved from https://academic.oup.com/brain/article-lookup/doi/
10.1093/brain/122.12.2279 doi: 10.1093/brain/122.12.2279
Lyons, D. a., Naylor, S. G., Scholze, A., & Talbot, W. S. (2009). Kif1b is essential for
References 181
mRNA localization in oligodendrocytes and development of myelinated axons.




Maegawa, S., Hinkal, G., Kim, H. S. H. S., Shen, L., Zhang, L., Zhang, J., . . .
Issa, J.-P. J.-P. J. (2010, mar). Widespread and tissue specific age-related






Mar, S., & Noetzel, M. (2010). Axonal Damage in Leukodystrophies. Pediatric
Neurology, 42(4), 239–242. Retrieved from http://dx.doi.org/10.1016/
j.pediatrneurol.2009.08.011 doi: 10.1016/j.pediatrneurol.2009.08.011
Marques, S., Zeisel, A., Codeluppi, S., van Bruggen, D., Mendanha Falcao, A., Xiao,
L., . . . Castelo-Branco, G. (2016, jun). Oligodendrocyte heterogeneity in the
mouse juvenile and adult central nervous system. Science, 352(6291), 1326–
1329. Retrieved from http://www.sciencemag.org/cgi/doi/10.1126/
science.aaf6463 doi: 10.1126/science.aaf6463
Martin, G. M. (2009). Epigenetic gambling and epigenetic drift as an antagonistic
pleiotropic mechanism of aging. Aging cell, 8(6), 761–764. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/19732045 doi: 10.1111/j.1474
-9726.2009.00515.x
Martinez, F. O., & Gordon, S. (2014). The M1 and M2 paradigm of macrophage




Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001). Interleukin-
1beta promotes repair of the CNS. Journal of Neuroscience, 21(18), 7046–7052.
doi: 21/18/7046[pii]
Mason, J. L., Xuan, S., Dragatsis, I., Efstratiadis, A., & Goldman, J. E. (2003).
Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays
an important role in remyelination. The Journal of neuroscience : the official
journal of the Society for Neuroscience, 23(20), 7710–7718. Retrieved from
http://www.jneurosci.org/content/23/20/7710.full.pdf doi: 23/20/
7710[pii]
Maxwell, P. H., Burhans, W. C., & Curcio, M. J. (2011). Retrotransposition is associ-
ated with genome instability during chronological aging. Proceedings of the
National Academy of Sciences of the United States of America, 108(51), 20376–
81. Retrieved from http://www.pubmedcentral.nih.gov/articlerender
.fcgi?artid=3251071{&}tool=pmcentrez{&}rendertype=abstract
doi: 10.1073/pnas.1100271108
McDonald, J. I., Celik, H., Rois, L. E., Fishberger, G., Fowler, T., Rees,
R., . . . Challen, G. A. (2016). Reprogrammable CRISPR/Cas9-based
system for inducing site-specific DNA methylation. Biology open,





Mckenzie, I. A., Ohayon, D., Li, H., Faria, J. P. D., Emery, B., Tohyama, K., & Richard-
son, W. D. (2014). Motor skill learning requires active central myelination.
Science, 346(6207), 318–322. doi: 10.1126/science.1254960
McKinnon, R. D. (1993, jun). A role for TGF-beta in oligodendrocyte dif-




McKinnon, R. D., Matsui, T., Dubois-Dalcq, M., & Aaronsont, S. A. (1990). FGF
modulates the PDGF-driven pathway of oligodendrocyte development. Neuron,
5(5), 603–614. doi: 10.1016/0896-6273(90)90215-2
McMurran, C. E., Jones, C. A., Fitzgerald, D. C., & Franklin, R. J. M.
(2016). CNS Remyelination and the Innate Immune System. Fron-




Metsalu, T., & Vilo, J. (2015). ClustVis: A web tool for visualizing clustering of
multivariate data using Principal Component Analysis and heatmap. Nucleic
Acids Research, 43(W1), W566–W570. doi: 10.1093/nar/gkv468
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., . . .
Prinz, M. (2007). Microglia in the adult brain arise from Ly-6ChiCCR2+
monocytes only under defined host conditions. Nature neuroscience, 10(12),
1544–53. Retrieved from http://dx.doi.org/10.1038/nn2015 doi: 10
.1038/nn2015
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., . . .
Ffrench-Constant, C. (2013, jul). M2 microglia and macrophages drive oligo-
dendrocyte differentiation during CNS remyelination. Nature Neuroscience,




Miyoshi, M., Miyano, K., Moriyama, N., Taniguchi, M., & Watanabe, T. (2008,
jan). Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced
stimulation of rat microglial cells by suppressing nuclear factor kB and activator
protein-1 activation. European Journal of Neuroscience, 27(2), 343–351. Re-
trieved from http://doi.wiley.com/10.1111/j.1460-9568.2007.06014
.x doi: 10.1111/j.1460-9568.2007.06014.x
Montgomery, J. R., & Coward, S. J. (1974, jul). On the Minimal Size of a Pla-
narian Capable of Regeneration. Transactions of the American Microscopi-
cal Society, 93(3), 386. Retrieved from http://www.jstor.org/stable/
3225439?origin=crossref doi: 10.2307/3225439
Morrison, B. M., Lee, Y., & Rothstein, J. D. (2013, dec). Oligoden-
droglia: metabolic supporters of axons. Trends in Cell Biology, 23(12),





Moyon, S., Dubessy, a. L., Aigrot, M. S., Trotter, M., Huang, J. K., Dauphinot, L.,
. . . Lubetzki, C. (2015, jan). Demyelination Causes Adult CNS Progenitors
to Revert to an Immature State and Express Immune Cues That Support Their
Migration. Journal of Neuroscience, 35(1), 4–20. Retrieved from http://
www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.0849-14.2015 doi:
10.1523/JNEUROSCI.0849-14.2015
Moyon, S., Huynh, J. L., Dutta, D., Zhang, F., Ma, D., Yoo, S., . . . Casaccia, P.
(2016). Functional Characterization of DNAMethylation in the Oligodendrocyte
Lineage. Cell Reports, 15(4), 748–760. Retrieved from http://dx.doi.org/
10.1016/j.celrep.2016.03.060 doi: 10.1016/j.celrep.2016.03.060
Moyon, S., Liang, J., & Casaccia, P. (2016). Epigenetics in NG2 glia cells. Brain
Research, 1638, 183–198. Retrieved from http://dx.doi.org/10.1016/
j.brainres.2015.06.009 doi: 10.1016/j.brainres.2015.06.009
Moyon, S., Ma, D., Huynh, J. L., Coutts, D. J. C., Zhao, C., Casac-
cia, P., & Franklin, R. J. M. (2017). Efficient Remyelination Re-




Muneoka, K., Allan, C. H., Yang, X., Lee, J., & Han, M. (2008). Mammalian
regeneration and regenerative medicine. Birth Defects Research Part C - Embryo
Today: Reviews, 84(4), 265–280. doi: 10.1002/bdrc.20137
Nakamura, Y., Sakakibara, S. I., Miyata, T., Ogawa, M., Shimazaki, T., Weiss, S.,
. . . Okano, H. (2000). The bHLH gene Hes1 as a repressor of the neuronal
commitment of CNS stem cell. The Journal of Neuroscience, 20(1), 283–293.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10627606
Nan, X., Bird, A., Ng, H.-H., Johnson, C. a., Laherty, C. D., Turner, B. M., & Eisenman,
R. N. (1998, may). Transcriptional repressionby themethyl-CpG-binding protein
MeCP2 involvesa histonedeacetylase complex. Nature, 393(6683), 386–389.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9620804http://
www.nature.com/doifinder/10.1038/30764 doi: 10.1038/30764
Natrajan, M. S., De La Fuente, A. G., Crawford, A. H., Linehan, E., Nuñez, V., Johnson,
K. R., . . . Franklin, R. J. M. (2015). Retinoid X receptor activation reverses
age-related deficiencies in myelin debris phagocytosis and remyelination. Brain,
138(12), 3581–3597. doi: 10.1093/brain/awv289
Nave, K. A. (2010). Myelination and the trophic support of long axons. Nat
Rev Neurosci, 11, 275–283. Retrieved from http://dx.doi.org/10.1038/
nrn2797 doi: 10.1038/nrn2797
Nebbioso, A., Carafa, V., Benedetti, R., & Altucci, L. (2012, dec). Trials with
’epigenetic’ drugs: an update. Molecular oncology, 6(6), 657–82. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/23103179 doi: 10.1016/
j.molonc.2012.09.004
Neumann, B., Baror, R., Dietmann, S., Wijngaarden, P., & Franklin, R. J. M. (n.d.).
Nature (under review).
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2009). Debris clearance by
microglia: An essential link between degeneration and regeneration. Brain,
132(2), 288–295. doi: 10.1093/brain/awn109
Nicolay, D. J., Doucette, J. R., & Nazarali, A. J. (2007). Transcriptional control of




Nielsen, J. A., Berndt, J. A., Hudson, L. D., & Armstrong, R. C. (2004). Myelin
transcription factor 1 (Myt1) modulates the proliferation and differentiation of
oligodendrocyte lineage cells. Molecular and Cellular Neuroscience, 25(1),
111–123. doi: 10.1016/j.mcn.2003.10.001
Nimmerjahn, A. (2005, may). Resting Microglial Cells Are Highly Dynamic




Njie, e. G., Boelen, E., Stassen, F. R., Steinbusch, H. W., Borchelt, D. R., &
Streit, W. J. (2012, jan). Ex vivo cultures of microglia from young
and aged rodent brain reveal age-related changes in microglial func-




Norden, D. M., & Godbout, J. P. (2013). Review: Microglia of the aged brain:
Primed to be activated and resistant to regulation. Neuropathology and Applied
Neurobiology, 39(1), 19–34. doi: 10.1111/j.1365-2990.2012.01306.x
Oda, M., Kumaki, Y., Shigeta, M., Jakt, L. M., Matsuoka, C., Yam-
agiwa, A., . . . Okano, M. (2013, jun). DNA methylation restricts
lineage-specific functions of transcription factor Gata4 during embry-




Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., & Boddeke,
H. W. G. M. (2012). Identification of a microglia phenotype supportive of
remyelination. Glia, 60(2), 306–321. doi: 10.1002/glia.21266
Palazuelos, J., Klingener, M., & Aguirre, A. (2014). TGF Signaling
Regulates the Timing of CNS Myelination by Modulating Oligoden-
drocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.




Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., . . .
Gross, C. T. (2011). Synaptic pruning by microglia is necessary for normal
brain development. Science (New York, N.Y.), 333(6048), 1456–8. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/21778362 doi: 10.1126/
science.1202529
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., . . .
Gan, W. B. (2013). Microglia promote learning-dependent synapse formation
through brain-derived neurotrophic factor. Cell, 155(7), 1596–1609. Retrieved
from http://dx.doi.org/10.1016/j.cell.2013.11.030 doi: 10.1016/
j.cell.2013.11.030
Pendleton, J. C., Shamblott, M. J., Gary, D. S., Belegu, V., Hur-
tado, A., Malone, M. L., & McDonald, J. W. (2013, sep).
Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination
References 185




Piaton, G., Aigrot, M. S., Williams, A., Moyon, S., Tepavcevic, V., Moutkine, I., . . .
Lubetzki, C. (2011). Class 3 semaphorins influence oligodendrocyte precursor
recruitment and remyelination in adult central nervous system. Brain, 134(4),
1156–1167. doi: 10.1093/brain/awr022
Pollina, E. a., & Brunet, A. (2011). Epigenetic regulation of aging stem cells.
Oncogene, 30(28), 3105–3126. Retrieved from http://www.ncbi.nlm.nih
.gov/pubmed/21441951 doi: 10.1038/onc.2011.45
Pouly, S., Becher, B., Blain, M., & Antel, J. P. (1999). Expression of a homologue of
rat NG2 on human microglia. Glia, 27(3), 259–268. doi: 10.1002/(SICI)1098
-1136(199909)27:3<259::AID-GLIA7>3.0.CO;2-8
Raff, M. C., Miller, R. H., & Noble, M. (1983, jun). A glial progenitor
cell that develops in vitro into an astrocyte or an oligodendrocyte de-




Ransohoff, R. M. (2012). Animal models of multiple sclerosis: the good, the bad
and the bottom line. Nature Neuroscience, 15(8), 1074–1077. Retrieved from
http://www.nature.com/doifinder/10.1038/nn.3168 doi: 10.1038/nn
.3168
Ransohoff, R. M. (2016, jul). A polarizing question: do M1 and M2




Ransom, B. R., Yamate, C. L., Black, J. A., & Waxman, S. G. (1985). Rat optic nerve:
Disruption of gliogenesis with 5-azacytidine during early postnatal development.
Brain Research, 337(1), 41–49. doi: 10.1016/0006-8993(85)91607-5
Raynal, N. J.-M., Si, J., Taby, R. F., Gharibyan, V., Ahmed, S., Je-
linek, J., . . . Issa, J.-P. J. (2012, mar). DNA methylation does
not stably lock gene expression but instead serves as a molecular mark




Redmond, S. A., Mei, F., Eshed-Eisenbach, Y., Osso, L. A., Leshkowitz, D., Shen,
Y.-A. A., . . . Chan, J. R. (2016). Somatodendritic Expression of JAM2 Inhibits
Oligodendrocyte Myelination. Neuron, 91(4), 824–836. Retrieved from http://
dx.doi.org/10.1016/j.neuron.2016.07.021 doi: 10.1016/j.neuron.2016
.07.021
Redwine, J. M., & Armstrong, R. C. (1998). In vivo proliferation of oligodendrocyte
progenitors expressing PDGF??R during early remyelination. Journal of Neuro-
biology, 37(3), 413–428. doi: 10.1002/(SICI)1097-4695(19981115)37:3<413::
AID-NEU7>3.0.CO;2-8
Rhodes, K. E., Raivich, G., & Fawcett, J. W. (2006). The injury response of
oligodendrocyte precursor cells is induced by platelets, macrophages and
186 References
inflammation-associated cytokines. Neuroscience, 140(1), 87–100. doi:
10.1016/j.neuroscience.2006.01.055
Richmond, C. A., Shah, M. S., Carlone, D. L., & Breault, D. T. (2016). An enduring
role for quiescent stem cells. Developmental Dynamics, 245(7), 718–726. doi:
10.1002/dvdy.24416
Roberts, C. J., Birkenmeier, T. M., McQuillan, J. J., Akiyama, S. K., Ya-
mada, S. S., Chen, W. T., . . . McDonald, J. A. (1988). Trans-
forming growth factor beta stimulates the expression of fibronectin and
of both subunits of the human fibronectin receptor by cultured hu-
man lung fibroblasts. J Biol Chem, 263(10), 4586–4592. Re-
trieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=
Retrieve{&}db=PubMed{&}dopt=Citation{&}list{_}uids=2965146
Robinson, S., & Miller, R. H. (1999). Contact with central nervous sys-
tem myelin inhibits oligodendrocyte progenitor maturation. Develop-





Roizen, M. (2010, jan). Rapamycin fed late in life extends lifespan in ge-
netically heterogenous mice. Yearbook of Anesthesiology and Pain




Ruckh, J. M., Zhao, J. W., Shadrach, J. L., Van Wijngaarden, P., Rao, T. N., Wagers,
A. J., & Franklin, R. J. M. (2012). Rejuvenation of regeneration in the aging
central nervous system. Cell Stem Cell, 10(1), 96–103. Retrieved from http://
dx.doi.org/10.1016/j.stem.2011.11.019 doi: 10.1016/j.stem.2011.11
.019
Salminen, A., Kaarniranta, K., Hiltunen, M., & Kauppinen, A. (2014, jul). Krebs
cycle dysfunction shapes epigenetic landscape of chromatin: Novel insights into
mitochondrial regulation of aging process. Cellular signalling, 26(7), 1598–
1603. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24704120
doi: 10.1016/j.cellsig.2014.03.030
Samanta, J., Grund, E. M., Silva, H. M., Lafaille, J. J., Fishell, G., & Salzer, J. L. (2015).
Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.
Nature, 526, 448–453. doi: 10.1038/nature14957
Sanchez Alvarado, A., & Tsonis, P. A. (2006). Bridging the regenera-
tion gap: genetic insights from diverse animal models. Nat Rev Genet,
7(11), 873–884. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
17047686{%}5Cnpapers2://publication/doi/10.1038/nrg1923 doi:
10.1038/nrg1923
Sato, F., Tsuchiya, S., Meltzer, S. J., & Shimizu, K. (2011, may). MicroRNAs and
epigenetics. The FEBS journal, 278(10), 1598–609. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/21395977 doi: 10.1111/j.1742-4658.2011
.08089.x
Schulz, R., Vogel, T., Dressel, R., & Krieglstein, K. (2008). TGF-?? superfamily
members, ActivinA and TGF-??1, induce apoptosis in oligodendrocytes by
different pathways. Cell and Tissue Research, 334(3), 327–338. doi: 10.1007/
References 187
s00441-008-0714-5
Schuster, N., Bender, H., Philippi, A., Subramaniam, S., Strelau, J., Wang, Z., &
Krieglstein, K. (2002, oct). TGF-? induces cell death in the oligodendroglial cell
line OLI-neu. Glia, 40(1), 95–108. Retrieved from http://doi.wiley.com/
10.1002/glia.10110 doi: 10.1002/glia.10110
Shen, S., Li, J., & Casaccia-Bonnefil, P. (2005). Histone modifications affect timing of
oligodendrocyte progenitor differentiation in the developing rat brain. Journal
of Cell Biology, 169(4), 577–589. doi: 10.1083/jcb.200412101
Shen, S., Liu, A., & Li, J. (2008). Epigenetic memory loss in aging oligodendrocytes
in the corpus callosum. . . . of aging, 29(3), 452–463. Retrieved from http://
www.sciencedirect.com/science/article/pii/S019745800600399X
Shen, S., Sandoval, J., Swiss, V. A., Li, J., Dupree, J., Franklin, R. J. M.,
& Casaccia-Bonnefil, P. (2008, sep). Age-dependent epigenetic
control of differentiation inhibitors is critical for remyelination effi-





Shi, J., Marinovich, a., & Barres, B. a. (1998). Purification and characterization of
adult oligodendrocyte precursor cells from the rat optic nerve. The Journal of
neuroscience : the official journal of the Society for Neuroscience, 18(12), 4627–
4636. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9614237
Shields, S. A., Gilson, J. M., Blakemore, W. F., & Franklin, R. J. (1999, oct).
Remyelination occurs as extensively but more slowly in old rats compared to





Shin, D., Shin, J. Y., McManus, M. T., Ptácˇek, L. J., & Fu, Y. H. (2009). Dicer
ablation in oligodendrocytes provokes neuronal impairment in mice. Annals of
Neurology, 66(6), 843–857. doi: 10.1002/ana.21927
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002). The age-related
decrease in CNS remyelination efficiency is attributable to an impairment of
both oligodendrocyte progenitor recruitment and differentiation. The Journal of
neuroscience : the official journal of the Society for Neuroscience, 22(7), 2451–
2459. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11923409
doi: 20026217
Singer, T., McConnell, M. J., Marchetto, M. C., Coufal, N. G., & Gage, F. H. (2010,
aug). LINE-1 retrotransposons: mediators of somatic variation in neuronal
genomes? Trends in Neurosciences, 33(8), 345–354. Retrieved from http://
linkinghub.elsevier.com/retrieve/pii/S0166223610000536 doi: 10
.1016/j.tins.2010.04.001
Slotkin, R. K., & Martienssen, R. (2007). Transposable elements and the epigenetic
regulation of the genome. Nature Reviews Genetics, 8(4), 272–85. doi: 10.1038/
nrg2072
Sobel, R. A., & Mitchell, M. E. (1989). Fibronectin in multiple sclero-




Sohn, J. (2006, sep). Identification of Sox17 as a Transcription Factor That Regu-
lates Oligodendrocyte Development. Journal of Neuroscience, 26(38), 9722–
9735. Retrieved from http://www.jneurosci.org/cgi/doi/10.1523/
JNEUROSCI.1716-06.2006 doi: 10.1523/JNEUROSCI.1716-06.2006
Song, Q., Decato, B., Hong, E. E., Zhou, M., Fang, F., Qu, J., . . . Smith, A. D. (2013,
dec). A Reference Methylome Database and Analysis Pipeline to Facilitate
Integrative and Comparative Epigenomics. PLoS ONE, 8(12), e81148. Re-
trieved from http://dx.plos.org/10.1371/journal.pone.0081148 doi:
10.1371/journal.pone.0081148
Stoffels, J. M. J., De Jonge, J. C., Stancic, M., Nomden, A., Van Strien, M. E., Ma,
D., . . . Baron, W. (2013). Fibronectin aggregation in multiple sclerosis lesions
impairs remyelination. Brain, 136(1), 116–131. doi: 10.1093/brain/aws313
Stolt, C. C. (2002, jan). Terminal differentiation of myelin-forming oligodendro-
cytes depends on the transcription factor Sox10. Genes & Development, 16(2),
165–170. Retrieved from http://www.genesdev.org/cgi/doi/10.1101/
gad.215802 doi: 10.1101/gad.215802
Sturm, Á., Ivics, Z., & Vellai, T. (2015). The mechanism of ageing: Primary role of
transposable elements in genome disintegration. Cellular and Molecular Life
Sciences, 72(10), 1839–1847. Retrieved from http://dx.doi.org/10.1007/
s00018-015-1896-0 doi: 10.1007/s00018-015-1896-0
Sugiarto, S., Persson, A. I., Munoz, E. G., Waldhuber, M., Lamagna, C., Andor, N.,
. . . Petritsch, C. (2011). Asymmetry-defective oligodendrocyte progenitors
are glioma precursors. Cancer Cell, 20(3), 328–340. Retrieved from http://
dx.doi.org/10.1016/j.ccr.2011.08.011 doi: 10.1016/j.ccr.2011.08.011
Sugimoto, K., Nishioka, R., Ikeda, A., Mise, A., Takahashi, H., Yano, H., . . . Tanaka, J.
(2014, feb). Activated microglia in a rat stroke model express NG2 proteoglycan
in peri-infarct tissue through the involvement of TGF-b1. Glia, 62(2), 185–
198. Retrieved from http://doi.wiley.com/10.1002/glia.22598 doi:
10.1002/glia.22598
Syed, Y. A., Hand, E., Möbius, W., Zhao, C., Hofer, M., Nave, K. a., & Kotter, M. R.
(2011). Inhibition of CNS remyelination by the presence of semaphorin 3A. The
Journal of neuroscience : the official journal of the Society for Neuroscience,
31(10), 3719–3728. doi: 10.1523/JNEUROSCI.4930-10.2011
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. a., Bandukwala, H.,
Brudno, Y., . . . Rao, A. (2009, may). Conversion of 5-
methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL




Takahashi, K., & Yamanaka, S. (2006). Induction of Pluripotent Stem Cells from
Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell,
126(4), 663–676. doi: 10.1016/j.cell.2006.07.024
Takase, O., Yoshikawa, M., Idei, M., Hirahashi, J., Fujita, T., Takato, T., . . . Hishikawa,
K. (2013). The Role of NF-kB Signaling in the Maintenance of Pluripotency of
Human Induced Pluripotent Stem Cells. PLoS ONE, 8(2), 1–9. doi: 10.1371/
journal.pone.0056399
Takebayashi, H., Nabeshima, Y., Yoshida, S., Chisaka, O., Ikenaka, K., & Nabeshima,
Y. I. (2002). The basic helix-loop-helix factor Olig2 is essential for the devel-
References 189
opment of motoneuron and oligodendrocyte lineages. Current Biology, 12(13),
1157–1163. doi: 10.1016/S0960-9822(02)00926-0
Talbott, J. F., Cao, Q., Bertram, J., Nkansah, M., Benton, R. L., Lavik, E., & Whitte-
more, S. R. (2007). CNTF promotes the survival and differentiation of adult
spinal cord-derived oligodendrocyte precursor cells in vitro but fails to pro-
mote remyelination in vivo. Experimental Neurology, 204(1), 485–489. doi:
10.1016/j.expneurol.2006.12.013
Talbott, J. F., Loy, D. N., Liu, Y., Qiu, M. S., Bunge, M. B., Rao, M. S., & Whittemore,
S. R. (2005). Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail
to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
Experimental Neurology, 192(1), 11–24. doi: 10.1016/j.expneurol.2004.05.038
Tan, F., Qian, C., Tang, K., Abd-Allah, S. M., & Jing, N. (2015). Inhibition of
transforming growth factor ?? (TGF-??) signaling can substitute for Oct4
protein in reprogramming and maintain pluripotency. Journal of Biological
Chemistry, 290(7), 4500–4511. doi: 10.1074/jbc.M114.609016
Tanaka, E. M. (2003). Regeneration: If they can do it, why can’t we? Cell, 113(5),
559–562. doi: 10.1016/S0092-8674(03)00395-7
Tirado-Magallanes, R., Rebbani, K., Lim, R., Pradhan, S., & Benoukraf, T. (2017).
Whole genome DNA methylation: beyond genes silencing. Oncotarget,
8(3), 5629–5637. Retrieved from http://www.oncotarget.com/abstract/
13562 doi: 10.18632/oncotarget.13562
Tokumoto, Y. M., Durand, B., & Raff, M. C. (1999). An analysis of the early events
when oligodendrocyte precursor cells are triggered to differentiate by thyroid
hormone, retinoic acid, or PDGF withdrawal. Developmental biology, 213(2),
327–339. doi: 10.1006/dbio.1999.9397
Tsai, H.-H., Niu, J., Munji, R., Davalos, D., Chang, J., Zhang, H., . . . Fancy, S. P. J.
(2016). Oligodendrocyte precursors migrate along vasculature in the developing
nervous system. Science, 351(6271), 379–384. doi: 10.1126/science.aad3839
Tyler, W. a., Gangoli, N., Gokina, P., Kim, H. a., Covey, M., Levison, S. W., &
Wood, T. L. (2009). Activation of the mammalian target of rapamycin (mTOR)
is essential for oligodendrocyte differentiation. The Journal of neuroscience




Vana, A. C., Lucchinetti, C. F., Le, T. Q., & Armstrong, R. C. (2007, may). Myelin
transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and
human CNS. Glia, 55(7), 687–697. Retrieved from http://doi.wiley.com/
10.1002/glia.20492 doi: 10.1002/glia.20492
Vargas, M. E., & Barres, B. A. (2007). Why Is Wallerian Degen-
eration in the CNS So Slow? Annual Review of Neuroscience,




Vela, J. M., Molina-Holgado, E., Arévalo-Martín, Á., Almazán, G., & Guaza, C. (2002).
Interleukin-1 Regulates Proliferation and Differentiation of Oligodendrocyte
Progenitor Cells. Molecular and Cellular Neuroscience, 20(3), 489–502. doi:
10.1006/mcne.2002.1127
Voskuhl, R. R., & Palaszynski, K. (2001). Sex hormones in experimental autoimmune
190 References
encephalomyelitis: implications for multiple sclerosis. Neuroscientist, 7(3),
258–270. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query
.fcgi?cmd=Retrieve{&}db=PubMed{&}dopt=Citation{&}list{_}uids=
11499404 doi: 10.1177/107385840100700310
Waddington, C. H. (2012). The epigenotype. International journal of epidemiol-
ogy, 41(1), 10–13. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
22186258 doi: 10.1093/ije/dyr184
Wang, S., Sdrulla, A., Johnson, J. E., Yokota, Y., & Barres, B. A. (2001). A role for
the helix-loop-helix protein Id2 in the control of oligodendrocyte development.
Neuron, 29(3), 603–614. doi: 10.1016/S0896-6273(01)00237-9
Wang, S., Sdrulla, A. D., DiSibio, G., Bush, G., Nofziger, D., Hicks, C., . . . Barres,
B. A. (1998). Notch receptor activation inhibits oligodendrocyte differentiation.
Neuron, 21(1), 63–75. doi: 10.1016/S0896-6273(00)80515-2
Windrem, M. S., Nunes, M. C., Rashbaum, W. K., Schwartz, T. H., Goodman, R. A.,
McKhann, G., . . . Goldman, S. A. (2004). Fetal and adult human oligoden-
drocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain.
Nature Medicine, 10(1), 93–97. Retrieved from http://www.nature.com/
doifinder/10.1038/nm974 doi: 10.1038/nm974
Witten, J. T., Zarnack, K., Tollervey, J. R., Wang, Z., Hortoba, T., Kayikci, M., . . .
Ule, J. (2011a). Analysis of alternative splicing associated with aging and
neurodegeneration in the human brain. Genome Research, 1572–1582. doi:
10.1101/gr.122226.111.1572
Witten, J. T., Zarnack, K., Tollervey, J. R., Wang, Z., Hortoba, T., Kayikci, M., . . .
Ule, J. (2011b). Analysis of alternative splicing associated with aging and
neurodegeneration in the human brain. Genome Research, 1572–1582. doi:
10.1101/gr.122226.111.1572
Wolffe, A. P., Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. a., &
Jones, P. L. (2000, jul). No Title. Nature Genetics, 25(3), 338–342. Re-
trieved from http://www.ncbi.nlm.nih.gov/pubmed/10888886http://
www.nature.com/doifinder/10.1038/77124 doi: 10.1038/77124
Wolswijk, G. (1998, jan). Chronic stage multiple sclerosis lesions contain a relatively
quiescent population of oligodendrocyte precursor cells. The Journal of neu-
roscience : the official journal of the Society for Neuroscience, 18(2), 601–9.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9425002
Wolswijk, G., & Noble, M. (1992). Cooperation between PDGF and FGF converts
slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with char-
acteristics of O-2Aperinatal progenitor cells. Journal of Cell Biology, 118(4),
889–900. doi: 10.1083/jcb.118.4.889
Wolswijk, G., Riddle, P. N., & Noble, M. (1991). Platelet-Derived Growth Factor Is
Mitogenic for 0-2A Progenitor Cells. Glia, 4(5), 495–503.
Woodcock, D. M., Lawler, C. B., Linsenmeyer, M. E., Doherty, J. P., & Warren, W. D.
(1997). Asymmetric methylation in the hypermethylated CpG promoter region
of the human L1 retrotransposon. Journal of Biological Chemistry, 272(12),
7810–7816. doi: 10.1074/jbc.272.12.7810
Woodruff, R. H., & Franklin, R. J. M. (1999). Demyelination and remyelination
of the caudal cerebellar peduncle of adult rats following stereotaxic injections
of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside:
A comparative study. Glia, 25(3), 216–228. doi: 10.1002/(SICI)1098
-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L
Woodruff, R. H., Fruttiger, M., Richardson, W. D., & Franklin, R. J. (2004,
References 191
feb). Platelet-derived growth factor regulates oligodendrocyte progeni-
tor numbers in adult CNS and their response following CNS demyeli-




Wu, H., Coskun, V., Tao, J., Xie, W., Ge, W., Yoshikawa, K., . . . Sun, Y. E. (2010,
jul). Dnmt3a-dependent nonpromoter DNA methylation facilitates transcrip-




Xing, Y. L., Röth, P. T., Stratton, J. A. S., Chuang, B. H. a., Danne, J., Ellis, S. L., . . .
Merson, T. D. (2014). Adult neural precursor cells from the subventricular zone
contribute significantly to oligodendrocyte regeneration and remyelination. The
Journal of neuroscience : the official journal of the Society for Neuroscience,
34(42), 14128–46. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
25319708 doi: 10.1523/JNEUROSCI.3491-13.2014
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., . . . Ransohoff,
R. M. (2014). Differential roles of microglia and monocytes in the inflamed cen-




Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X.-h., Bu, H., . . . Lu, Q. R.
(2009, jul). HDAC1 and HDAC2 regulate oligodendrocyte differentiation
by disrupting the b -catenin–TCF interaction. Nature Neuroscience, 12(7),




Young, K., Psachoulia, K., Tripathi, R., Dunn, S.-J., Cossell, L., Attwell, D., . . .
Richardson, W. (2013, mar). Oligodendrocyte Dynamics in the Healthy




young Kim, S., Kelland, E. E., hong Kim, J., Lund, B. T., Chang, X., Wang, K., &
Weiner, L. P. (2017). The influence of retinoic acid on the human oligodendro-
cyte precursor cells by RNA-sequencing. Biochemistry and Biophysics Reports,
9(June 2016), 166–172. Retrieved from http://linkinghub.elsevier.com/
retrieve/pii/S2405580816303557 doi: 10.1016/j.bbrep.2016.12.004
Yu, P., Wang, H., Katagiri, Y., & Geller, H. M. (2012). An In Vitro Model of Reactive




Yuen, T. J., Johnson, K. R., Miron, V. E., Zhao, C., Quandt, J., Harrisingh, M. C., . . .
Ffrench-Constant, C. (2013). Identification of endothelin 2 as an inflammatory
factor that promotes central nervous system remyelination. Brain, 136(4), 1035–
192 References
1047. doi: 10.1093/brain/awt024
Zalc, B., Goujet, D., & Colman, D. (2008). The origin of the myelination program in
vertebrates. Current Biology, 18(12), 511–512. doi: 10.1016/j.cub.2008.04.010
Zawadzka, M., Rivers, L. E., Fancy, S. P. J., Zhao, C., Tripathi, R., Ja-
men, F., . . . Franklin, R. J. M. (2010). CNS-resident glial progen-
itor/stem cells produce Schwann cells as well as oligodendrocytes dur-




Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O’Keeffe, S., . . .
Wu, J. Q. (2014). An RNA-sequencing transcriptome and splicing database of
glia, neurons, and vascular cells of the cerebral cortex. Journal of Neuroscience,
34(36), 11929–11947. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/25186741 doi: 10.1523/JNEUROSCI.1860-14.2014
Zhao, C., Li, W.-w., & Franklin, R. J. (2006, sep). Differences in the early in-
flammatory responses to toxin-induced demyelination are associated with the
age-related decline in CNS remyelination. Neurobiology of Aging, 27(9), 1298–
1307. Retrieved from http://linkinghub.elsevier.com/retrieve/pii/
S0197458005001831 doi: 10.1016/j.neurobiolaging.2005.06.008
Zhao, C., Ma, D., Zawadzka, M., Fancy, S. P. J., Elis-Williams, L., Bouvier, G.,
. . . Franklin, R. J. M. (2015). Sox2 Sustains Recruitment of Oligodendro-
cyte Progenitor Cells following CNS Demyelination and Primes Them for
Differentiation during Remyelination. The Journal of neuroscience : the of-
ficial journal of the Society for Neuroscience, 35(33), 11482–99. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/26290228 doi: 10.1523/
JNEUROSCI.3655-14.2015
Zhu, L., Su, Q., Jie, X., Liu, A., Wang, H., He, B., . . . Li, J. (2016). NG2 expression
in microglial cells affects the expression of neurotrophic and proinflammatory
factors by regulating FAK phosphorylation. Scientific Reports, 6(June), 27983.
Retrieved from http://www.nature.com/articles/srep27983 doi: 10
.1038/srep27983
Zhu, L., Xiang, P., Guo, K., Wang, A., Lu, J., Tay, S. S. W., . . . He, B. P. (2012,
sep). Microglia/monocytes with NG2 expression have no phagocytic function
in the cortex after LPS focal injection into the rat brain. Glia, 60(9), 1417–
1426. Retrieved from http://doi.wiley.com/10.1002/glia.22362 doi:
10.1002/glia.22362
